Ensembl_ID	Gene_symbol	logFC	FDR	Comparison	LncBook ID	Type	Conservation	miRNA	GWAS	nearest PC
ENSG00000291077	ENSG00000291077	-5.19941260921399	1.54825206708962e-21	MSU_vs_LPS	NA	NA	NA	NA	NA	ARHGEF19
ENSG00000197536	IRF1-AS1	-4.02318336630262	3.9657047880830996e-19	MSU_vs_LPS	HSALNG0044848	anti_sense,sense	Q50	hsa-miR-33b-5p,hsa-miR-4257,hsa-miR-4463,hsa-miR-6748-3p,hsa-miR-6803-5p	Fibrinogen measurement,Chronic obstructive pulmonary disease,Metabolite measurement,Apolipoprotein b measurement,Glycine measurement,Red blood cell distribution width,Neutrophil percentage of leukocytes,Ulcerative colitis; Diastolic blood pressure; Inflammatory bowel disease; Crohn's disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Adult onset asthma; Sclerosing cholangitis,Fibrinogen measurement; Sex hormone-binding globulin measurement,Urinary albumin to creatinine ratio,Diastolic blood pressure; Crohn's disease,Atopic asthma,Eosinophil count; Eosinophil percentage of leukocytes,Mean corpuscular hemoglobin,Nasal cavity polyp; Perceived unattractiveness to mosquitos measurement; Adult onset asthma,Serum metabolite measurement; Low density lipoprotein cholesterol measurement; Crohn's disease; Eczema; Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis; Rheumatoid arthritis; Aspartate aminotransferase measurement,Respiratory system disease; Adult onset asthma,Carotid plaque build,Low density lipoprotein cholesterol measurement,Chronic obstructive pulmonary disease; Smoking status measurement,Neutrophil count,Fibrinogen measurement; Lymphocyte count,Polycystic ovary syndrome,Fibrinogen measurement; Sex hormone-binding globulin measurement; Balding measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes; Mosquito bite reaction itch intensity measurement; Basophil count; Mosquito bite reaction size measurement; Eosinophil percentage of leukocytes; Eosinophil count,Mitochondrial dna measurement,Estrogen-receptor positive breast cancer; Breast carcinoma,Inhalant adrenergic use measurement,Cardiovascular disease,Eosinophil count,Diastolic blood pressure,Lymphocyte percentage of leukocytes,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Platelet count,Platelet crit,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Eczema; Allergic rhinitis,Fev/fec ratio,Autoimmune thyroid disease; Psoriasis; Common variable immunodeficiency; Mosquito bite reaction itch intensity measurement; Ulcerative colitis; Ankylosing spondylitis; Basophil count; Systemic lupus erythematosus; Crohn's disease; Mosquito bite reaction size measurement; Celiac disease; Autoimmune disease; Juvenile idiopathic arthritis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Leukocyte count; Crohn's disease; Eosinophil percentage of leukocytes; Eosinophil count; Sclerosing cholangitis; Aspartate aminotransferase measurement,Hemoglobin a1 measurement,Reticulocyte count; Reticulocyte measurement,-	NA
ENSG00000197989	SNHG12	2.2838644870719	6.60180367002299e-19	MSU_vs_LPS	HSALNG0002075	anti_sense	Q50	hsa-miR-363-5p,hsa-miR-324-5p,hsa-miR-3178,hsa-miR-4466,hsa-miR-6089,hsa-miR-6890-3p	-	TAF12
ENSG00000237232	ZNF295-AS1	5.02668698037336	1.20004227860145e-18	MSU_vs_LPS	HSALNG0133274	integenic	Not conserved	hsa-miR-8485		UMODL1
ENSG00000272449	ENSG00000272449	4.02895405855418	3.2063521480710297e-18	MSU_vs_LPS	HSALNG0000274	integenic	Not conserved	hsa-miR-8485		TNFRSF14
ENSG00000251230	MIR3945HG	-5.07213471438494	1.60765385671431e-17	MSU_vs_LPS	HSALNG0039050	integenic	Not conserved	hsa-miR-619-5p	Mean platelet volume,Mean reticulocyte volume,-	ACSL1
ENSG00000278330	ENSG00000278330	4.33489357672067	1.69018146102287e-17	MSU_vs_LPS	HSALNG0122607	anti_sense	Not conserved		-	GALR1
ENSG00000253891	ENSG00000253891	-5.72841883922316	2.39463825224957e-17	MSU_vs_LPS	HSALNG0064035	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1249-5p,hsa-miR-4447,hsa-miR-4463,hsa-miR-4505,hsa-miR-7106-5p	Bmi-adjusted waist circumference; Body height; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Body height,Ankylosing spondylitis,Cleft palate,Necrotizing enterocolitis,Hair colour measurement,Susceptibility to scarlet fever measurement,White matter integrity,Corneal endothelial cell measurement,Idiopathic dilated cardiomyopathy,Mathematical ability,Age at onset,Nicotine withdrawal symptom count,Pallidum volume,Myopia,Brain volume measurement,Seasonality measurement,Interleukin-6 measurement,Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,Fev/fec ratio; Response to bronchodilator,Myocarditis; Response to clozapine,Cingulate cortex measurement; Amyloid-beta measurement,Brain volume measurement; Neuroimaging measurement,-	STC1
ENSG00000258667	HIF1A-AS3	5.5826999335413	3.3909837017018702e-15	MSU_vs_LPS	HSALNG0101781	anti_sense	Q50	hsa-miR-619-5p	-	TMEM30B
ENSG00000225964	NRIR	-7.03551932026352	4.3838052022164e-15	MSU_vs_LPS	HSALNG0012717	integenic	Q75		Depressive symptom measurement,-	CMPK2
ENSG00000263574	ENSG00000263574	9.30749567720177	3.11165910779635e-14	MSU_vs_LPS	HSALNG0118605	integenic	Q50		Body mass index,-	RPL38
ENSG00000285744	ENSG00000285744	-5.01379120864856	5.5302246432622e-14	MSU_vs_LPS	HSALNG0066417	integenic	Not conserved			ZC2HC1A
ENSG00000266709	ENSG00000266709	-3.49355630690511	6.3863340904158e-14	MSU_vs_LPS	HSALNG0114719	intronic_sense	Q50			HS3ST3B1
ENSG00000290525	GBP1P1	-5.26650321088419	1.2353572127831599e-13	MSU_vs_LPS	NA	NA	NA	NA	NA	GBP6
ENSG00000239445	ST3GAL6-AS1	3.23972243264507	1.75411246715616e-13	MSU_vs_LPS	HSALNG0027499	anti_sense	Q50	hsa-miR-937-5p	Leukocyte count; Monocyte count,Vascular endothelial growth factor receptor 3 measurement,Monocyte percentage of leukocytes,Eosinophil count,Keratinocyte carcinoma; Basal cell carcinoma,Leukocyte count,Eosinophil count; Skin neoplasm,Eosinophil count; Eosinophil percentage of leukocytes,Unipolar depression,Non-melanoma skin carcinoma,-	DCBLD2
ENSG00000231808	LINC01388	-6.18742877313335	2.05455895388638e-13	MSU_vs_LPS	HSALNG0069521	integenic	Not conserved	hsa-miR-4722-5p	-	FOXD4
ENSG00000230149	ENSG00000230149	-3.60608182410573	3.09239914816817e-13	MSU_vs_LPS	HSALNG0135439	anti_sense,sense	Q90	hsa-miR-1227-5p,hsa-miR-500b-3p	White matter microstructure measurement,-	GTPBP1
ENSG00000290793	ENSG00000290793	3.78302732454784	3.33603079337477e-13	MSU_vs_LPS	NA	NA	NA	NA	NA	AMZ2
ENSG00000226004	LINC02528	-7.1977743359094	3.86292845659191e-13	MSU_vs_LPS	HSALNG0053802	integenic	Q50		Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,-	PERP
ENSG00000276462	LINC03025	-4.81280436609182	7.45656289870364e-13	MSU_vs_LPS	HSALNG0071581	integenic	Not conserved			FOXD4L6
ENSG00000185433	LINC00158	-4.73969516389856	1.1128071026348899e-12	MSU_vs_LPS	HSALNG0132374	integenic	Not conserved			MRPL39
ENSG00000223960	CHROMR	-2.04463322880688	1.4316281065444599e-12	MSU_vs_LPS	HSALNG0020702	anti_sense	Q50	hsa-miR-6089	Blood protein measurement,Psoriasis; Atopic eczema,-,Oligoclonal band measurement	OSBPL6
ENSG00000225450	ENSG00000225450	-4.4936242466526	2.00460034570891e-12	MSU_vs_LPS	HSALNG0135443	anti_sense	Not conserved	hsa-miR-6779-5p		GTPBP1
ENSG00000272669	ENSG00000272669	-3.26707763857326	2.00611156864891e-12	MSU_vs_LPS	HSALNG0135442	anti_sense	Not conserved	hsa-miR-210-5p,hsa-miR-6763-3p		GTPBP1
ENSG00000232618	HIVEP2-DT	-4.19343027522417	3.2254563604654998e-12	MSU_vs_LPS	HSALNG0054003	anti_sense	Q50	hsa-miR-4279	Mean platelet volume,-	AIG1
ENSG00000248429	GASK1B-AS1	2.90234248300106	3.72358501073002e-12	MSU_vs_LPS	HSALNG0038152	anti_sense,sense	Q50	hsa-miR-486-3p,hsa-miR-4466	Blood osmolality measurement,-	TMEM144
ENSG00000282851	BISPR	-2.43443999867938	4.46339819425302e-12	MSU_vs_LPS	HSALNG0124521	sense	Not conserved	hsa-miR-6775-3p	Blood phosphate measurement,-	MVB12A
ENSG00000259354	ENSG00000259354	-2.7626449223245	5.73971901976024e-12	MSU_vs_LPS	HSALNG0105653	intronic_antisense	Not conserved			C15orf48
ENSG00000256262	USP30-AS1	-4.59506733644286	5.90782591507879e-12	MSU_vs_LPS	HSALNG0093872	anti_sense	Not conserved	hsa-miR-4467,hsa-miR-3960	Platelet-to-lymphocyte ratio; Platelet count; Platelet crit,-	SVOP
ENSG00000238045	MVP-DT	-4.37352945534149	9.068863631755009e-12	MSU_vs_LPS	HSALNG0144898	anti_sense	Q90	hsa-miR-4745-3p		CDIPT
ENSG00000260708	TBC1D22A-DT	3.7667289015177	1.0055566910486699e-11	MSU_vs_LPS	HSALNG0136034	integenic	Not conserved			CERK
ENSG00000267737	ENSG00000267737	-6.53882402026311	1.3390186899609698e-11	MSU_vs_LPS	HSALNG0119029	integenic	Not conserved			PGS1
ENSG00000103472	RRN3P2	5.40075053307789	1.9939559160994397e-11	MSU_vs_LPS	HSALNG0110562	integenic	Not conserved			LAT
ENSG00000255197	ENSG00000255197	1.75412098243477	4.50757994854631e-11	MSU_vs_LPS	HSALNG0143174	anti_sense	Q90		Alcohol consumption measurement	SPI1
ENSG00000274461	LINC02930	4.43760510669913	7.20350882477567e-11	MSU_vs_LPS	HSALNG0081109	integenic	Not conserved		Adolescent idiopathic scoliosis,Left inferior lateral ventricle volume measurement; T-tau measurement; Cerebrospinal fluid biomarker measurement,-	PLPP4
ENSG00000287263	ENSG00000287263	-2.47508390994878	2.05092611146087e-10	MSU_vs_LPS	HSALNG0041483	integenic	Not conserved	hsa-miR-6807-3p	Intelligence,Cytokine measurement	ANXA2R
ENSG00000223969	ENSG00000223969	4.74241790061501	4.4035304111374103e-10	MSU_vs_LPS	HSALNG0059467	anti_sense	Q75		-	FAM237B
ENSG00000226137	BAIAP2-DT	2.53892054379594	4.6022870944288e-10	MSU_vs_LPS	HSALNG0119226	integenic	Not conserved	hsa-miR-3943	-	AATK
ENSG00000268858	ENSG00000268858	1.55314716619393	5.97793070660145e-10	MSU_vs_LPS	HSALNG0131701	anti_sense	Q75	hsa-miR-1227-5p,hsa-miR-4281,hsa-miR-6791-5p,hsa-miR-6816-5p,hsa-miR-6852-5p	-	ZBTB46
ENSG00000253838	ENSG00000253838	-5.05923587394196	1.09015362337887e-9	MSU_vs_LPS	HSALNG0150187	sense	Q50		-	IDO1
ENSG00000234741	GAS5	2.04608978935712	1.3748720391664e-9	MSU_vs_LPS	HSALNG0008545	anti_sense	Q50	hsa-miR-4292	Intelligence,Body height,Erythrocyte count,Hematocrit; Hemoglobin measurement,-,Red blood cell density measurement; Erythrocyte count	CENPL
ENSG00000261618	LINC02605	-4.04187750067276	1.5232919960981502e-9	MSU_vs_LPS	HSALNG0150243	integenic	Not conserved		Platelet-to-lymphocyte ratio; Lymphocyte count	ZC2HC1A
ENSG00000275202	ENSG00000275202	3.20321815058356	1.6317221535965202e-9	MSU_vs_LPS	HSALNG0097019	anti_sense	Q75	hsa-miR-4268,hsa-miR-4280,hsa-miR-3960,hsa-miR-4707-5p	-	CAB39L
ENSG00000253982	CLN8-AS1	2.02136121494349	2.07284187213973e-9	MSU_vs_LPS	HSALNG0062950	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-1225-3p,hsa-miR-6165,hsa-miR-6727-3p		ERICH1
ENSG00000204054	LINC00963	1.95273353811453	3.66964029969439e-9	MSU_vs_LPS	HSALNG0074742	integenic	Q75	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-378g,hsa-miR-4686,hsa-miR-2467-5p,hsa-miR-5088-5p,hsa-miR-6089,hsa-miR-6742-5p,hsa-miR-6803-5p	Body height,-	NTMT1
ENSG00000219665	ZNF433-AS1	2.75025581722328	3.83587440992872e-9	MSU_vs_LPS	HSALNG0124080	anti_sense,sense	Q75	hsa-miR-619-5p,hsa-miR-4290,hsa-miR-4488,hsa-miR-6735-5p	Corneal endothelial cell measurement,Heel bone mineral density,-	NA
ENSG00000230631	ENSG00000230631	-6.29722816281834	4.00982094645194e-9	MSU_vs_LPS	HSALNG0048221	integenic	Not conserved	hsa-miR-920	Cytokine measurement,-	MCUR1
ENSG00000226281	ENSG00000226281	3.43598919721476	4.02216067446098e-9	MSU_vs_LPS	HSALNG0047836	integenic	Not conserved	hsa-miR-762,hsa-miR-5787		F13A1
ENSG00000270640	ENSG00000270640	3.66556656593837	5.129797621529281e-9	MSU_vs_LPS	HSALNG0013867	intronic_sense	Q90		-	FOSL2
ENSG00000260360	ENSG00000260360	-3.77375853557171	6.182149767560971e-9	MSU_vs_LPS	HSALNG0008786	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-10392-3p	Prostate carcinoma,-	TOR1AIP2
ENSG00000275210	ENSG00000275210	-4.10335999708618	7.437801653861011e-9	MSU_vs_LPS	NA	NA	NA	NA	NA	LILRA4
ENSG00000204261	PSMB8-AS1	-1.98993153597348	7.84053605871763e-9	MSU_vs_LPS	HSALNG0049455	anti_sense,sense	Q75		Systemic lupus erythematosus,Iga glomerulonephritis,Kidney disease,-,Platelet-to-lymphocyte ratio,Autoimmune disease	PSMB9
ENSG00000270120	ENSG00000270120	-4.20339557445415	1.01092089040517e-8	MSU_vs_LPS	HSALNG0111360	sense	Q50			NOD2
ENSG00000283213	ENSG00000283213	5.7544520291815	1.01417319728933e-8	MSU_vs_LPS	HSALNG0110217	anti_sense	Q90		-	USP31
ENSG00000269893	SNHG8	1.94628174219995	1.0185029177728e-8	MSU_vs_LPS	HSALNG0036656	anti_sense	Q75		-	NDST3
ENSG00000232956	SNHG15	-1.67195559626587	1.16961890054806e-8	MSU_vs_LPS	HSALNG0057702	anti_sense,sense	Q50	hsa-miR-4726-3p,hsa-miR-7107-5p	Body height,Diastolic blood pressure,-	MYO1G
ENSG00000276900	ENSG00000276900	4.58140562225019	1.23302203278146e-8	MSU_vs_LPS	HSALNG0143376	anti_sense	Not conserved	hsa-miR-363-5p,hsa-miR-6089	-	ETFBKMT
ENSG00000178803	ADORA2A-AS1	-3.17128413672797	1.51682108590484e-8	MSU_vs_LPS	HSALNG0134495	anti_sense	Q50	hsa-miR-370-3p,hsa-miR-6807-3p	Alcohol consumption measurement,Acne,Sodium measurement,Glucagon measurement,Coffee consumption measurement,Supramarginal gyrus volume measurement,Tea consumption measurement,Cups of coffee per day measurement,Serum gamma-glutamyl transferase measurement,Coffee consumption measurement; Tea consumption measurement,Alcohol use disorder measurement; Alcohol consumption measurement,-	GUCD1
ENSG00000270069	MIR222HG	3.99142307018987	1.99723202613469e-8	MSU_vs_LPS	HSALNG0137593	integenic	Q90	hsa-miR-574-5p,hsa-miR-1343-3p,hsa-miR-6803-5p,hsa-miR-6873-3p,hsa-miR-9899	Body height; Inguinal hernia; Body weight	DIPK2B
ENSG00000230647	ENSG00000230647	-4.20944225102029	2.42364627379255e-8	MSU_vs_LPS	HSALNG0145008	integenic	Q75	hsa-miR-619-5p	Heel bone mineral density,-	HS3ST3B1
ENSG00000257354	MIRLET7IHG	-2.26247145353663	2.6145325414535e-8	MSU_vs_LPS	HSALNG0091856	integenic	Q50	hsa-miR-4286	Waist circumference,-	MON2
ENSG00000224307	LINC02975	3.71439388322965	2.62563551732175e-8	MSU_vs_LPS	HSALNG0074715	integenic	Not conserved	hsa-miR-520a-5p,hsa-miR-4492,hsa-miR-4684-3p,hsa-miR-4748,hsa-miR-5693		NA
ENSG00000274605	PCCA-DT	4.23269471778845	2.63543036297647e-8	MSU_vs_LPS	HSALNG0098967	integenic	Q50			ZIC5
ENSG00000260911	ENSG00000260911	3.58287285576836	4.45108643305828e-8	MSU_vs_LPS	HSALNG0110810	integenic	Not conserved			STX4
ENSG00000233038	PTPRN2-AS1	3.69356693598629	5.06935055269886e-8	MSU_vs_LPS	HSALNG0062762	anti_sense	Not conserved	hsa-miR-762,hsa-miR-3195,hsa-miR-4297,hsa-miR-5787,hsa-miR-6813-5p,hsa-miR-7113-3p	-	DNAJB6
ENSG00000260898	ADPGK-AS1	-2.48414665121514	5.70539523828979e-8	MSU_vs_LPS	HSALNG0107094	anti_sense	Q75	hsa-miR-484,hsa-miR-6089,hsa-miR-6848-5p,hsa-miR-8485	Urate measurement,Grip strength measurement,Body weight,Vital capacity,Body mass index,Body mass index; Visceral adipose tissue measurement,Triglyceride measurement; Body mass index,-	BBS4
ENSG00000261087	ZNNT1	4.26066806470615	6.48733054067894e-8	MSU_vs_LPS	HSALNG0067345	integenic	Not conserved			ZNF706
ENSG00000230438	SERPINB9P1	-3.68148095214092	6.97196960413112e-8	MSU_vs_LPS	HSALNG0047525	integenic	Not conserved			SERPINB9
ENSG00000291066	ENSG00000291066	2.58351645990238	8.63803183005176e-8	MSU_vs_LPS	HSALNG0110139	integenic	Not conserved	hsa-miR-619-5p	-	NPIPB4
ENSG00000275454	ENSG00000275454	5.20149768029438	8.71480050629191e-8	MSU_vs_LPS	HSALNG0107302	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-6752-5p	Sex hormone-binding globulin measurement,Creatinine measurement; Serum urea measurement; Glomerular filtration rate; Response to radiation,Breast carcinoma,-	SNX33
ENSG00000224821	COL4A2-AS2	4.0775035678312	8.85093813906524e-8	MSU_vs_LPS	NA	NA	NA	NA	NA	RAB20
ENSG00000224789	ENSG00000224789	-4.50269690968456	9.98385508568751e-8	MSU_vs_LPS	HSALNG0018360	anti_sense,sense	Q75		Serum albumin measurement,Glucuronate measurement,Glomerular filtration rate,-	TMEM185B
ENSG00000236901	MIR600HG	3.67538541783227	1.01993206463382e-7	MSU_vs_LPS	HSALNG0074272	sense	Not conserved		-	STRBP
ENSG00000290241	ENSG00000290241	5.25616843615809	1.62351982179448e-7	MSU_vs_LPS	HSALNG0028834	integenic	Not conserved			ACAD9
ENSG00000274213	ENSG00000274213	2.9136580110767	1.62621872607219e-7	MSU_vs_LPS	HSALNG0117605	integenic	Not conserved	hsa-miR-500b-3p	-	DGKE
ENSG00000239213	NCK1-DT	2.6787763657682	1.73285257541465e-7	MSU_vs_LPS	HSALNG0029189	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-135a-3p,hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4447,hsa-miR-3960,hsa-miR-6089	Lymphocyte count,Body mass index,-	STAG1
ENSG00000286940	MICB-DT	-3.96428286956436	1.86909640016583e-7	MSU_vs_LPS	HSALNG0049272	anti_sense	Not conserved	hsa-miR-4701-3p,hsa-miR-6089	Renal system measurement,Myositis,Polymyositis; Physical activity measurement; Bmi-adjusted waist-hip ratio; Myositis,Eosinophil count; Platelet count,Squamous cell lung carcinoma; Mmr-related febrile seizures; Bmi-adjusted waist circumference; Lung carcinoma; Eosinophil count,Appendicular lean mass,Glucose measurement,Visual perception measurement,Carpal tunnel syndrome,Herpes zoster,Thyrotoxic periodic paralysis,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Eosinophil percentage of leukocytes,Bmi-adjusted hip circumference,Eosinophil count,Susceptibility to childhood ear infection measurement,Body height,Neonatal systemic lupus erythematosus; Myositis; Metabolic syndrome,Hodgkins lymphoma,Lymphocyte count; Basophil count; Myositis; Leukocyte count; Monocyte count,Ulcerative colitis,Atopic asthma,Serum alanine aminotransferase measurement,Bmi-adjusted waist-hip ratio; Mhc class i polypeptide-related sequence b measurement,Angina pectoris,Clinical treatment,Beta blocking agent use measurement,Blood protein measurement; Susceptibility to mumps measurement,Anti-tetanus toxoid igg measurement; Response to vaccine; Malaria,Arterial stiffness measurement,Bmi-adjusted waist circumference; Autism spectrum disorder; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to plantar warts measurement,Mhc class i polypeptide-related sequence a measurement,Mhc class i polypeptide-related sequence b measurement,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Autism spectrum disorder,Alcohol use disorder measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Cytokine measurement,Testosterone measurement,Monocyte count,Platelet crit,Lobe attachment; Lymphocyte count,Bmi-adjusted waist circumference,Response to thioamide; Drug-induced agranulocytosis,Prion disease; Psychotic symptoms,Response to bezlotoxumab; Clostridium difficile infection,Colorectal cancer; Colorectal adenoma,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Human papilloma virus infection; Oropharynx cancer,Blood protein measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference	ATP6V1G2-DDX39B
ENSG00000262580	ENSG00000262580	2.00194477731559	2.18565063674337e-7	MSU_vs_LPS	HSALNG0119173	anti_sense	Q50		Fasting blood glucose measurement,-,Psoriasis; Hirschsprung disease	SGSH
ENSG00000225032	ENSG00000225032	-3.43240471097299	2.20072757067392e-7	MSU_vs_LPS	HSALNG0074542	anti_sense	Q50	hsa-miR-6089	-	FPGS
ENSG00000267270	PARD6G-AS1	2.97826511864734	2.74978405439273e-7	MSU_vs_LPS	HSALNG0122821	anti_sense,sense	Q50	hsa-miR-33b-3p	-	ADNP2
ENSG00000286511	ENSG00000286511	-3.64479893843842	2.87154466810392e-7	MSU_vs_LPS	HSALNG0052591	integenic	Not conserved	hsa-miR-619-5p	Serum albumin measurement,Risk-taking behaviour,-	ARMC2
ENSG00000262097	LINC02185	3.7572503471099	3.00229413505307e-7	MSU_vs_LPS	HSALNG0109713	integenic	Q50	hsa-miR-645,hsa-miR-4330,hsa-miR-4453	-	PARN
ENSG00000266970	SOCS3-DT	-3.39565966371307	4.57798936365317e-7	MSU_vs_LPS	HSALNG0119032	integenic	Q50	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-4639-3p,hsa-miR-6089,hsa-miR-6794-5p,hsa-miR-6803-5p	Creativity measurement,Heel bone mineral density,C-reactive protein measurement,-	PGS1
ENSG00000230844	ZNF674-AS1	3.25432733241593	5.10707576037165e-7	MSU_vs_LPS	HSALNG0137651	anti_sense	Not conserved			CHST7
ENSG00000244491	ENSG00000244491	-4.97531473579536	5.67033949538177e-7	MSU_vs_LPS	HSALNG0135439	anti_sense,sense	Q90	hsa-miR-1227-5p,hsa-miR-500b-3p	White matter microstructure measurement,-	GTPBP1
ENSG00000226950	DANCR	2.19837215549914	6.19934103837871e-7	MSU_vs_LPS	HSALNG0148096	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-7108-3p	Response to citalopram; Mood disorder; Response to escitalopram; Unipolar depression,-	RASL11B
ENSG00000289942	ENSG00000289942	-4.99758831015442	7.04908231654391e-7	MSU_vs_LPS	NA	NA	NA	NA	NA	TMPRSS11E
ENSG00000242125	SNHG3	1.68420068385033	7.62758335435278e-7	MSU_vs_LPS	HSALNG0002066	sense	Not conserved	hsa-miR-30b-3p,hsa-miR-4492,hsa-miR-5787,hsa-miR-6890-5p	Systolic blood pressure,Nighttime rest measurement,-	RCC1
ENSG00000224945	ENSG00000224945	5.62145888995935	7.70935943836115e-7	MSU_vs_LPS	HSALNG0072581	sense	Not conserved			SHC3
ENSG00000290013	ENSG00000290013	2.82353647174625	8.35206820226425e-7	MSU_vs_LPS	NA	NA	NA	NA	NA	JUN
ENSG00000269951	ENSG00000269951	3.61711018315398	1.21327933750899e-6	MSU_vs_LPS	HSALNG0107375	sense	Q75			TSPAN3
ENSG00000289425	ENSG00000289425	-4.24489375363746	1.25300069428548e-6	MSU_vs_LPS	NA	NA	NA	NA	NA	RABGAP1L
ENSG00000289852	ENSG00000289852	5.01329486836064	1.30871182578036e-6	MSU_vs_LPS	HSALNG0096744	integenic	Q50		Dupuytren contracture; Chronic obstructive pulmonary disease,Heel bone mineral density,Body height,Peripheral arterial disease; Traffic air pollution measurement,Cortical thickness,-	SERP2
ENSG00000227076	ENSG00000227076	4.05651070229163	1.39986996444429e-6	MSU_vs_LPS	HSALNG0081497	sense	Not conserved	hsa-miR-548b-3p,hsa-miR-937-5p,hsa-miR-4472,hsa-miR-6780b-5p	Response to drug,-	PTPRE
ENSG00000289015	ENSG00000289015	2.423165417627	1.41795702302938e-6	MSU_vs_LPS	HSALNG0058614	anti_sense	Not conserved		-	SBDS
ENSG00000251022	THAP9-AS1	1.67634885593661	1.44462527008166e-6	MSU_vs_LPS	HSALNG0035549	anti_sense,sense	Not conserved		Neutrophil percentage of leukocytes,Eosinophil count,-	SEC31A
ENSG00000230943	LINC02541	-2.47041249815128	1.49982887104539e-6	MSU_vs_LPS	HSALNG0052910	integenic	Not conserved			HDAC2
ENSG00000228315	GUSBP11	1.87158959055244	1.5080934397457e-6	MSU_vs_LPS	HSALNG0134423	integenic	Not conserved		Adolescent idiopathic scoliosis	DRICH1
ENSG00000288879	ENSG00000288879	4.87528339054054	1.51530791690656e-6	MSU_vs_LPS	HSALNG0049604	integenic	Q75	hsa-miR-3195,hsa-miR-4292,hsa-miR-6803-5p	Body height,Bmi-adjusted waist circumference,Mean corpuscular volume,Mean corpuscular hemoglobin,-	SMIM29
ENSG00000267519	MIR23AHG	1.48638794596317	1.5206224251124e-6	MSU_vs_LPS	HSALNG0124251	anti_sense	Q90		Waist-hip ratio,Neutrophil-to-lymphocyte ratio; Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Leukocyte count; Lymphocyte count; Myeloid white cell count,Leukocyte count; Lymphocyte count,Lymphocyte count,Fev/fec ratio; Monocyte count,Leukocyte count,Myeloid white cell count; Lymphocyte count,Cortical thickness,-	BRME1
ENSG00000269902	ENSG00000269902	5.94865303809199	1.77088809361387e-6	MSU_vs_LPS	HSALNG0137593	integenic	Q90	hsa-miR-574-5p,hsa-miR-1343-3p,hsa-miR-6803-5p,hsa-miR-6873-3p,hsa-miR-9899	Body height; Inguinal hernia; Body weight	DIPK2B
ENSG00000288863	ENSG00000288863	3.69882205050131	1.90037975161154e-6	MSU_vs_LPS	HSALNG0143506	intronic_sense	Not conserved			PLBD2
ENSG00000285103	ENSG00000285103	-2.64502268945158	2.00234174562597e-6	MSU_vs_LPS	HSALNG0070557	anti_sense	Q75	hsa-miR-874-3p	Sporadic amyotrophic lateral sclerosis,Heart failure,-	IFNK
ENSG00000275180	ENSG00000275180	-2.67416035570633	2.05299818860226e-6	MSU_vs_LPS	HSALNG0091856	integenic	Q50	hsa-miR-4286	Waist circumference,-	MON2
ENSG00000253535	ADAM7-AS1	-3.24258062129755	2.31577170830219e-6	MSU_vs_LPS	HSALNG0064058	integenic	Not conserved			NEFL
ENSG00000266378	ENSG00000266378	-4.56773473429419	2.32765724599498e-6	MSU_vs_LPS	HSALNG0114722	intronic_sense	Q50			HS3ST3B1
ENSG00000253320	MAILR	-2.58285514978593	2.4115288532406e-6	MSU_vs_LPS	HSALNG0067488	integenic	Q50			ATP6V1C1
ENSG00000250742	LINC02381	-7.18053492085678	2.97383237581157e-6	MSU_vs_LPS	HSALNG0091335	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4667-3p,hsa-miR-4749-3p,hsa-miR-5001-3p,hsa-miR-6791-3p,hsa-miR-6803-5p,hsa-miR-6769b-3p	Coronary artery disease; Myocardial infarction,Bmi-adjusted waist-hip ratio,Red blood cell distribution width,Adolescent idiopathic scoliosis,-	HOXC4
ENSG00000239911	PRKAG2-AS1	3.03150195863277	3.20640250940803e-6	MSU_vs_LPS	HSALNG0062390	anti_sense	Q90	hsa-miR-1227-5p,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-6791-5p	-	GALNTL5
ENSG00000229771	ENSG00000229771	2.93317065504469	3.21830055780078e-6	MSU_vs_LPS	HSALNG0130126	integenic	Q90		Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement	MAFB
ENSG00000260269	ENSG00000260269	4.186220907168	3.44578272628049e-6	MSU_vs_LPS	HSALNG0144573	overlap_sense,sense	Not conserved	hsa-miR-619-5p	Antibody measurement,Body height; Body weight,Creatinine measurement; Glomerular filtration rate; Cystatin c measurement,Bmi-adjusted hip circumference,-	PTPN9
ENSG00000228526	MIR34AHG	1.74088144087182	3.70082316689468e-6	MSU_vs_LPS	HSALNG0000682	integenic	Q50	hsa-miR-4279,hsa-miR-500b-3p,hsa-miR-4723-3p,hsa-miR-6724-5p,hsa-miR-6744-3p,hsa-miR-7150,hsa-miR-7152-5p	Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count; Aspartate aminotransferase measurement,Body height,Lean body mass,Linguistic error measurement; Specific language impairment,-	GPR157
ENSG00000272463	ENSG00000272463	-3.59655344456168	3.91688018813678e-6	MSU_vs_LPS	HSALNG0047304	integenic	Q50		-	EXOC2
ENSG00000260997	ENSG00000260997	-2.72414349951604	4.06040970900037e-6	MSU_vs_LPS	NA	NA	NA	NA	NA	MYO1G
ENSG00000248187	ENSG00000248187	1.97503437816134	4.38633624106264e-6	MSU_vs_LPS	HSALNG0037074	integenic	Q50	hsa-miR-6855-5p,hsa-miR-6769b-5p		PGRMC2
ENSG00000228436	RRAGC-DT	-1.77564476716443	4.56074668312802e-6	MSU_vs_LPS	HSALNG0002723	overlap_antisense,anti_sense	Q90	hsa-miR-363-5p,hsa-miR-619-5p	Protein measurement,Blood protein measurement,Kunitz-type protease inhibitor 1 measurement,Triglyceride measurement,Age at menopause,Unipolar depression,Sweet beverage consumption measurement,-	AKIRIN1
ENSG00000262533	ENSG00000262533	3.3630205496777	4.71712232090017e-6	MSU_vs_LPS	HSALNG0113878	anti_sense	Q75	hsa-miR-3178,hsa-miR-4640-3p,hsa-miR-4747-5p,hsa-miR-8485	Hepatocyte growth factor measurement,-	SMG6
ENSG00000245060	LINC00847	1.74121669621021	4.86742253802985e-6	MSU_vs_LPS	HSALNG0047201	integenic	Not conserved	hsa-miR-3960,hsa-miR-6728-3p		BTNL8
ENSG00000255031	ENSG00000255031	2.00068453148647	5.19963915764013e-6	MSU_vs_LPS	HSALNG0085213	anti_sense,sense	Q75	hsa-miR-1249-5p	-	TCIRG1
ENSG00000234394	LINC03025	-4.85530020094396	5.23875027292086e-6	MSU_vs_LPS	HSALNG0071679	sense	Q50	hsa-miR-762,hsa-miR-4447,hsa-miR-5787,hsa-miR-6124	-	PGM5
ENSG00000290427	ENSG00000290427	3.10211533373793	5.71781441750122e-6	MSU_vs_LPS	HSALNG0123614	integenic	Not conserved		Susceptibility to chronic sinus infection measurement	MBD3L2B
ENSG00000271614	ATP2B1-AS1	2.45264121535917	6.16328767007084e-6	MSU_vs_LPS	HSALNG0092957	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4787-5p,hsa-miR-6749-3p,hsa-miR-6797-5p,hsa-miR-8485	Diastolic blood pressure,Risk-taking behaviour,Pulse pressure measurement; Mean arterial pressure; Alcohol drinking; Systolic blood pressure; Agents acting on the renin-angiotensin system use measurement,Hair colour measurement,Prostate carcinoma,Calcium measurement,Heel bone mineral density,Age at onset,Body mass index,Body height; Body mass index,Coronary artery disease,Body height,Chronotype measurement,Mean corpuscular volume,Magnesium measurement,Spine bone mineral density,Febrile seizure (within the age range of 3 months to 6 years); Mmr-related febrile seizures,Volumetric bone mineral density,Bone density,Heart rate,Biological sex,Systolic blood pressure,Creatinine measurement,C-reactive protein measurement,Pulse pressure measurement; Systolic blood pressure,Optic disc size measurement,Chronotype measurement; Heel bone mineral density,Diffusing capacity of the lung for carbon monoxide,Osteoarthritis, hip, osteoarthritis, knee,Diastolic blood pressure; Alcohol consumption measurement,Response to citalopram; Response to escitalopram; Triglyceride measurement,Ischemic stroke; Coronary artery disease,Diastolic blood pressure; Smoking status measurement; Systolic blood pressure,Body fat percentage,-	TMTC3
ENSG00000256633	PDE2A-AS2	4.33083610788946	6.85259983857468e-6	MSU_vs_LPS	HSALNG0143016	anti_sense	Q90	hsa-miR-6749-5p,hsa-miR-6763-5p	-	ATG16L2
ENSG00000233975	LINC02574	-4.11153242487153	7.58672449333403e-6	MSU_vs_LPS	HSALNG0002009	integenic	Q50	hsa-miR-619-5p	Body weight,Systolic blood pressure; Pulse pressure measurement; Mean arterial pressure,Body mass index,-	IFI6
ENSG00000246273	SBF2-AS1	2.05665145213176	8.31373614734066e-6	MSU_vs_LPS	HSALNG0082633	integenic	Not conserved		Platelet count	SWAP70
ENSG00000233016	SNHG7	2.01250299326009	8.33250638962074e-6	MSU_vs_LPS	HSALNG0075291	anti_sense	Q90	hsa-miR-6089,hsa-miR-6829-3p	Body height,-	NA
ENSG00000249173	LINC01093	-3.20591247958385	8.7442923318456e-6	MSU_vs_LPS	HSALNG0039055	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6808-5p,hsa-miR-6769b-5p		ACSL1
ENSG00000259321	ENSG00000259321	-4.98508074294733	9.46705015435964e-6	MSU_vs_LPS	HSALNG0100096	anti_sense,sense	Q90	hsa-miR-619-5p	Serum igg glycosylation measurement,-	PSME1
ENSG00000289050	ENSG00000289050	3.72188657396403	1.03328217759842e-5	MSU_vs_LPS	NA	NA	NA	NA	NA	ST3GAL1
ENSG00000257924	LINC02416	-4.36940105464353	1.1718760747211e-5	MSU_vs_LPS	HSALNG0090757	integenic	Not conserved	hsa-miR-619-5p	-	PCED1B
ENSG00000235385	LINC02154	-3.64042602089792	1.18047634638381e-5	MSU_vs_LPS	HSALNG0136703	overlap_sense	Not conserved			ATXN3L
ENSG00000247271	ZBED5-AS1	1.53151063320366	1.32991721430781e-5	MSU_vs_LPS	HSALNG0082661	anti_sense	Q90	hsa-miR-4489	Heel bone mineral density,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,-	CTR9
ENSG00000274092	ENSG00000274092	3.43884576326853	1.37700097638553e-5	MSU_vs_LPS	HSALNG0110444	anti_sense	Not conserved	hsa-miR-3960,hsa-miR-4707-5p,hsa-miR-8072		NSMCE1
ENSG00000258301	VASH1-AS1	2.36440512809486	1.39332198149723e-5	MSU_vs_LPS	HSALNG0102587	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4433a-3p,hsa-miR-4447,hsa-miR-4505,hsa-miR-1587,hsa-miR-4787-5p	-	ANGEL1
ENSG00000233621	ZC3H12A-DT	-2.73775360976918	1.48119944800121e-5	MSU_vs_LPS	HSALNG0002623	integenic	Not conserved			MEAF6
ENSG00000261026	ENSG00000261026	5.59405912104327	1.51247575560252e-5	MSU_vs_LPS	HSALNG0063933	integenic	Q50	hsa-miR-503-3p	Superior temporal gyrus volume measurement,Age at onset; Refractive error; Myopia	EGR3
ENSG00000286177	ENSG00000286177	2.95957385039105	1.52111123881122e-5	MSU_vs_LPS	HSALNG0126176	anti_sense,sense	Q75		Urinary albumin to creatinine ratio; Liver fibrosis measurement; Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,-	TGFB1
ENSG00000234617	SNRK-AS1	3.01083561211788	1.55820701124942e-5	MSU_vs_LPS	HSALNG0025486	anti_sense,sense	Q90		-	ANO10
ENSG00000291136	ENSG00000291136	1.23296789510395	1.57756168077303e-5	MSU_vs_LPS	HSALNG0058610	integenic	Not conserved		Cotinine glucuronidation measurement	SBDS
ENSG00000288818	ENSG00000288818	2.4522842262121	1.60240449281242e-5	MSU_vs_LPS	HSALNG0065278	anti_sense	Q50		Leptin measurement,Mitochondrial dna measurement,Bmi-adjusted waist circumference,Comparative body size at age 10, self-reported,Quality of life during menstruation measurement; Dysmenorrheic pain measurement,-	NPBWR1
ENSG00000263050	DPH1-AS1	2.92783037199977	1.61379002263559e-5	MSU_vs_LPS	HSALNG0113878	anti_sense	Q75	hsa-miR-3178,hsa-miR-4640-3p,hsa-miR-4747-5p,hsa-miR-8485	Hepatocyte growth factor measurement,-	SMG6
ENSG00000265458	NARF-AS2	-1.82668261608082	1.70909448885485e-5	MSU_vs_LPS	HSALNG0119438	anti_sense	Not conserved	hsa-miR-3192-5p,hsa-miR-6089,hsa-miR-6871-5p	Forced expiratory volume,-	CYBC1
ENSG00000230417	LINC00595	3.75092221648623	1.77212953463536e-5	MSU_vs_LPS	HSALNG0079098	integenic	Not conserved	hsa-miR-4269		RPS24
ENSG00000271555	ENSG00000271555	4.7352697089192	1.79133700261852e-5	MSU_vs_LPS	HSALNG0065278	anti_sense	Q50		Leptin measurement,Mitochondrial dna measurement,Bmi-adjusted waist circumference,Comparative body size at age 10, self-reported,Quality of life during menstruation measurement; Dysmenorrheic pain measurement,-	NPBWR1
ENSG00000290838	NCF1B	-5.6443517531015	1.80306629339275e-5	MSU_vs_LPS	HSALNG0058823	integenic	Not conserved	hsa-miR-619-5p		FKBP6
ENSG00000291129	PPIEL	2.00202454557825	1.86898373110984e-5	MSU_vs_LPS	HSALNG0002774	anti_sense	Q90	hsa-miR-631,hsa-miR-3135b,hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-8485	Forced expiratory volume; Red blood cell distribution width; Traffic air pollution measurement; Fev/fec ratio; Peak expiratory flow; Peripheral arterial disease,Peripheral arterial disease; Alkaline phosphatase measurement; Traffic air pollution measurement,Testosterone measurement,Diastolic blood pressure,Triglyceride measurement; Mean corpuscular volume,Mean corpuscular volume; Mean corpuscular hemoglobin,Mean corpuscular hemoglobin,High density lipoprotein cholesterol measurement; Waist-hip ratio,Triglyceride measurement; C-reactive protein measurement; Waist-hip ratio,Chronic obstructive pulmonary disease; Resting heart rate,-	PABPC4
ENSG00000257696	UHRF1BP1L-DT	5.14675970536055	1.92133555053218e-5	MSU_vs_LPS	HSALNG0093431	integenic	Not conserved			ACTR6
ENSG00000271646	IRF2-DT	-3.32226135812469	1.93841668922308e-5	MSU_vs_LPS	HSALNG0039019	integenic	Q75	hsa-miR-4466,hsa-miR-6749-3p	-	PRIMPOL
ENSG00000254325	ENSG00000254325	-4.32519398243079	2.08664958689336e-5	MSU_vs_LPS	HSALNG0065443	intronic_sense	Not conserved			LYN
ENSG00000236700	LINC01010	2.67257078366427	2.24517062284797e-5	MSU_vs_LPS	HSALNG0053623	integenic	Q50	hsa-miR-619-5p,hsa-miR-4267,hsa-miR-4430,hsa-miR-6089	Dental caries,-	TBPL1
ENSG00000234584	ENSG00000234584	4.96902916485962	2.2824717204973e-5	MSU_vs_LPS	HSALNG0019854	integenic	Not conserved		-	ACVR1
ENSG00000289298	ENSG00000289298	2.95453874984891	2.32305472063353e-5	MSU_vs_LPS	HSALNG0126206	integenic	Not conserved			CEACAM4
ENSG00000261253	ENSG00000261253	4.09791819057877	2.36952797566544e-5	MSU_vs_LPS	HSALNG0113602	anti_sense	Not conserved	hsa-miR-505-5p,hsa-miR-1587,hsa-miR-3972,hsa-miR-6812-5p	Carotid plaque build	ZNF778
ENSG00000259590	LINC02244	2.64268517004346	2.81187570612813e-5	MSU_vs_LPS	HSALNG0108537	anti_sense	Q75		-	TTC23
ENSG00000267321	SNHG30	2.91297533434038	2.87681551885538e-5	MSU_vs_LPS	HSALNG0115960	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-7107-5p	Mean platelet volume; Platelet component distribution width; Platelet count,-	AP2B1
ENSG00000228863	ENSG00000228863	-3.30533271418559	3.06521996088887e-5	MSU_vs_LPS	HSALNG0007856	anti_sense	Not conserved	hsa-miR-4776-3p	Moderate albuminuria,-	SLAMF7
ENSG00000250802	ZBED3-AS1	2.42544939415379	3.09144467076814e-5	MSU_vs_LPS	HSALNG0042820	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-877-3p,hsa-miR-4505,hsa-miR-4722-5p,hsa-miR-6803-5p,hsa-miR-6892-3p	Self-injurious behavior,Fasting blood glucose measurement,Autism,Glucose measurement; Fasting blood glucose measurement,Hemoglobin a1 measurement; Bmi-adjusted waist-hip ratio,Body mass index,Glucose measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Hba1c measurement,Glucose measurement; Hba1c measurement,Hba1c measurement; Bmi-adjusted waist-hip ratio,Dental caries,Testosterone measurement,Hematocrit; Hemoglobin measurement,Hematocrit; Hemoglobin measurement; Red blood cell density measurement; Erythrocyte count,Thyroid stimulating hormone measurement; Erythrocyte count,Hematocrit; Hemoglobin measurement; Red blood cell density measurement,Hemoglobin measurement,Bmi-adjusted waist-hip ratio,-	NA
ENSG00000174370	KCNJ5-AS1	1.83465545168699	3.12423801611571e-5	MSU_vs_LPS	NA	NA	NA	NA	NA	TP53AIP1
ENSG00000255717	SNHG1	1.32917430940349	3.27057963210756e-5	MSU_vs_LPS	HSALNG0084672	integenic	Q50		-	WDR74
ENSG00000260805	ENSG00000260805	2.9436587396436	3.58800429581508e-5	MSU_vs_LPS	HSALNG0010371	integenic	Q50	hsa-miR-6090,hsa-miR-10392-3p	-	BATF3
ENSG00000273033	LINC02035	1.71035702935101	3.59309867383583e-5	MSU_vs_LPS	HSALNG0028514	integenic	Q75		Protein measurement,-	SLC49A4
ENSG00000290095	ENSG00000290095	4.29129606749752	3.6421694737705e-5	MSU_vs_LPS	NA	NA	NA	NA	NA	GALNTL5
ENSG00000232748	ENSG00000232748	6.24528974688936	3.98890610822275e-5	MSU_vs_LPS	NA	NA	NA	NA	NA	ZNF646
ENSG00000224032	EPB41L4A-AS1	2.12026277535511	4.00062424520974e-5	MSU_vs_LPS	HSALNG0044150	anti_sense	Q50	hsa-miR-1237-5p	-	APC
ENSG00000235513	L3MBTL2-AS1	-3.63511483294999	4.10526091279511e-5	MSU_vs_LPS	HSALNG0135617	anti_sense	Q75	hsa-miR-6731-5p	Anorexia nervosa; Autism spectrum disorder; Depressive symptom measurement; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome; Neuroticism measurement,Neuroticism measurement,Breast carcinoma,Red blood cell distribution width,Mood instability measurement,Anxiety measurement; Neuroticism measurement,Depressive symptom measurement; Unipolar depression; Wellbeing measurement; Bipolar disorder; Neuroticism measurement,-	CHADL
ENSG00000225938	S1PR1-DT	-4.11023738540214	4.11523111099862e-5	MSU_vs_LPS	HSALNG0005575	integenic	Q50	hsa-miR-3194-3p,hsa-miR-4279,hsa-miR-6752-5p,hsa-miR-6845-3p	-	DPH5
ENSG00000267745	ENSG00000267745	-3.33543825457579	4.88145429387606e-5	MSU_vs_LPS	HSALNG0115943	integenic	Not conserved		-	SLFN12
ENSG00000281398	SNHG4	1.68110064022273	4.95266538660773e-5	MSU_vs_LPS	HSALNG0045213	anti_sense,sense	Q50	hsa-miR-3170,hsa-miR-6089,hsa-miR-6736-5p	-	MATR3
ENSG00000197182	MIRLET7BHG	-2.14577590481542	4.97721348116023e-5	MSU_vs_LPS	HSALNG0135994	integenic	Q50	hsa-miR-920,hsa-miR-939-5p,hsa-miR-3620-5p,hsa-miR-4472,hsa-miR-4505,hsa-miR-1587,hsa-miR-3972,hsa-miR-4707-5p,hsa-miR-5587-3p,hsa-miR-5589-5p,hsa-miR-6775-3p	Birth weight,Wellbeing measurement; Dupuytren contracture,Alcohol use disorder measurement; Alcohol consumption measurement,Body weight,Body height; Body weight,Smoking status measurement,Attention deficit hyperactivity disorder; Bipolar disorder; Major depressive disorder; Autism spectrum disorder,-	PPARA
ENSG00000249096	LINC02362	2.59587624489489	5.34848964695483e-5	MSU_vs_LPS	HSALNG0039015	integenic	Not conserved	hsa-miR-6089,hsa-miR-6127,hsa-miR-6129		IRF2
ENSG00000261067	ENSG00000261067	3.00812921948035	5.78617765230293e-5	MSU_vs_LPS	HSALNG0110553	sense	Not conserved			LAT
ENSG00000253307	ENSG00000253307	5.2138009192365	5.9824449668262e-5	MSU_vs_LPS	NA	NA	NA	NA	NA	SLC45A4
ENSG00000290746	CA5BP1	2.01292224465409	6.20335697024999e-5	MSU_vs_LPS	NA	NA	NA	NA	NA	CA5B
ENSG00000274020	LINC01138	-2.38130559828925	6.57657232020646e-5	MSU_vs_LPS	HSALNG0006866	integenic	Not conserved			PPIAL4G
ENSG00000265666	RARA-AS1	3.47599012509004	6.58363179258891e-5	MSU_vs_LPS	HSALNG0116345	anti_sense	Q90	hsa-miR-1237-5p,hsa-miR-6809-3p,hsa-miR-6861-3p	-	GJD3
ENSG00000213062	ENSG00000213062	3.78214756522637	7.07188999650884e-5	MSU_vs_LPS	HSALNG0008334	integenic	Q75		Pneumonia,Prothrombin time measurement,-	BLZF1
ENSG00000247982	LINC00926	2.39307527459758	7.08117133381614e-5	MSU_vs_LPS	HSALNG0106171	sense	Q50	hsa-miR-4492,hsa-miR-4508,hsa-miR-6803-5p	-	TCF12
ENSG00000290870	ENSG00000290870	-3.20372777163685	7.13370536956266e-5	MSU_vs_LPS	HSALNG0049093	integenic	Not conserved		Neutrophil-to-lymphocyte ratio,Susceptibility to shingles measurement,Lymphocyte percentage of leukocytes	ZFP57
ENSG00000247556	OIP5-AS1	1.09452175153994	7.15247254058034e-5	MSU_vs_LPS	HSALNG0105345	anti_sense,sense	Not conserved			NUSAP1
ENSG00000237310	LINC03011	3.41345720319108	7.33341043073859e-5	MSU_vs_LPS	HSALNG0058603	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-6782-5p,hsa-miR-6803-5p,hsa-miR-6833-3p	-	TPST1
ENSG00000260306	ENSG00000260306	3.38324268484001	7.48663899079342e-5	MSU_vs_LPS	HSALNG0110138	integenic	Not conserved		-	NPIPB4
ENSG00000289445	ENSG00000289445	-3.87460096319609	7.68901307931128e-5	MSU_vs_LPS	HSALNG0133098	integenic	Not conserved	hsa-miR-30b-3p,hsa-miR-6089	Heel bone mineral density,Body height,Bone fracture,Tpe interval measurement; Response to exercise,-	ETS2
ENSG00000291223	FAM86DP	1.94342575422352	7.9494568630113e-5	MSU_vs_LPS	HSALNG0026916	integenic	Not conserved	hsa-miR-485-5p		ZNF717
ENSG00000287188	ENSG00000287188	-3.91542451641953	7.96057760482255e-5	MSU_vs_LPS	HSALNG0038414	anti_sense	Q50		-	DDX60
ENSG00000279277	ENSG00000279277	-3.42737179798607	8.50320467539834e-5	MSU_vs_LPS	HSALNG0027881	integenic	Q50	hsa-miR-5787	Bipolar disorder,-	CD47
ENSG00000245522	LINC02709	4.38294003038403	8.66101959670782e-5	MSU_vs_LPS	HSALNG0082630	anti_sense	Q50	hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-4701-3p	Systolic blood pressure; Mean arterial pressure,Ischemic stroke,Rheumatoid arthritis; Myocardial infarction,Mean corpuscular hemoglobin concentration,Hba1c measurement,Coronary artery disease,Platelet count	SBF2
ENSG00000288007	ENSG00000288007	4.46602351394768	8.99481330947752e-5	MSU_vs_LPS	HSALNG0010370	integenic	Q50	hsa-miR-4505	Loneliness measurement,Forced expiratory volume; Response to bronchodilator,-	ATF3
ENSG00000270673	YTHDF3-DT	2.70939014086455	9.24282653012889e-5	MSU_vs_LPS	HSALNG0065750	integenic	Not conserved	hsa-miR-4539,hsa-miR-5001-3p,hsa-miR-6746-3p		TTPA
ENSG00000291265	ENSG00000291265	3.39089503471737	9.42500700005834e-5	MSU_vs_LPS	HSALNG0112405	integenic	Not conserved	hsa-miR-3201	Information processing speed,Vital capacity,Age at menarche,-	EXOSC6
ENSG00000286674	ENSG00000286674	-3.98541481825078	9.65644855686932e-5	MSU_vs_LPS	HSALNG0055150	anti_sense,sense	Not conserved		Self reported educational attainment,Neuritic plaque measurement,Parental longevity,Response to alcohol,Urinary metabolite measurement,Serum metabolite measurement,Skin pigmentation measurement,Serum igg glycosylation measurement,Seasonal gut microbiome measurement,Cognitive function measurement,Uterine fibroid measurement,-	GPR31
ENSG00000273415	LINC02725	3.51480928324178	9.678969270035e-5	MSU_vs_LPS	HSALNG0088083	integenic	Q50		Eye morphology measurement,Mean corpuscular volume,Bmi-adjusted waist circumference,Mean corpuscular volume; Mean corpuscular hemoglobin; Erythrocyte count,Mean reticulocyte volume; Mean corpuscular volume; Mean corpuscular hemoglobin; Red blood cell density measurement,Mean corpuscular volume; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration,Mean corpuscular hemoglobin,Red blood cell density measurement,Mean corpuscular volume; Erythrocyte count,Body height,Forced expiratory volume; Vital capacity,Nicotine withdrawal measurement,Glucose measurement,Platelet count,Lip morphology measurement,Leukocyte count,3-hydroxypropylmercapturic acid measurement,Leukocyte count; Neutrophil count,-	FLI1
ENSG00000289029	ENSG00000289029	3.34269671698584	9.72153652988704e-5	MSU_vs_LPS	NA	NA	NA	NA	NA	NPIPB11
ENSG00000235314	LINC00957	2.31956026595431	9.98193070927892e-5	MSU_vs_LPS	HSALNG0057613	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4466,hsa-miR-4505,hsa-miR-5585-3p,hsa-miR-6747-3p,hsa-miR-6784-5p	-	DBNL
ENSG00000260256	ENSG00000260256	-3.30236969360404	1.0536004437407e-4	MSU_vs_LPS	HSALNG0133530	integenic	Not conserved	hsa-miR-1178-5p	-	CFAP410
ENSG00000184068	SREBF2-AS1	3.4346245779372	1.0552782241943e-4	MSU_vs_LPS	HSALNG0135666	anti_sense	Q90		Aspartate aminotransferase to alanine aminotransferase ratio; Serum alanine aminotransferase measurement,-	SHISA8
ENSG00000229337	ENSG00000229337	2.3504032579451	1.0668853644857e-4	MSU_vs_LPS	HSALNG0146662	integenic	Not conserved			NFE2L2
ENSG00000224596	ZMIZ1-AS1	1.96112399387556	1.1294128186647e-4	MSU_vs_LPS	HSALNG0079114	anti_sense	Q50	hsa-miR-762,hsa-miR-939-3p,hsa-miR-3195,hsa-miR-4430,hsa-miR-4447,hsa-miR-4472,hsa-miR-4516,hsa-miR-4534,hsa-miR-3960,hsa-miR-6735-3p,hsa-miR-6780a-3p,hsa-miR-6788-5p,hsa-miR-6795-3p,hsa-miR-6803-5p,hsa-miR-6813-5p	Blood osmolality measurement,Hypermetropia,Interleukin 13 measurement,Susceptibility to rubella infection measurement,Body fat distribution,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Testosterone measurement,Mean corpuscular volume; Mean corpuscular hemoglobin; Red blood cell density measurement; Erythrocyte count,Mean corpuscular hemoglobin concentration,Body weight,Mean corpuscular volume,Mean reticulocyte volume; Reticulocyte count; Mean corpuscular volume; Reticulocyte measurement; Erythrocyte count,Mean corpuscular hemoglobin,Red blood cell distribution width,Erythrocyte count,Colorectal cancer; C-reactive protein measurement; Colorectal adenoma,Prostate carcinoma,-	ZCCHC24
ENSG00000214900	LINC01588	-2.22261100975689	1.1548679096973e-4	MSU_vs_LPS	HSALNG0101158	integenic	Q50			VCPKMT
ENSG00000226239	ENSG00000226239	-3.36268294775865	1.1806228201768e-4	MSU_vs_LPS	HSALNG0129532	anti_sense	Q50		Cystatin c measurement,Cognitive decline measurement,-	PDRG1
ENSG00000268205	ENSG00000268205	-1.9641945844292	1.2061551838547e-4	MSU_vs_LPS	HSALNG0127823	integenic	Not conserved			ZNF460
ENSG00000225855	RUSC1-AS1	-2.14867067626713	1.2364036007342e-4	MSU_vs_LPS	HSALNG0007497	anti_sense	Q90	hsa-miR-6891-5p	Vitamin d measurement,-	ASH1L
ENSG00000162888	C1orf147	-5.07838171788506	1.2712380889226e-4	MSU_vs_LPS	NA	NA	NA	NA	NA	EIF2D
ENSG00000253557	ENSG00000253557	-2.3312082873546	1.2874963405245e-4	MSU_vs_LPS	HSALNG0063737	integenic	Q50	hsa-miR-7155-5p	Bone quantitative ultrasound measurement,Platelet count,Mean platelet volume,Gout,Smooth surface dental caries,Urate measurement,Intelligence,Insulin measurement,Telomere length,-	PSD3
ENSG00000257621	PSMA3-AS1	1.18332625690833	1.2938938453523e-4	MSU_vs_LPS	HSALNG0101614	overlap_antisense,anti_sense,sense	Q75	hsa-miR-619-5p,hsa-miR-5047,hsa-miR-6769b-5p,hsa-miR-8485	Smoking status measurement,Non-melanoma skin carcinoma,Triglyceride measurement,Red blood cell distribution width,Reticulocyte measurement,Mean corpuscular volume,Erythrocyte count,Mean corpuscular hemoglobin concentration,Mean corpuscular hemoglobin,Red blood cell density measurement,Bitter alcoholic beverage consumption measurement; Alcohol use disorder measurement; Alcohol consumption measurement,Venous thromboembolism,Mean corpuscular hemoglobin concentration; Red blood cell distribution width,Myocardial infarction,Bmi-adjusted waist-hip ratio,C-reactive protein measurement,Mean corpuscular hemoglobin; Bmi-adjusted waist-hip ratio,Ovarian carcinoma; Progression free survival,-,Alcohol consumption measurement,Mean corpuscular volume; Mean corpuscular hemoglobin	ARMH4
ENSG00000244879	GABPB1-AS1	1.71025272839532	1.3029040174525e-4	MSU_vs_LPS	HSALNG0105872	anti_sense,sense	Q90	hsa-miR-619-5p,hsa-miR-4505	Superior frontal gyrus volume measurement,Adolescent idiopathic scoliosis,Testosterone measurement,Platelet crit,Breast carcinoma,Fev/fec ratio,Body height,Blood phosphate measurement,-	USP8
ENSG00000251364	SYT9-AS1	2.54942137690746	1.3276622136227e-4	MSU_vs_LPS	HSALNG0082493	anti_sense	Q50	hsa-miR-6763-5p,hsa-miR-6895-5p	Serum igg glycosylation measurement,Stroke outcome severity measurement,-	CYB5R2
ENSG00000181577	LINC03040	-2.39505097534705	1.3915603886102e-4	MSU_vs_LPS	NA	NA	NA	NA	NA	TMEM63B
ENSG00000260196	ENSG00000260196	1.38690395718258	1.4034883033815e-4	MSU_vs_LPS	HSALNG0082946	integenic	Not conserved		Pulse pressure measurement; Body mass index; Systolic blood pressure; Bmi-adjusted waist-hip ratio; Social communication impairment,Systolic blood pressure; Alcohol drinking	NCR3LG1
ENSG00000262223	LINC03048	-2.98884204991069	1.4207054881961e-4	MSU_vs_LPS	HSALNG0119251	integenic	Q50	hsa-miR-132-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-6769b-5p,hsa-miR-4433b-3p	Dental caries; Bmi-adjusted hip circumference; Dentures,Self reported educational attainment,Body height,Systolic blood pressure,Beta blocking agent use measurement,-	SLC38A10
ENSG00000226312	CFLAR-AS1	4.25241718068003	1.4539187016282e-4	MSU_vs_LPS	HSALNG0021529	anti_sense	Q50	hsa-miR-30b-3p	Total blood protein measurement,-	HYCC2
ENSG00000228536	LYPLAL1-AS1	-2.63502587532672	1.4652624430221e-4	MSU_vs_LPS	HSALNG0010664	integenic	Q50	hsa-miR-4492,hsa-miR-8485	Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Heel bone mineral density,Triglyceride measurement; Bmi-adjusted waist circumference,Protein measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Lean body mass,Appendicular lean mass,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Triglyceride measurement; Aspartate aminotransferase measurement,Body mass index,Visceral:subcutaneous adipose tissue ratio; Body mass index,Body height,Body weight,Reticulocyte measurement; Bmi-adjusted hip circumference,Insulin measurement,Pulse pressure measurement; Obesity; Osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty,Visceral:subcutaneous adipose tissue ratio,Osteoarthritis, hip; Body mass index; Physical activity measurement; Bmi-adjusted waist-hip ratio; Fasting blood insulin measurement; Osteoarthritis, hip, osteoarthritis, knee,Waist-hip ratio,Hip circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Triglyceride measurement; Reticulocyte measurement; Bmi-adjusted hip circumference; Reticulocyte count,Red blood cell density measurement; Hemorrhoid; Erythrocyte count,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio,Nose morphology measurement,Bmi-adjusted waist-hip ratio; Physical activity measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Serum alanine aminotransferase measurement,High density lipoprotein cholesterol measurement,Open-angle glaucoma,Smoking behavior; Bmi-adjusted waist-hip ratio,Triglyceride measurement; High density lipoprotein cholesterol measurement,Adiponectin measurement,Apolipoprotein a 1 measurement,Body fat percentage; Bmi-adjusted hip circumference,Total blood protein measurement; High density lipoprotein cholesterol measurement,Astigmatism,Bmi-adjusted waist circumference; Drugs used in diabetes use measurement; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Physical activity measurement,Bmi-adjusted waist circumference; Appendicular lean mass,Varicose veins; Inguinal hernia,Acne; Bmi-adjusted hip circumference,Serum gamma-glutamyl transferase measurement,Bmi-adjusted waist circumference; Total cholesterol measurement; Low density lipoprotein cholesterol measurement; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement,Body mass index; Adiponectin measurement; Fasting blood insulin measurement,Systolic blood pressure,Sex hormone-binding globulin measurement; Adiponectin measurement,-	ZC3H11B
ENSG00000255874	PRECSIT	1.90326301121073	1.5147776554493e-4	MSU_vs_LPS	HSALNG0141617	integenic	Not conserved		Sitting height ratio	ANKRD10
ENSG00000249249	TICAM2-AS1	-2.47129572596678	1.5503043704948e-4	MSU_vs_LPS	HSALNG0044270	anti_sense	Q90		-	AP3S1
ENSG00000234771	SLC25A25-AS1	2.16965715636531	1.6677496666882e-4	MSU_vs_LPS	HSALNG0074573	anti_sense	Q90	hsa-miR-328-5p,hsa-miR-1228-5p,hsa-miR-3714,hsa-miR-2392,hsa-miR-6803-5p	-	PTGES2
ENSG00000180539	LINC02908	2.17858040452728	1.7292130352864e-4	MSU_vs_LPS	HSALNG0075339	anti_sense	Q50	hsa-miR-210-5p,hsa-miR-619-5p,hsa-miR-4308,hsa-miR-4270,hsa-miR-6752-3p	Leukocyte count,Lymphocyte count,-	PAXX
ENSG00000274528	ENSG00000274528	3.12000730212149	1.782307667273e-4	MSU_vs_LPS	HSALNG0105948	anti_sense	Q90	hsa-miR-612,hsa-miR-619-5p,hsa-miR-3621,hsa-miR-7113-3p	-	LEO1
ENSG00000178412	CTDP1-DT	5.74095836993142	1.8126551877282e-4	MSU_vs_LPS	HSALNG0122776	integenic	Not conserved	hsa-miR-6867-3p	Monocyte count,Mean corpuscular hemoglobin	SLC66A2
ENSG00000178977	LINC00324	2.36767621288249	1.858902777867e-4	MSU_vs_LPS	HSALNG0114404	overlap_sense,sense	Q75	hsa-miR-23a-5p,hsa-miR-1260b,hsa-miR-4526	Apolipoprotein a 1 measurement,Mitochondrial dna measurement,Panic disorder; Anxiety disorder,Diastolic blood pressure,-,Neuroticism measurement,Monocyte count	CTC1
ENSG00000270426	ENSG00000270426	-3.26780942113341	1.8922651609186e-4	MSU_vs_LPS	HSALNG0039018	sense	Q90			IRF2
ENSG00000267257	ENSG00000267257	5.12959834959303	1.9706147599883e-4	MSU_vs_LPS	HSALNG0121819	anti_sense	Not conserved		Systolic blood pressure,Eosinophil count,Eosinophil count; Eosinophil percentage of leukocytes,Serum gamma-glutamyl transferase measurement,-	MALT1
ENSG00000254966	IGSF22-AS1	4.78501212737513	2.0422168568437e-4	MSU_vs_LPS	HSALNG0083030	anti_sense	Q75	hsa-miR-6086	-	TMEM86A
ENSG00000234148	LINC01961	-3.88942466474755	2.0969708987134e-4	MSU_vs_LPS	HSALNG0018065	integenic	Not conserved		-	FOXD4L1
ENSG00000290418	TPTEP1	2.16897241773236	2.1744311660752e-4	MSU_vs_LPS	HSALNG0133819	integenic	Not conserved		-	IL17RA
ENSG00000237436	CAMTA1-DT	4.72253023696671	2.2514795382871e-4	MSU_vs_LPS	HSALNG0000547	integenic	Q90	hsa-miR-3178,hsa-miR-6769b-5p	-	DNAJC11
ENSG00000287561	ENSG00000287561	2.36713405126731	2.2796398235096e-4	MSU_vs_LPS	HSALNG0146901	anti_sense	Not conserved		Platelet crit	PDYN
ENSG00000289972	ENSG00000289972	-3.99476082901885	2.3659489469393e-4	MSU_vs_LPS	HSALNG0080384	anti_sense	Q90	hsa-miR-4327	Self reported educational attainment,White matter hyperintensity measurement,White matter microstructure measurement,-	NEURL1
ENSG00000274828	ENSG00000274828	2.71023484810779	2.3761406962701e-4	MSU_vs_LPS	HSALNG0122776	integenic	Not conserved	hsa-miR-6867-3p	Monocyte count,Mean corpuscular hemoglobin	SLC66A2
ENSG00000229664	ENSG00000229664	-3.00286579774961	2.4427877686236e-4	MSU_vs_LPS	HSALNG0075911	anti_sense	Not conserved	hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-6873-3p	Liver fibrosis measurement; Epstein barr virus nuclear antigen 1 igg measurement,Response to diisocyanate,Interleukin 2 receptor antagonist measurement,Crohn's disease; Inflammatory bowel disease,Hypothyroidism; Thyroid preparation use measurement,Eosinophil count; Respiratory system disease; Eosinophil percentage of leukocytes,Tonsillectomy risk measurement,Ovarian serous carcinoma; Response to carboplatin; Response to paclitaxel; Progression free survival,-	RBM17
ENSG00000234869	LINC02925	2.79511516956542	2.571384455971e-4	MSU_vs_LPS	HSALNG0136023	integenic	Q50	hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-4437,hsa-miR-4505,hsa-miR-1587,hsa-miR-6131	Ocular sarcoidosis,Adolescent idiopathic scoliosis,-	GRAMD4
ENSG00000281404	LINC01176	-1.66063856552182	2.810639577275e-4	MSU_vs_LPS	HSALNG0149630	sense	Not conserved			NA
ENSG00000272638	ENSG00000272638	-2.58563293859556	2.870115107222e-4	MSU_vs_LPS	HSALNG0057001	anti_sense	Not conserved			NA
ENSG00000258655	ARHGAP5-AS1	2.28923482496601	2.8780646713191e-4	MSU_vs_LPS	HSALNG0100434	anti_sense	Q90		-	GPR33
ENSG00000261158	ENSG00000261158	4.80725626366538	2.9147142380829e-4	MSU_vs_LPS	HSALNG0109655	intronic_antisense	Q50	hsa-miR-1304-3p,hsa-miR-4274,hsa-miR-4279,hsa-miR-4478		SHISA9
ENSG00000291153	STAG3L4	1.49862030147897	2.9823353713037e-4	MSU_vs_LPS	HSALNG0058661	integenic	Not conserved			SPDYE21
ENSG00000291140	AMZ2P1	2.14320456282262	2.9830001615569e-4	MSU_vs_LPS	HSALNG0118163	integenic	Not conserved			GNA13
ENSG00000232977	LINC00327	3.96238555342809	3.01261668423e-4	MSU_vs_LPS	HSALNG0095730	integenic	Q50	hsa-miR-619-5p,hsa-miR-6838-3p	Hypothyroidism,Pack-years measurement; Systolic blood pressure,-	TNFRSF19
ENSG00000245694	CRNDE	2.20189604969382	3.1412633870571e-4	MSU_vs_LPS	HSALNG0111608	integenic	Q50	hsa-miR-619-5p,hsa-miR-4266,hsa-miR-6746-5p,hsa-miR-6754-5p,hsa-miR-10392-3p	Adolescent idiopathic scoliosis,Diet measurement; Body mass index,-	IRX3
ENSG00000247240	UBL7-DT	1.83928757433584	3.1593013503489e-4	MSU_vs_LPS	HSALNG0107191	integenic	Q50	hsa-miR-619-5p,hsa-miR-885-3p,hsa-miR-1227-5p,hsa-miR-6763-5p,hsa-miR-8072	Mean corpuscular volume,Caffeine metabolite measurement,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-	ARID3B
ENSG00000260807	CEROX1	2.50259463357554	3.3208520042196e-4	MSU_vs_LPS	HSALNG0108830	sense	Q50	hsa-miR-505-5p,hsa-miR-615-5p,hsa-miR-762,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-7106-3p,hsa-miR-7160-3p	Body height,-	LMF1
ENSG00000257261	SLC38A4-AS1	3.36215449708084	3.4603431312727e-4	MSU_vs_LPS	HSALNG0090714	integenic	Not conserved			PCED1B
ENSG00000273124	ENSG00000273124	-2.01875662268173	3.5314017126253e-4	MSU_vs_LPS	HSALNG0079637	integenic	Q50	hsa-miR-4650-5p,hsa-miR-6132,hsa-miR-6763-5p	Fibroblast growth factor basic measurement,-	ANKRD1
ENSG00000238164	TNFRSF14-AS1	2.00377529773479	3.6372414818247e-4	MSU_vs_LPS	HSALNG0000275	anti_sense	Q75	hsa-miR-505-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4481,hsa-miR-1343-3p,hsa-miR-5589-5p,hsa-miR-6751-3p,hsa-miR-6769a-3p,hsa-miR-6813-5p,hsa-miR-6852-5p	Eosinophil count,Rheumatoid arthritis,Eosinophil count; Eosinophil percentage of leukocytes,-	HES5
ENSG00000250929	LINC01181	-1.92438492577899	3.6380637486346e-4	MSU_vs_LPS	HSALNG0067501	integenic	Q50		Small vessel stroke,Idiopathic osteonecrosis of the femoral head,Attention deficit hyperactivity disorder,Growth-regulated alpha protein measurement,Pelvic organ prolapse,-	BAALC
ENSG00000277511	ENSG00000277511	-2.70291817717302	3.649451447755e-4	MSU_vs_LPS	HSALNG0115754	integenic	Not conserved	hsa-miR-6089,hsa-miR-7847-3p	-	RHOT1
ENSG00000287403	ENSG00000287403	3.74191583920374	3.7156857955065e-4	MSU_vs_LPS	HSALNG0119210	anti_sense	Not conserved			AATK
ENSG00000235437	LINC01278	1.13452687302439	3.7569311176527e-4	MSU_vs_LPS	HSALNG0138225	sense	Not conserved	hsa-miR-4328,hsa-miR-4447	Periodontitis,Balding measurement	SPIN4
ENSG00000277999	ENSG00000277999	2.68041702304343	4.1047605530494e-4	MSU_vs_LPS	HSALNG0110586	integenic	Not conserved			SLX1B
ENSG00000289198	ENSG00000289198	-1.87696131165752	4.1797209264121e-4	MSU_vs_LPS	HSALNG0052920	integenic	Q90		-	MARCKS
ENSG00000231971	CT69	4.56639026893899	4.2985240864079e-4	MSU_vs_LPS	HSALNG0053626	integenic	Q90	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4447,hsa-miR-4486,hsa-miR-6089	Mean corpuscular hemoglobin,Urate measurement,Erythrocyte count,Glomerular filtration rate,Abnormality of refraction,Mean corpuscular volume,Melanoma,Varicose veins,Hair colour measurement,Eosinophil count,Electrocardiography,Monocyte count,Platelet component distribution width; Platelet crit; Platelet count,Reticulocyte count,Leukocyte count,Platelet count,Triacylglycerol 52:5 measurement; Triacylglycerol 54:8 measurement,Calcium measurement,Platelet crit,Lymphocyte count,Coronary artery calcification,Red blood cell distribution width,Platelet-to-lymphocyte ratio,Cirrhosis of liver; Non-alcoholic fatty liver disease,Mean corpuscular hemoglobin; Erythrocyte count,Pulse pressure measurement,-	SGK1
ENSG00000273356	LINC02019	2.90602625590187	4.3051621944552e-4	MSU_vs_LPS	HSALNG0026057	integenic	Q90		-	DOCK3
ENSG00000291152	SBDSP1	1.65918241796215	4.3783486312775e-4	MSU_vs_LPS	HSALNG0058819	anti_sense,sense	Not conserved	hsa-miR-1268b,hsa-miR-6089,hsa-miR-6873-3p,hsa-miR-1273h-5p,hsa-miR-8485	Subcutaneous adipose tissue measurement,Reaction time measurement,Triglyceride measurement; Serum gamma-glutamyl transferase measurement,Intelligence,Bmi-adjusted waist circumference,Body mass index,Bmi-adjusted hip circumference,Alkaline phosphatase measurement,Body height,Triglyceride measurement,High density lipoprotein cholesterol measurement,Response to vaccine; Cytokine measurement,Qt interval,Protein c measurement,-	POM121
ENSG00000289100	ENSG00000289100	3.15962416015307	4.653746272352e-4	MSU_vs_LPS	HSALNG0049520	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-7846-3p		PFDN6
ENSG00000281103	TRG-AS1	-1.43744839853196	4.8211924743923e-4	MSU_vs_LPS	HSALNG0057335	integenic	Not conserved			STARD3NL
ENSG00000247095	MIR210HG	-2.78163340685366	4.8216678835602e-4	MSU_vs_LPS	HSALNG0081992	anti_sense	Q50	hsa-miR-766-3p,hsa-miR-4707-5p,hsa-miR-5587-3p,hsa-miR-6735-5p,hsa-miR-6735-3p,hsa-miR-6858-5p,hsa-miR-7843-5p	Systemic lupus erythematosus,High density lipoprotein cholesterol measurement,-	LMNTD2
ENSG00000260971	ENSG00000260971	4.10391671417611	4.8218706108632e-4	MSU_vs_LPS	HSALNG0003879	sense	Not conserved	hsa-miR-1268b,hsa-miR-6763-5p	Platelet-to-lymphocyte ratio; Reticulocyte measurement; Lymphocyte count,Lymphocyte percentage of leukocytes; Neutrophil count; Granulocyte percentage of myeloid white cells; Myeloid white cell count; Leukocyte count; Neutrophil-to-lymphocyte ratio; Neutrophil percentage of leukocytes; Eosinophil count; Granulocyte count,Myeloid white cell count; Lymphocyte percentage of leukocytes; Neutrophil count; Basophil count,Reticulocyte count; Reticulocyte measurement; Lymphocyte count,Reticulocyte count,Hematocrit,Hematocrit; Hemoglobin measurement,Platelet count	NA
ENSG00000272512	ENSG00000272512	2.06128074657398	5.6445939656869e-4	MSU_vs_LPS	HSALNG0000065	integenic	Not conserved		Apolipoprotein a 1 measurement,Parental longevity,-	HES4
ENSG00000259760	ENSG00000259760	2.45534139420497	5.6951792529214e-4	MSU_vs_LPS	HSALNG0108537	anti_sense	Q75		-	TTC23
ENSG00000221949	LINC01465	-2.22804154089517	5.7286905592718e-4	MSU_vs_LPS	HSALNG0143651	integenic	Q75	hsa-miR-4447	-	PPM1H
ENSG00000231407	GORAB-AS1	-5.38260983444409	5.7692928792184e-4	MSU_vs_LPS	HSALNG0008377	anti_sense	Q50	hsa-miR-5011-3p,hsa-miR-8485	Bmi-adjusted waist-hip ratio,Adolescent idiopathic scoliosis,Bmi-adjusted waist circumference,Soluble triggering receptor expressed on myeloid cells 2 measurement,-,Androgenetic alopecia	KIFAP3
ENSG00000231131	LNCAROD	-1.51298545539584	5.78571556946e-4	MSU_vs_LPS	HSALNG0078017	integenic	Not conserved	hsa-miR-6895-5p	Heel bone mineral density,Bone density; Dickkopf‐related protein 1 measurement; Heel bone mineral density,Bone density,Bone density; Heel bone mineral density,Dickkopf‐related protein 1 measurement,Femoral neck bone mineral density; Spine bone mineral density,Bone fracture,Velocity of sound measurement; Bone quantitative ultrasound measurement; Heel bone mineral density,Bone quantitative ultrasound measurement	MBL2
ENSG00000291104	BTN2A3P	-2.23721950469707	6.1000624061555e-4	MSU_vs_LPS	HSALNG0048771	integenic	Not conserved			BTN3A1
ENSG00000240057	NEPRO-AS1	-1.97171582275955	6.1432605605378e-4	MSU_vs_LPS	HSALNG0028082	integenic	Q90	hsa-miR-296-3p	Telomere length,Myopia,Body height	GTPBP8
ENSG00000279762	ENSG00000279762	-2.31464995587424	6.1987098445228e-4	MSU_vs_LPS	HSALNG0115783	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-6089	Systolic blood pressure,-	MYO1D
ENSG00000234263	MAP3K5-AS1	-4.90950132028797	6.2457406119583e-4	MSU_vs_LPS	HSALNG0053716	anti_sense	Q75		Unipolar depression	PEX7
ENSG00000258559	ENSG00000258559	1.86371556434818	6.4920721772792e-4	MSU_vs_LPS	HSALNG0102422	sense	Not conserved	hsa-miR-604,hsa-miR-619-5p	-	ABCD4
ENSG00000289634	ENSG00000289634	2.6824330483412	7.0695828348679e-4	MSU_vs_LPS	NA	NA	NA	NA	NA	SLCO4A1
ENSG00000214106	PAXIP1-AS2	-1.10026011004026	7.2558918263669e-4	MSU_vs_LPS	HSALNG0062534	anti_sense	Q75		Corneal endothelial cell measurement,Cognitive function measurement,-	DPP6
ENSG00000243810	CFAP61-AS1	2.76018380643345	7.3163335842674e-4	MSU_vs_LPS	HSALNG0129040	anti_sense	Q50		Stem cell growth factor beta measurement,-	RALGAPA2
ENSG00000256628	ZBTB11-AS1	-1.22085579437905	7.5756065312888e-4	MSU_vs_LPS	HSALNG0027619	anti_sense	Q90	hsa-miR-4488,hsa-miR-6089	Response to drug,Body height,-	CEP97
ENSG00000261572	ENSG00000261572	4.68458735351514	7.91448625043e-4	MSU_vs_LPS	HSALNG0024984	anti_sense	Q50			OSBPL10
ENSG00000255355	PATL1-DT	-2.7350624374631902	8.031242704809e-4	MSU_vs_LPS	HSALNG0084422	integenic	Not conserved	hsa-miR-619-5p		STX3
ENSG00000287093	ENSG00000287093	3.36332981366877	8.0942000665429e-4	MSU_vs_LPS	HSALNG0056723	integenic	Not conserved		Anorexia nervosa; Autism spectrum disorder; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome,Trauma exposure measurement,-	OSBPL3
ENSG00000231113	LINC02976	1.96331339237766	8.6177240668169e-4	MSU_vs_LPS	HSALNG0050136	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089	Diabetic nephropathy; Mean corpuscular hemoglobin,Apolipoprotein a 1 measurement,-	CNPY3
ENSG00000278607	ENSG00000278607	4.45523778238971	9.0862271644968e-4	MSU_vs_LPS	HSALNG0122474	anti_sense	Not conserved		Total blood protein measurement; Insomnia,-	PTGR3
ENSG00000273174	ENSG00000273174	-2.43658919578709	9.0862271644968e-4	MSU_vs_LPS	HSALNG0028857	anti_sense	Q50		-	GP9
ENSG00000290060	ENSG00000290060	2.33635731842921	9.1145226102691e-4	MSU_vs_LPS	HSALNG0022124	integenic	Q75			SMARCAL1
ENSG00000234717	TMEM212-AS1	-4.34375668319781	9.1808521026141e-4	MSU_vs_LPS	HSALNG0030700	anti_sense	Q50	hsa-miR-5004-3p,hsa-miR-6089	Sex hormone-binding globulin measurement,Body mass index,Colorectal cancer,Corneal resistance factor,White matter hyperintensity measurement; Hypertension,-	PLD1
ENSG00000260657	ENSG00000260657	3.46947715112419	9.2213541921959e-4	MSU_vs_LPS	HSALNG0106796	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4279,hsa-miR-6845-3p	Hematocrit,Hematocrit; Hemoglobin measurement,-	CLN6
ENSG00000254827	SLC22A18AS	2.31911104975987	9.2279458645708e-4	MSU_vs_LPS	NA	NA	NA	NA	NA	CDKN1C
ENSG00000267898	ENSG00000267898	3.51331055260276	9.3959587161562e-4	MSU_vs_LPS	HSALNG0126933	sense	Not conserved	hsa-miR-4447,hsa-miR-6852-5p,hsa-miR-7155-5p	-	FTL
ENSG00000272839	ENSG00000272839	3.27371457341503	9.5275361524373e-4	MSU_vs_LPS	HSALNG0062763	anti_sense	Not conserved	hsa-miR-4463		DNAJB6
ENSG00000291144	ENSG00000291144	-2.66798292910798	9.6348942102699e-4	MSU_vs_LPS	HSALNG0082349	overlap_sense	Not conserved		Lung carcinoma,Mean corpuscular hemoglobin concentration,Hip bone mineral density; Hip bone size,Diastolic blood pressure,-	OR52K1
ENSG00000284930	ENSG00000284930	2.26427497527497	0.00104079140962519	MSU_vs_LPS	HSALNG0102347	sense	Q90		Creatinine measurement; Hemoglobin measurement; Hematocrit,Macula measurement,Hypertension; White matter hyperintensity measurement,-	NUMB
ENSG00000258303	ENSG00000258303	2.12569282779462	0.0010433203263330601	MSU_vs_LPS	HSALNG0093142	sense	Q50	hsa-miR-6089		CRADD
ENSG00000257433	RPAP3-DT	-2.12645334853594	0.00105292157266402	MSU_vs_LPS	HSALNG0090786	anti_sense	Q90	hsa-miR-4478,hsa-miR-4505,hsa-miR-1587,hsa-miR-4717-5p,hsa-miR-6744-3p,hsa-miR-6763-5p,hsa-miR-6855-5p,hsa-miR-8485	Cup-to-disc ratio measurement,Periodontitis,Blood protein measurement,-	SLC48A1
ENSG00000287553	ENSG00000287553	2.22470155855308	0.00106368618275974	MSU_vs_LPS	HSALNG0113878	anti_sense	Q75	hsa-miR-3178,hsa-miR-4640-3p,hsa-miR-4747-5p,hsa-miR-8485	Hepatocyte growth factor measurement,-	RTN4RL1
ENSG00000227039	ITGB2-AS1	1.69431641802926	0.00108612810811787	MSU_vs_LPS	HSALNG0133581	anti_sense	Not conserved	hsa-miR-4456,hsa-miR-5090,hsa-miR-6732-5p	Heel bone mineral density,-	SLX9
ENSG00000267416	HEATR6-DT	-2.30531123504809	0.00108932887094308	MSU_vs_LPS	HSALNG0117818	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6779-3p	-	CA4
ENSG00000242474	LINC03015	2.46886800288345	0.00109368279110951	MSU_vs_LPS	HSALNG0055495	integenic	Not conserved		-	PDGFA
ENSG00000214870	LINC02981	2.40990487512302	0.00109641120608625	MSU_vs_LPS	HSALNG0056819	integenic	Not conserved			SNX10
ENSG00000205444	KU-MEL-3	-5.13165470680146	0.0011368020868344	MSU_vs_LPS	HSALNG0047755	integenic	Not conserved	hsa-miR-3619-5p	Balding measurement,-	CDYL
ENSG00000225138	SLC9A3-AS1	1.88564560373128	0.00113739424989178	MSU_vs_LPS	HSALNG0039449	anti_sense	Q75	hsa-miR-762,hsa-miR-541-3p,hsa-miR-4279,hsa-miR-3619-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-4632-3p,hsa-miR-1343-5p,hsa-miR-4722-5p,hsa-miR-4749-3p,hsa-miR-5787,hsa-miR-6132,hsa-miR-6720-3p,hsa-miR-6747-5p,hsa-miR-6873-3p	-,Hemoglobin measurement	EXOC3
ENSG00000289504	ENSG00000289504	2.19073264526152	0.00123719336777577	MSU_vs_LPS	NA	NA	NA	NA	NA	MAPKAPK3
ENSG00000266962	HSD17B1-AS1	-1.32788313382658	0.00127194932591941	MSU_vs_LPS	HSALNG0116536	anti_sense	Q50	hsa-miR-328-3p,hsa-miR-4447,hsa-miR-6816-5p,hsa-miR-6848-5p	C-reactive protein measurement; Hemoglobin a1 measurement,Cortical surface area measurement; Eczema; Body mass index,-	PSMC3IP
ENSG00000247134	ENSG00000247134	1.68232330849091	0.00132240442844414	MSU_vs_LPS	HSALNG0064447	integenic	Q50	hsa-miR-4441,hsa-miR-4463,hsa-miR-6069,hsa-miR-6803-5p	Airway imaging measurement,Protein measurement,-	NRG1
ENSG00000260253	ENSG00000260253	5.0917301535165	0.0013335817171808	MSU_vs_LPS	HSALNG0064274	integenic	Not conserved			DUSP4
ENSG00000262979	ENSG00000262979	-4.12808685459691	0.0013488454802406	MSU_vs_LPS	HSALNG0119186	sense	Not conserved		-	RNF213
ENSG00000231346	LINC01160	2.32987121397573	0.00135101153634614	MSU_vs_LPS	HSALNG0006063	anti_sense	Q75	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4787-5p,hsa-miR-6089	Leukocyte count,Lymphocyte count,-	TMIGD3
ENSG00000273008	CSGALNACT2-DT	2.55070018875193	0.00135682126943351	MSU_vs_LPS	HSALNG0077525	integenic	Not conserved			RASGEF1A
ENSG00000283648	ENSG00000283648	-4.76845591962581	0.00144344491511952	MSU_vs_LPS	HSALNG0062073	anti_sense	Q50	hsa-miR-6791-3p	Protein measurement,Parkinson's disease symptom measurement,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Gut microbiome measurement,Crohn's disease,Asparagine measurement,Uterine fibroid measurement,Chronic kidney disease; Diabetic nephropathy,Cardiovascular event measurement; Response to angiotensin-converting enzyme inhibitor; Response to angiotensin receptor blocker,-	EZH2
ENSG00000260367	ENSG00000260367	4.01177250663304	0.001445266125668	MSU_vs_LPS	HSALNG0110551	anti_sense	Q50	hsa-miR-4800-3p	Body mass index,-	RABEP2
ENSG00000237797	MACORIS	2.7976914608088	0.00147949840477968	MSU_vs_LPS	HSALNG0077098	integenic	Q50		Waist-hip ratio; Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio	ARHGAP12
ENSG00000197813	ENSG00000197813	3.79340591297359	0.00149220710584276	MSU_vs_LPS	HSALNG0126981	anti_sense	Q50	hsa-miR-4456	-	TEAD2
ENSG00000163597	SNHG16	1.01634692148473	0.0015019023916005	MSU_vs_LPS	HSALNG0118862	integenic	Not conserved		Adolescent idiopathic scoliosis,Macular telangiectasia type 2,-	PRCD
ENSG00000285693	ENSG00000285693	2.59192193433715	0.00151166490948886	MSU_vs_LPS	HSALNG0085586	sense	Q50	hsa-miR-4279,hsa-miR-4492,hsa-miR-5589-5p	Protein measurement,Platelet count,Aspartate aminotransferase measurement,Serum alanine aminotransferase measurement	STARD10
ENSG00000267100	ILF3-DT	1.3940448540908	0.00154006437605114	MSU_vs_LPS	HSALNG0123950	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4784		AP1M2
ENSG00000275763	ZNF516-DT	2.722903070311	0.00155531765973438	MSU_vs_LPS	HSALNG0145503	integenic	Q75		-	ZNF236
ENSG00000215068	ANXA2R-AS1	-1.59759981704666	0.00166038263515497	MSU_vs_LPS	HSALNG0148589	integenic	Not conserved			ZNF131
ENSG00000251867	ENSG00000251867	2.01051102732204	0.00167721722993822	MSU_vs_LPS	HSALNG0066501	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1237-5p,hsa-miR-4324,hsa-miR-5787	Atopic eczema,Adult onset asthma,Eosinophil count,Eczema; Respiratory system disease; Allergic rhinitis,Sex hormone-binding globulin measurement,Hallux valgus,Late-onset alzheimers disease,Breast carcinoma,Urinary albumin to creatinine ratio; Late-onset myasthenia gravis,Urinary albumin to creatinine ratio,Body mass index,Hemoglobin measurement,Basal cell carcinoma,Keratinocyte carcinoma; Basal cell carcinoma,Systolic blood pressure,Diastolic blood pressure,Testosterone measurement,-	ZNF704
ENSG00000290911	ENSG00000290911	3.32179239006544	0.00174778805991924	MSU_vs_LPS	HSALNG0095593	integenic	Not conserved	hsa-miR-619-5p	-	ZDHHC20
ENSG00000286872	ENSG00000286872	3.03879568935543	0.00176160053805843	MSU_vs_LPS	HSALNG0107736	integenic	Not conserved	hsa-miR-4447,hsa-miR-4505		HDGFL3
ENSG00000272256	ENSG00000272256	4.90191849547364	0.0017747561519218	MSU_vs_LPS	HSALNG0064335	anti_sense	Q50	hsa-miR-1228-5p,hsa-miR-6726-3p,hsa-miR-6816-5p	-	LEPROTL1
ENSG00000274565	ENSG00000274565	2.88273354222457	0.00182387332262176	MSU_vs_LPS	HSALNG0117970	anti_sense	Q75		-	MARCHF10
ENSG00000265287	ENSG00000265287	4.82821292047312	0.00183230639294991	MSU_vs_LPS	HSALNG0115486	anti_sense	Not conserved	hsa-miR-6089		SUPT6H
ENSG00000232628	ENSG00000232628	4.33084109161982	0.0018349801912522	MSU_vs_LPS	HSALNG0010945	integenic	Not conserved		Ceramide measurement	NVL
ENSG00000250378	ENSG00000250378	2.50230926172294	0.0018729461340271	MSU_vs_LPS	HSALNG0045056	sense	Not conserved			SLC25A48
ENSG00000267757	EML2-AS1	3.13421761705638	0.00188041142351844	MSU_vs_LPS	HSALNG0126580	anti_sense	Q90	hsa-miR-1227-5p	Body mass index,-	GIPR
ENSG00000241743	XACT	4.0198629720248	0.00189645777507066	MSU_vs_LPS	HSALNG0139599	integenic	Not conserved			AMOT
ENSG00000224875	EML4-AS1	-3.0433154562836	0.00192225423901504	MSU_vs_LPS	HSALNG0014464	anti_sense	Q75		C-reactive protein measurement,-	COX7A2L
ENSG00000236682	MAP3K2-DT	2.56995756475102	0.0019297405117674	MSU_vs_LPS	HSALNG0018617	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-1237-5p,hsa-miR-4292,hsa-miR-3180,hsa-miR-4488,hsa-miR-3960	Protein c measurement,Self reported educational attainment,-	PROC
ENSG00000271216	LINC01050	1.89302926963475	0.00195694980349896	MSU_vs_LPS	HSALNG0096679	anti_sense	Q75	hsa-miR-6735-3p	Cognitive decline measurement,-	EPSTI1
ENSG00000291174	ENSG00000291174	-1.84257488049763	0.00196164868157893	MSU_vs_LPS	NA	NA	NA	NA	NA	FRMD8
ENSG00000233834	MACC1-DT	-1.88902039304994	0.00200079603957938	MSU_vs_LPS	HSALNG0056475	anti_sense	Q50	hsa-miR-204-3p	Response to antineoplastic agent; Response to etoposide,-	ITGB8
ENSG00000233397	ENSG00000233397	4.64931212582915	0.00201289288797483	MSU_vs_LPS	HSALNG0020016	integenic	Q50	hsa-miR-1236-3p	-	SLC4A10
ENSG00000288990	ENSG00000288990	2.07501230762816	0.00211376135730718	MSU_vs_LPS	HSALNG0031952	anti_sense	Q50		Inhalant adrenergic use measurement,Respiratory system disease,-	CEP19
ENSG00000250303	LINC02762	2.35807744881988	0.00213678135890339	MSU_vs_LPS	HSALNG0087198	integenic	Not conserved			PTS
ENSG00000206344	HCG27	-2.25385742817047	0.00216814289824463	MSU_vs_LPS	HSALNG0049246	integenic	Not conserved	hsa-miR-4640-3p,hsa-miR-6769b-5p	Sneeze,Multiple myeloma,Platelet-to-lymphocyte ratio,Bmi-adjusted waist-hip ratio,Squamous cell lung carcinoma; Peptic ulcer and gastro-oesophageal reflux disease (gord) drug use measurement; Upper aerodigestive tract neoplasm; Susceptibility to pneumonia measurement,Blood protein measurement,Intelligence; Diastolic blood pressure; Susceptibility to mycobacterium tuberculosis infection measurement,Cytokine measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to shingles measurement,Lymphocyte count,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Serum igg glycosylation measurement,Coronary artery disease,Platelet count,Autism spectrum disorder; Parental longevity,Von willebrand factor measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Autism spectrum disorder,High density lipoprotein cholesterol measurement,Lung carcinoma,Response to thioamide; Drug-induced agranulocytosis,Handedness,Lupus nephritis; Blood protein measurement,-	TCF19
ENSG00000257702	LBX2-AS1	1.27576855285028	0.00218081915533218	MSU_vs_LPS	HSALNG0016063	anti_sense	Q90	hsa-miR-4492,hsa-miR-6726-5p	-	TTC31
ENSG00000289574	ENSG00000289574	-2.70207897241775	0.00223687758324853	MSU_vs_LPS	HSALNG0030964	sense	Q75	hsa-miR-363-5p,hsa-miR-1268b,hsa-miR-6089	-	MFN1
ENSG00000257913	DDN-AS1	3.59512493137279	0.00225067284461168	MSU_vs_LPS	HSALNG0090908	anti_sense	Q90	hsa-miR-939-3p,hsa-miR-4463,hsa-miR-4722-5p,hsa-miR-6721-5p,hsa-miR-6746-3p,hsa-miR-6810-3p	Chronotype measurement; Heel bone mineral density,Pulse pressure measurement; Red blood cell distribution width; Bmi-adjusted waist circumference; Body mass index; Systolic blood pressure; Body height; Hba1c measurement; High density lipoprotein cholesterol measurement,Self reported educational attainment,Verbal-numerical reasoning measurement,Blood protein measurement,Intelligence,Mathematical ability,-	WNT1
ENSG00000229140	CCDC26	3.42397652823912	0.00229555373137757	MSU_vs_LPS	HSALNG0068551	integenic	Q50	hsa-miR-575,hsa-miR-619-5p,hsa-miR-885-3p,hsa-miR-4287,hsa-miR-4328,hsa-miR-3677-3p,hsa-miR-6809-3p,hsa-miR-6873-3p,hsa-miR-6892-3p,hsa-miR-8485	Dna methylation,Eczema,Balding measurement,Heel bone mineral density,Lip morphology measurement,Facial morphology measurement,Unipolar depression,Creatinine measurement,Cleft lip; Oral cleft; Cleft palate,Myeloid white cell count,Cleft lip; Progranulin measurement,Cortical surface area measurement; Cortical thickness,Alkaline phosphatase measurement,Cleft lip; Neuroimaging measurement; Heel bone mineral density; Blood phosphate measurement; Cleft palate; Brain measurement,Cleft lip; Oral cleft,Lung adenocarcinoma,Leukocyte count,Neutrophil count,Cleft lip,Eosinophil count,Vital capacity,Self reported educational attainment,Forced expiratory volume,Mathematical ability,Fev/fec ratio,Acute lymphoblastic leukemia,Body height,Monocyte count,Monocyte percentage of leukocytes,B-cell acute lymphoblastic leukemia,Gut microbiome measurement,Creatinine measurement; Glomerular filtration rate,Nicotine dependence,Glioma,Central nervous system cancer,Hypospadias,Urate measurement,Lateral occipital cortex volume measurement,Uterine fibroid,Platelet count; Platelet crit,Indole-3-propionate measurement,Bullous pemphigoid,Cortical surface area measurement,Mitochondrial dna measurement,Inflammatory bowel disease; Mean corpuscular hemoglobin concentration; Mean corpuscular hemoglobin; Monocyte count; Mean corpuscular volume,Leukocyte count; Monocyte count,Mean corpuscular volume; Mean corpuscular hemoglobin; Erythrocyte count,Eosinophil count; Monocyte count; Basophil count; Eosinophil percentage of leukocytes,Eosinophil count; Eosinophil percentage of granulocytes; Eosinophil percentage of leukocytes,Neutrophil-to-lymphocyte ratio,Cortical thickness,Leukocyte count; Neutrophil count; Myeloid white cell count,Neutrophil percentage of leukocytes; Mean corpuscular hemoglobin,Mosaic loss of chromosome y measurement,Resistin measurement; Myeloperoxidase measurement,Lymphocyte percentage of leukocytes; Neutrophil count,Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Leukocyte count; Neutrophil count; Monocyte count,Neutrophil percentage of granulocytes; Neutrophil percentage of leukocytes,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Inflammatory bowel disease; Ulcerative colitis; Monocyte count; Monocyte:lymphocyte ratio; Mean corpuscular volume; Red blood cell density measurement; Erythrocyte count,Adolescent idiopathic scoliosis,Monocyte count; Mean corpuscular hemoglobin concentration; Erythrocyte count,Neutrophil count; Basophil count; Leukocyte count; Eosinophil count; Granulocyte count,Mean corpuscular volume; Mean corpuscular hemoglobin; Monocyte count,Erythrocyte count,Leukocyte count; Lymphocyte percentage of leukocytes; Neutrophil count; Myeloid white cell count,Red blood cell density measurement,Mean reticulocyte volume,Neutrophil percentage of leukocytes,Basophil percentage of granulocytes; Educational attainment; Basophil count; Basophil percentage of leukocytes,Granulocyte percentage of myeloid white cells,Eye color,Monocyte percentage of leukocytes; Monocyte count,Neuroimaging measurement; Glioblastoma multiforme; Glioma; White matter microstructure measurement; Brain volume measurement; Age at onset; Central nervous system cancer,Platelet count,Basophil count,Retinopathy,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Leukocyte count; Lymphocyte percentage of leukocytes; Myeloid white cell count,Basophil count; Eosinophil percentage of leukocytes,Platelet crit,Eosinophil count; Eosinophil percentage of leukocytes,Response to methotrexate; Juvenile idiopathic arthritis,Cleft lip; Cleft palate,Unipolar depression; Endometriosis,Brain volume measurement; Neuroimaging measurement; Brain measurement,-	GSDMC
ENSG00000290865	RRN3P3	1.24776384813515	0.0023399148480779	MSU_vs_LPS	HSALNG0110195	intronic_sense	Not conserved	hsa-miR-6763-5p		CDR2
ENSG00000256006	ENSG00000256006	-4.5018998134632	0.00241422455508123	MSU_vs_LPS	HSALNG0083004	sense	Q75	hsa-miR-4430	-	LDHA
ENSG00000250548	LINC01303	-2.12160510424934	0.00242498704604648	MSU_vs_LPS	HSALNG0101771	anti_sense	Q75		Susceptibility to vaginal yeast infection measurement,Asthma exacerbation measurement,-	TMEM30B
ENSG00000289073	ENSG00000289073	3.64951690402251	0.00252806767018212	MSU_vs_LPS	HSALNG0109549	anti_sense	Not conserved	hsa-miR-1268b,hsa-miR-6089		TVP23A
ENSG00000227543	SPAG5-AS1	2.40076182724758	0.0026291260243254	MSU_vs_LPS	HSALNG0115483	overlap_antisense,anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4763-3p,hsa-miR-6089	Insomnia measurement,-	SUPT6H
ENSG00000280007	ENSG00000280007	-3.19808882390267	0.00267777228887263	MSU_vs_LPS	HSALNG0133953	anti_sense	Not conserved	hsa-miR-619-5p	Atrial fibrillation,T-tau measurement,Carotid plaque build,-,Mean platelet volume	MICAL3
ENSG00000233429	HOTAIRM1	2.11916281262467	0.00267804332168296	MSU_vs_LPS	HSALNG0056850	anti_sense	Q90	hsa-miR-1224-3p,hsa-miR-3960	Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Tonsillectomy risk measurement,-	EVX1
ENSG00000281005	LINC00921	1.83401824623078	0.00268108096139981	MSU_vs_LPS	HSALNG0109143	sense	Not conserved	hsa-miR-3925-3p		NA
ENSG00000180066	LINC02870	2.08702205782826	0.0027046500091026	MSU_vs_LPS	HSALNG0081790	integenic	Q50	hsa-miR-1227-5p,hsa-miR-4485-5p,hsa-miR-4514,hsa-miR-4763-3p,hsa-miR-5001-3p,hsa-miR-6813-5p	-	PWWP2B
ENSG00000259380	LINC02895	-3.04303566128309	0.00281325751714222	MSU_vs_LPS	HSALNG0105106	integenic	Q75	hsa-miR-103a-1-5p,hsa-miR-4535	Lycopene measurement,Femoral neck bone mineral density; Spine bone mineral density,Bone density,Body height,Tryptophan measurement,Self reported educational attainment; Mathematical ability,Chagas cardiomyopathy,Hypersomnia,Mathematical ability,Bipolar disorder,Lean body mass,Body weight,Fev/fec ratio; Response to bronchodilator,-	RASGRP1
ENSG00000232680	ENSG00000232680	-4.209521663457	0.00284578586033918	MSU_vs_LPS	HSALNG0125614	integenic	Not conserved			KRTDAP
ENSG00000231249	ITPR1-DT	2.92842990152251	0.00288473383755	MSU_vs_LPS	HSALNG0023876	integenic	Q75	hsa-miR-6090,hsa-miR-6763-3p		SUMF1
ENSG00000289010	ENSG00000289010	3.36568129881401	0.00296126278766025	MSU_vs_LPS	HSALNG0099372	anti_sense	Not conserved	hsa-miR-574-5p	-	RAB20
ENSG00000258944	ENSG00000258944	1.84616986640784	0.00299996391651772	MSU_vs_LPS	HSALNG0102342	anti_sense	Q90	hsa-miR-6769a-3p	Albuminuria,-	NUMB
ENSG00000257027	ENSG00000257027	-1.47684545370838	0.00303244217415283	MSU_vs_LPS	HSALNG0089164	integenic	Not conserved			CLEC2D
ENSG00000258376	PAPLN-AS1	1.60617674763393	0.00304533891818338	MSU_vs_LPS	HSALNG0102336	anti_sense	Not conserved		Red blood cell distribution width,Sapho syndrome,-	NUMB
ENSG00000289883	ENSG00000289883	3.3415629431387	0.00308048129311733	MSU_vs_LPS	HSALNG0084898	integenic	Not conserved		Bmi-adjusted hip circumference	LTBP3
ENSG00000285601	ENSG00000285601	5.56423692145382	0.00309066881278082	MSU_vs_LPS	HSALNG0064273	integenic	Q75	hsa-miR-4443	Prostate carcinoma,-	HMBOX1
ENSG00000277969	ENSG00000277969	1.24630128260517	0.00312266194654185	MSU_vs_LPS	HSALNG0116179	integenic	Q75	hsa-miR-1247-5p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6721-5p		MLLT6
ENSG00000272273	IER3-AS1	2.82971351875161	0.00329003732460776	MSU_vs_LPS	HSALNG0049194	anti_sense	Q90	hsa-miR-1237-5p,hsa-miR-4285,hsa-miR-6089,hsa-miR-6773-5p,hsa-miR-7703,hsa-miR-8072	Chronic obstructive pulmonary disease; Unipolar depression,Bmi-adjusted waist-hip ratio,Psoriatic arthritis,Sarcoidosis,Response to risperidone,Platelet-to-lymphocyte ratio; Autism spectrum disorder,Intelligence,Small cell lung carcinoma,Bmi-adjusted hip circumference,Mean platelet volume,Unipolar depression,Reticulocyte count,Autism spectrum disorder; Post-traumatic stress disorder symptom measurement,Colorectal cancer,Breast carcinoma,-	TUBB
ENSG00000229873	OGFR-AS1	-2.67294755629808	0.00330546016063947	MSU_vs_LPS	HSALNG0131564	anti_sense	Q90	hsa-miR-1271-5p,hsa-miR-6800-3p	-	TCFL5
ENSG00000223745	CCDC18-AS1	1.24158570909464	0.00333137244505583	MSU_vs_LPS	HSALNG0005250	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4768-3p	Triglyceride measurement,Neutrophil percentage of granulocytes; Eosinophil count; Eosinophil percentage of granulocytes,Self reported educational attainment,Testosterone measurement,Mathematical ability,-	TMED5
ENSG00000272106	ENSG00000272106	1.09375490816274	0.00333866798943331	MSU_vs_LPS	HSALNG0000180	anti_sense	Not conserved		Visceral adipose tissue measurement,-	FNDC10
ENSG00000287883	ENSG00000287883	2.9874730773499	0.00339097972917763	MSU_vs_LPS	HSALNG0055491	anti_sense	Q50	hsa-miR-564,hsa-miR-619-5p,hsa-miR-4279,hsa-miR-4283,hsa-miR-4467,hsa-miR-4492,hsa-miR-6089,hsa-miR-7150	Heel bone mineral density,Non-word reading,Response to opioid,Glioma,-	PDGFA
ENSG00000224137	LINC01857	2.3544782076718	0.00339101847202758	MSU_vs_LPS	HSALNG0021881	integenic	Q50	hsa-miR-619-5p,hsa-miR-1285-3p,hsa-miR-6089	-	CCNYL1
ENSG00000271474	UNC5C-AS1	-3.54550606542205	0.00345972481550175	MSU_vs_LPS	HSALNG0035909	anti_sense	Q50		-	PDHA2
ENSG00000232931	LINC00342	1.07132166442083	0.00350285865106438	MSU_vs_LPS	HSALNG0146543	integenic	Not conserved			ANKRD36C
ENSG00000287665	ENSG00000287665	-2.96499669973736	0.00352010111076759	MSU_vs_LPS	HSALNG0149593	sense	Not conserved			FOXK1
ENSG00000291149	ENSG00000291149	-3.25507742853136	0.0035547131181206	MSU_vs_LPS	HSALNG0061972	anti_sense,sense	Not conserved	hsa-miR-6779-5p	-	CTAGE6
ENSG00000285646	ENSG00000285646	4.27738103689762	0.00357251245570744	MSU_vs_LPS	HSALNG0000911	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4448	Hypertension,Waist-hip ratio,Mean arterial pressure; Alcohol drinking,Cleft lip; Cleft palate,-	PLOD1
ENSG00000229178	ENSG00000229178	3.44448531037303	0.00358057311287763	MSU_vs_LPS	HSALNG0031830	integenic	Not conserved	hsa-miR-5693	-	APOD
ENSG00000259341	ENSG00000259341	2.96352446447029	0.00358306382363614	MSU_vs_LPS	HSALNG0108542	integenic	Q50	hsa-miR-4505,hsa-miR-1587	-	TTC23
ENSG00000272734	ADIRF-AS1	1.2340940520252	0.00359278876875975	MSU_vs_LPS	HSALNG0079425	anti_sense,sense	Q75	hsa-miR-3620-5p,hsa-miR-4447,hsa-miR-4505,hsa-miR-1587	-	MMRN2
ENSG00000285631	ENSG00000285631	2.72781839044562	0.0036419348312297	MSU_vs_LPS	HSALNG0028966	integenic	Q50	hsa-miR-504-3p,hsa-miR-619-5p	Restless legs syndrome,Waist circumference,-	ATP2C1
ENSG00000229619	MBNL1-AS1	-1.42362111044478	0.00372544118055784	MSU_vs_LPS	HSALNG0029874	anti_sense	Q50	hsa-miR-4492,hsa-miR-5587-3p	Body height,Balding measurement,Colorectal cancer,Pulse pressure measurement,Hematocrit; Hemoglobin measurement,Lymphocyte percentage of leukocytes; Neutrophil count,Neutrophil count,Myeloid white cell count,-	IGSF10
ENSG00000271133	ITGB8-AS1	-2.42636819210354	0.00376312416668087	MSU_vs_LPS	HSALNG0056485	anti_sense	Q90	hsa-miR-5572,hsa-miR-7113-3p	-	MACC1
ENSG00000287091	ENSG00000287091	2.30349477150823	0.00379441921522471	MSU_vs_LPS	HSALNG0146641	sense	Q50	hsa-miR-1203		CD302
ENSG00000285967	NIPBL-DT	1.3239722417015	0.00386503599171802	MSU_vs_LPS	HSALNG0041218	integenic	Q50	hsa-miR-1268b	-	CPLANE1
ENSG00000267199	ENSG00000267199	2.26857982358629	0.00395212730214032	MSU_vs_LPS	HSALNG0120110	anti_sense	Q75		-	PRELID3A
ENSG00000177738	ANXA2R-OT1	-1.14725075703954	0.00396764015495782	MSU_vs_LPS	HSALNG0041489	integenic	Not conserved	hsa-miR-619-5p	Conotruncal heart malformations	ANXA2R
ENSG00000215533	LINC00189	-3.09541091365898	0.00397954584512065	MSU_vs_LPS	HSALNG0132537	sense	Not conserved	hsa-miR-4772-3p	Myocardial infarction,Serum alanine aminotransferase measurement,Response to mtor inhibitor,Qt interval,Serum gamma-glutamyl transferase measurement,Hemorrhoid,High density lipoprotein cholesterol measurement,-	BACH1
ENSG00000254554	ADM-DT	-2.42934932978576	0.00398931303851971	MSU_vs_LPS	HSALNG0082648	integenic	Q50	hsa-miR-6132	Waist-hip ratio; Bmi-adjusted waist-hip ratio,Appendicular lean mass,Total cholesterol measurement,Breast carcinoma,-	SBF2
ENSG00000273335	ENSG00000273335	3.93605239054244	0.0040231468555847	MSU_vs_LPS	HSALNG0119918	anti_sense	Not conserved			PPP4R1
ENSG00000289028	ENSG00000289028	2.73582124895723	0.00408268600726058	MSU_vs_LPS	HSALNG0108655	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-4449,hsa-miR-4710,hsa-miR-6782-5p		OR4F6
ENSG00000231563	ENSG00000231563	-4.11630356053876	0.00411487289107387	MSU_vs_LPS	HSALNG0011246	integenic	Not conserved			OBSCN
ENSG00000273314	ENSG00000273314	-1.76719236797127	0.00421107552555379	MSU_vs_LPS	HSALNG0062087	anti_sense	Q50	hsa-miR-668-5p		EZH2
ENSG00000232504	ST3GAL5-AS1	1.80869047729008	0.00434808653820394	MSU_vs_LPS	HSALNG0016544	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4298	Mean platelet volume,Erythrocyte count,Monocyte percentage of leukocytes,Testosterone measurement,-	ATOH8
ENSG00000245750	DRAIC	5.4024423939131	0.00441359307684256	MSU_vs_LPS	HSALNG0106878	integenic	Q75		-	RPLP1
ENSG00000254231	WWP1-AS1	2.99742807877926	0.00441835195385018	MSU_vs_LPS	HSALNG0066736	anti_sense	Not conserved		Protein measurement,-	SLC7A13
ENSG00000289341	ENSG00000289341	5.31007870281794	0.00446256306769469	MSU_vs_LPS	HSALNG0011037	integenic	Q75		-	H3-3A
ENSG00000269970	ENSG00000269970	3.51221025691491	0.00446256306769469	MSU_vs_LPS	HSALNG0074238	sense	Not conserved			PTGS1
ENSG00000226149	ENSG00000226149	2.3610513762747	0.00448361069600107	MSU_vs_LPS	HSALNG0053423	anti_sense	Q50	hsa-miR-6763-5p,hsa-miR-8485	Sporadic amyotrophic lateral sclerosis,Hypermetropia; Self reported educational attainment; Refractive error; Retinal break; Retinal detachment; Age at onset; Myopia; Axial length measurement,Abnormality of refraction,Refractive error,Cortical surface area measurement,Body height,Cortical thickness,Sleep duration,Body mass index,Periodontitis,Cytokine measurement,Response to alcohol,-	ARHGAP18
ENSG00000291224	ENSG00000291224	1.95829182607553	0.0045261934206829	MSU_vs_LPS	HSALNG0024079	anti_sense	Not conserved	hsa-miR-6736-3p	Blood protein measurement,Body weight,3-hydroxypropylmercapturic acid measurement,-	FANCD2
ENSG00000270049	ATP6V0D1-DT	2.39309457284664	0.00460348687378231	MSU_vs_LPS	HSALNG0112213	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4433a-3p,hsa-miR-4740-3p	Agouti-related protein measurement,Mean corpuscular hemoglobin concentration,Mean reticulocyte volume; Mean corpuscular volume; Mean corpuscular hemoglobin,-	RIPOR1
ENSG00000279529	ENSG00000279529	-1.98258146322377	0.00461270791405302	MSU_vs_LPS	HSALNG0124449	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4463,hsa-miR-6746-3p	-	C19orf44
ENSG00000288848	ENSG00000288848	2.85919514815054	0.00461646417236744	MSU_vs_LPS	HSALNG0027797	integenic	Q50			ALCAM
ENSG00000258441	LINC00641	1.08796946383472	0.00462525521655034	MSU_vs_LPS	HSALNG0099873	integenic	Not conserved		Bipolar disorder,-	HNRNPC
ENSG00000286558	ENSG00000286558	4.22416081606185	0.00475436048263683	MSU_vs_LPS	HSALNG0148220	integenic	Not conserved		-	TMEM144
ENSG00000265100	ENSG00000265100	4.06206822615222	0.00477846488971206	MSU_vs_LPS	HSALNG0118356	anti_sense	Not conserved	hsa-miR-6089		SLC16A6
ENSG00000228109	MELTF-AS1	2.44762682702087	0.00480686765572589	MSU_vs_LPS	HSALNG0031988	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-1228-5p,hsa-miR-4472,hsa-miR-4492,hsa-miR-4701-3p,hsa-miR-4734,hsa-miR-7108-3p	-	NCBP2AS2
ENSG00000234572	LINC01800	3.66207725649433	0.00485190167135025	MSU_vs_LPS	HSALNG0015493	integenic	Q50	hsa-miR-27a-5p,hsa-miR-200c-5p,hsa-miR-7113-3p	Cholesteryl ester 22:6 measurement,Ccl2 measurement,Visceral adipose tissue measurement,Dna methylation,Epithelial cell adhesion molecule measurement,Sex hormone-binding globulin measurement,Obstructive sleep apnea; Sleep apnea measurement,Protein measurement,Monocyte percentage of leukocytes,-	SERTAD2
ENSG00000291151	NSUN5P1	2.25150888576775	0.00486647263604003	MSU_vs_LPS	HSALNG0149717	anti_sense,sense	Not conserved	hsa-miR-619-5p	Body mass index,Uric acid measurement,Energy intake,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body mass index; Body fat percentage; Body height; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Parental longevity; Body mass index,Body weight,Serum gamma-glutamyl transferase measurement,Systemic lupus erythematosus,Visceral adipose tissue measurement,Systolic blood pressure,Systolic blood pressure; Diastolic blood pressure; Mean arterial pressure,Self reported educational attainment; Pulse pressure measurement; Diastolic blood pressure; Body mass index; Physical activity measurement; Mathematical ability; Systolic blood pressure; Body height; Smoking behavior,C-reactive protein measurement,Ankle injury,Mathematical ability; Fasting blood insulin measurement,Large artery stroke,Basophil percentage of granulocytes; Basophil count; Basophil percentage of leukocytes,Basophil count,Ccl24 measurement,Dna methylation,Cognitive behavioural therapy,Essential tremor,Colorectal cancer,Covid-19,Carotid plaque build,Eosinophil count; Eosinophil percentage of granulocytes; Basophil count; Eosinophil percentage of leukocytes,Sarcoidosis,Eosinophil count; Eosinophil percentage of leukocytes,Eosinophil count,Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-,Age-related nuclear cataract,Age at first sexual intercourse measurement; Health study participation; Cognitive function measurement,Age at menarche	TRIM73
ENSG00000287287	ENSG00000287287	5.21169797448878	0.00488084780883614	MSU_vs_LPS	HSALNG0150805	intronic_antisense	Q50	hsa-miR-30b-3p		FAM166B
ENSG00000272247	ENSG00000272247	3.88661762960256	0.00492437716152759	MSU_vs_LPS	HSALNG0030170	intronic_antisense	Not conserved		Periodontitis,-	RARRES1
ENSG00000289317	ENSG00000289317	3.35048711368335	0.00492648007321661	MSU_vs_LPS	HSALNG0042985	integenic	Not conserved	hsa-miR-328-5p		ANKRD34B
ENSG00000177340	FLJ13224	-2.39991734935944	0.00501382468097258	MSU_vs_LPS	NA	NA	NA	NA	NA	DDX11
ENSG00000204971	ENSG00000204971	3.48453856717076	0.00517819818712842	MSU_vs_LPS	HSALNG0085534	integenic	Not conserved	hsa-miR-412-3p,hsa-miR-6769b-5p		PHOX2A
ENSG00000223768	LINC00205	1.38229314267375	0.00518728666707316	MSU_vs_LPS	HSALNG0133618	integenic	Q50	hsa-miR-92b-5p,hsa-miR-619-5p,hsa-miR-1205,hsa-miR-3692-5p,hsa-miR-3934-5p,hsa-miR-4472,hsa-miR-4505,hsa-miR-6751-3p,hsa-miR-6803-5p	Systemic lupus erythematosus,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,-	ADARB1
ENSG00000291158	LINC00869	-2.81941868081454	0.00537224712349561	MSU_vs_LPS	HSALNG0141914	integenic	Not conserved			PPIAL4C
ENSG00000284977	ENSG00000284977	-2.14323712923406	0.0054263232149334	MSU_vs_LPS	HSALNG0074045	sense	Q50	hsa-miR-8485	Ischemic stroke,Pepsinogen i/ii ratio,Susceptibility to strep throat measurement,Low density lipoprotein cholesterol measurement,Body mass index,Response to antipsychotic drug,Behavioural disinhibition measurement,Self reported educational attainment,-	NA
ENSG00000289589	ENSG00000289589	-2.76837038018779	0.0054263232149334	MSU_vs_LPS	HSALNG0008846	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7108-5p	Eosinophil count; Eosinophil percentage of leukocytes,Eosinophil count,Neuroimaging measurement; Cortical thickness; Brain measurement,-	STX6
ENSG00000287185	ENSG00000287185	3.43731004497748	0.00559663912950259	MSU_vs_LPS	HSALNG0150371	integenic	Not conserved	hsa-miR-615-5p,hsa-miR-4300		NEFL
ENSG00000273272	ENSG00000273272	-2.52755195499802	0.00561212394746731	MSU_vs_LPS	HSALNG0147331	integenic	Not conserved		Monocyte count	KLHDC7B
ENSG00000251323	LINC02728	-3.28598332801916	0.0056377145026921	MSU_vs_LPS	HSALNG0085981	integenic	Q75	hsa-miR-4530	Creatinine measurement; Body height,Total blood protein measurement	GAB2
ENSG00000290051	ENSG00000290051	4.05476554952963	0.00581452005528835	MSU_vs_LPS	HSALNG0048960	anti_sense	Not conserved		Eosinophil count,Lung carcinoma,-	ZKSCAN3
ENSG00000222042	ENSG00000222042	-4.63181620873028	0.00591315502244431	MSU_vs_LPS	HSALNG0132366	integenic	Not conserved			MRPL39
ENSG00000287978	ENSG00000287978	2.88104607871985	0.00605533031296507	MSU_vs_LPS	HSALNG0141895	integenic	Not conserved			POLR3GL
ENSG00000243701	DUBR	-2.00055447572077	0.00612356550137031	MSU_vs_LPS	HSALNG0027862	integenic	Q50			CCDC54
ENSG00000288703	ENSG00000288703	3.28929769901768	0.00622434116643124	MSU_vs_LPS	HSALNG0025666	integenic	Q50	hsa-miR-4281		CCR3
ENSG00000291086	LGALS17A	-4.83105290822224	0.00626572001790767	MSU_vs_LPS	HSALNG0126029	integenic	Not conserved			LGALS14
ENSG00000240859	LINC03014	2.80005406960088	0.00631253095139947	MSU_vs_LPS	HSALNG0055497	integenic	Not conserved	hsa-miR-4447,hsa-miR-4478,hsa-miR-6784-5p,hsa-miR-6808-5p	-	FAM20C
ENSG00000290600	ENSG00000290600	2.4084854121881	0.00640214102348229	MSU_vs_LPS	HSALNG0062142	sense	Not conserved	hsa-miR-331-3p,hsa-miR-4323,hsa-miR-6090		ZNF783
ENSG00000272851	ENSG00000272851	-2.63521701839259	0.00644926004079568	MSU_vs_LPS	HSALNG0021892	anti_sense	Q90		-	FZD5
ENSG00000260302	LINC01882	-4.11171246395439	0.00648487272008219	MSU_vs_LPS	HSALNG0120126	integenic	Not conserved	hsa-miR-149-3p,hsa-miR-1268b,hsa-miR-4441,hsa-miR-8485	Interleukin 9 measurement; Macrophage inflammatory protein 1a measurement,Red blood cell density measurement,Psoriasis,Autoimmune disease; Celiac disease,Juvenile idiopathic arthritis,Sarcoidosis,Alopecia areata,-	PTPN2
ENSG00000228800	ENSG00000228800	-4.0203199947191	0.00668766379462816	MSU_vs_LPS	HSALNG0077038	integenic	Not conserved		-	LYZL2
ENSG00000255182	ENSG00000255182	1.98329043931099	0.00684907126153476	MSU_vs_LPS	HSALNG0069435	anti_sense	Q75	hsa-miR-892b,hsa-miR-4488	-	RECQL4
ENSG00000276116	FUT8-AS1	3.97702971805297	0.00705224830494842	MSU_vs_LPS	HSALNG0144243	anti_sense	Q75		Serum igg glycosylation measurement,-	MAX
ENSG00000287601	ENSG00000287601	3.31439187397828	0.00706025102575434	MSU_vs_LPS	HSALNG0012108	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7150	-	HNRNPU
ENSG00000283078	ENSG00000283078	2.84953509031467	0.00717676585363697	MSU_vs_LPS	HSALNG0131475	anti_sense	Not conserved	hsa-miR-6826-3p,hsa-miR-6848-3p	-	LSM14B
ENSG00000288952	ENSG00000288952	2.79123356372299	0.00743925450262155	MSU_vs_LPS	HSALNG0024203	integenic	Q50			TIMP4
ENSG00000258001	R3HDM2-DT	4.1487653138436	0.00750543254050968	MSU_vs_LPS	HSALNG0091615	integenic	Q50	hsa-miR-619-5p	Apolipoprotein a 1 measurement; Urate measurement,-	INHBC
ENSG00000286681	ENSG00000286681	2.10914600978305	0.00761367501222763	MSU_vs_LPS	HSALNG0069476	integenic	Not conserved			COMMD5
ENSG00000267296	CEBPA-DT	3.12356022119666	0.00783278042114656	MSU_vs_LPS	HSALNG0125425	integenic	Q50	hsa-miR-1303,hsa-miR-6764-5p	Bmi-adjusted waist circumference,Reticulocyte count; Reticulocyte measurement,-	CEBPG
ENSG00000261578	ENSG00000261578	3.91838655676735	0.00783278042114656	MSU_vs_LPS	HSALNG0143028	integenic	Not conserved		-	TSKU
ENSG00000233117	LINC00702	2.6545146534977	0.00804564861729661	MSU_vs_LPS	HSALNG0075773	integenic	Q50	hsa-miR-4279,hsa-miR-4710	Anti-thyroglobulin antibody measurement,Biological sex,Body height,-	KLF6
ENSG00000230140	NPAS2-AS1	4.25206255447039	0.00816261690651859	MSU_vs_LPS	HSALNG0017338	anti_sense	Q75	hsa-miR-4447	3-hydroxy-1-methylpropylmercapturic acid measurement,Chronotype measurement; Aspartate aminotransferase measurement,Lip morphology measurement,-	TBC1D8
ENSG00000259972	ENSG00000259972	1.51751906796261	0.00824162982736331	MSU_vs_LPS	HSALNG0112676	integenic	Not conserved	hsa-miR-7703		CLEC18B
ENSG00000205562	FLRT2-AS1	3.14416843190912	0.00856475726982464	MSU_vs_LPS	HSALNG0102926	integenic	Q50		-	GALC
ENSG00000253395	LINC03044	3.46898402371514	0.00863669384883157	MSU_vs_LPS	HSALNG0067337	integenic	Q50	hsa-miR-619-5p,hsa-miR-4710,hsa-miR-6736-5p	Gut microbiome measurement,-	ZNF706
ENSG00000272341	ENSG00000272341	2.10661977189234	0.00868511837056045	MSU_vs_LPS	HSALNG0048332	anti_sense	Q75	hsa-miR-6799-5p	-	STMND1
ENSG00000290867	LINC01145	-2.33472430263425	0.0088754941984867	MSU_vs_LPS	HSALNG0142314	integenic	Not conserved		-	PPIAL4D
ENSG00000249171	ENSG00000249171	4.29756414116824	0.0089284986419356	MSU_vs_LPS	HSALNG0035597	integenic	Not conserved		Autism spectrum disorder	ABRAXAS1
ENSG00000237605	DYRK3-AS1	2.29096838693616	0.00897186297958425	MSU_vs_LPS	HSALNG0010037	anti_sense	Q50	hsa-miR-149-3p,hsa-miR-1224-3p,hsa-miR-4297,hsa-miR-4492,hsa-miR-4749-3p,hsa-miR-6763-5p	-	EIF2D
ENSG00000242048	PRKAG2-AS2	-2.12285211137091	0.00903866252500577	MSU_vs_LPS	HSALNG0149841	anti_sense	Not conserved			GALNTL5
ENSG00000286062	ENSG00000286062	2.18687423068446	0.00912872836341694	MSU_vs_LPS	HSALNG0042332	integenic	Q75	hsa-miR-508-5p	Sepsis; Mortality,Systolic blood pressure,-	SGTB
ENSG00000213742	ZNF337-AS1	2.78946770273281	0.00933784981835896	MSU_vs_LPS	HSALNG0129400	integenic	Not conserved	hsa-miR-619-5p		GINS1
ENSG00000183242	WT1-AS	-4.18523226317021	0.00938511538748094	MSU_vs_LPS	HSALNG0083478	integenic	Q90		-	EIF3M
ENSG00000258583	LINC01500	3.31580646093883	0.00940775246872552	MSU_vs_LPS	HSALNG0101652	integenic	Not conserved			DACT1
ENSG00000286646	MAP3K5-AS2	1.40131337452974	0.00963900269411986	MSU_vs_LPS	HSALNG0053719	anti_sense	Q50	hsa-miR-619-5p		PEX7
ENSG00000291106	LINC00888	1.49311390550132	0.00967351382089094	MSU_vs_LPS	HSALNG0031153	integenic	Q75		-	B3GNT5
ENSG00000258018	LINC02457	-2.33235901248359	0.00974033597233999	MSU_vs_LPS	HSALNG0094325	integenic	Not conserved			MAP1LC3B2
ENSG00000176124	DLEU1	1.53685601456943	0.00975674418028178	MSU_vs_LPS	HSALNG0097105	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4286,hsa-miR-4710,hsa-miR-7152-5p,hsa-miR-8485	Bmi-adjusted waist-hip ratio,Appendicular lean mass; Monocyte count,Sex hormone-binding globulin measurement,Body height,Serum alanine aminotransferase measurement; Forced expiratory volume; Lean body mass; Body height; Vital capacity; Triglyceride measurement,Intelligence,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Glomerular filtration rate; Creatinine measurement; Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference,Monocyte percentage of leukocytes; Monocyte count,Diabetic maculopathy,Body height; Bmi-adjusted hip circumference,Basophil count,Lymphocyte percentage of leukocytes; Lymphocyte count,Leukocyte count,Electrocardiography,Psoriasis,Psoriasis; Bmi-adjusted hip circumference; Primary biliary cirrhosis; Bmi-adjusted waist-hip ratio; Autoimmune disease,Appendicular lean mass,Hematocrit; Hemoglobin measurement; Erythrocyte count,Hypothyroidism,Snoring measurement; Aortic root size,Eczema; Allergic rhinitis,High density lipoprotein cholesterol measurement,Celiac disease,Leukocyte count; Lymphocyte count,Tnf-related apoptosis-inducing ligand measurement,Fatty acid measurement,Diffuse large b-cell lymphoma; Bmi-adjusted hip circumference; Chronic lymphocytic leukemia; Triglyceride measurement,Hematocrit; Hemoglobin measurement,Thyroid peroxidase antibody measurement,Lipoprotein a measurement,Creatinine measurement; Glomerular filtration rate,Eosinophil count; Eosinophil percentage of granulocytes; Eosinophil percentage of leukocytes,Adiponectin measurement,Bmi-adjusted adiponectin measurement,Body mass index,Low density lipoprotein cholesterol measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Triglyceride measurement,Left ventricular structural measurement,Fear of severe pain measurement,Hemoglobin measurement,Gamma-aminoisobutyric acid measurement,Eosinophil count,Heel bone mineral density,Prostate carcinoma,Grip strength measurement,Prostate specific antigen measurement,Blood urea nitrogen measurement; Forced expiratory volume,Grip strength measurement; Appendicular lean mass,Magnesium measurement,Caudal anterior cingulate cortex volume measurement,Blood urea nitrogen measurement,Breast carcinoma,Puberty; Heel bone mineral density; Bmi-adjusted hip circumference; Body height; Height growth measurement,Body height; Diastolic blood pressure; Systolic blood pressure,Hip circumference,Body height; Cardiovascular disease; Bmi-adjusted hip circumference; Systolic blood pressure,Transforming growth factor beta measurement,Primary biliary cirrhosis,Appendicular lean mass; Bmi-adjusted hip circumference,Body weight,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Protein measurement,Tumor necrosis factor-alpha measurement,Urinary albumin to creatinine ratio,Body height; Attention deficit hyperactivity disorder,Hematocrit,Bmi-adjusted waist circumference,Osteosarcoma; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio; Inguinal hernia,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Waist-hip ratio; Bmi-adjusted waist-hip ratio,Interleukin 9 measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Triglyceride measurement,Snoring measurement,Sphingomyelin 22:0 measurement,Platelet component distribution width,Lymphocyte count,Total blood protein measurement,Hematocrit; Odontogenesis,Blood phosphate measurement,Platelet count,Reticulocyte count; Reticulocyte measurement,Reticulocyte measurement,Hemorrhoid,Anthropometric measurement; Brachial circumference,Bipolar disorder; Unipolar depression,Benign prostatic hyperplasia; Lower urinary tract symptom,Platelet-to-lymphocyte ratio,Eosinophil count; Eosinophil percentage of leukocytes,Total cholesterol measurement,Adolescent idiopathic scoliosis,-	RNASEH2B
ENSG00000250274	ENSG00000250274	-1.42887952549897	0.0098540074828925	MSU_vs_LPS	NA	NA	NA	NA	NA	LCP2
ENSG00000269303	GRAMD1A-AS1	-4.01336453981183	0.00988264437006528	MSU_vs_LPS	HSALNG0125556	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-5787,hsa-miR-6791-3p	Triacylglycerol 54:4 measurement	ZNF792
ENSG00000278834	ENSG00000278834	-1.6203036616226	0.0101516052415867	MSU_vs_LPS	HSALNG0116388	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-2392,hsa-miR-6089	-	IGFBP4
ENSG00000286369	ENSG00000286369	-2.86975224540603	0.0103206132964684	MSU_vs_LPS	HSALNG0085227	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4281,hsa-miR-3665,hsa-miR-4443,hsa-miR-4453,hsa-miR-5047,hsa-miR-6089,hsa-miR-6510-5p	Body height	LRP5
ENSG00000236871	LINC00106	1.77207379613096	0.0103261823109123	MSU_vs_LPS	HSALNG0136360	integenic	Not conserved	hsa-miR-1227-5p,hsa-miR-3178,hsa-miR-6089,hsa-miR-6816-5p,hsa-miR-8485		IL3RA
ENSG00000259398	ENSG00000259398	3.05620314206722	0.0104264156327825	MSU_vs_LPS	HSALNG0105949	sense	Not conserved	hsa-miR-4430		MAPK6
ENSG00000272434	ENSG00000272434	4.46983104330701	0.0109080148129175	MSU_vs_LPS	HSALNG0025904	anti_sense	Q90		-	NDUFAF3
ENSG00000196204	RNF216P1	-1.1268779210939	0.0109668940796925	MSU_vs_LPS	HSALNG0055848	sense	Not conserved	hsa-miR-1227-5p		RBAK-RBAKDN
ENSG00000261468	ENSG00000261468	3.94853460250719	0.0110642562595793	MSU_vs_LPS	HSALNG0024922	integenic	Not conserved	hsa-miR-6165		TGFBR2
ENSG00000289592	ENSG00000289592	4.66133990842001	0.0112579496063666	MSU_vs_LPS	HSALNG0078740	integenic	Not conserved			PSAP
ENSG00000224195	CAMK2G-AS1	-3.55158888809406	0.0112918766023908	MSU_vs_LPS	HSALNG0078882	anti_sense	Q90	hsa-miR-4755-3p	Self reported educational attainment; Vital capacity,-	ZSWIM8
ENSG00000227017	ENSG00000227017	-3.69289043917242	0.0115110075222216	MSU_vs_LPS	HSALNG0056985	integenic	Q50		-	FKBP14
ENSG00000242094	FOXP1-IT1	-4.43485935704142	0.0115175286630229	MSU_vs_LPS	HSALNG0147842	sense	Q90		Basal cell carcinoma,-	FOXP1
ENSG00000267452	LINC02073	3.32401631680925	0.0117588177563294	MSU_vs_LPS	HSALNG0117381	integenic	Not conserved			UTP18
ENSG00000247679	ENSG00000247679	2.07854178595979	0.01196896654588	MSU_vs_LPS	HSALNG0046959	integenic	Not conserved		Mathematical ability,-	B4GALT7
ENSG00000271888	JARID2-DT	2.60402319783869	0.0121393332008149	MSU_vs_LPS	HSALNG0048272	anti_sense	Q90	hsa-miR-3960,hsa-miR-6769b-3p	-	DTNBP1
ENSG00000234362	LINC01914	-4.23075736926763	0.0122219232527423	MSU_vs_LPS	HSALNG0014404	integenic	Q75	hsa-miR-622	Chronotype measurement,Fasting blood glucose measurement,Gastric carcinoma,Self reported educational attainment; Cognitive function measurement,Cognitive function measurement,Intelligence,Self reported educational attainment; Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body mass index; Body fat percentage; Body height; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Body mass index,Eye colour measurement,Lifestyle measurement,Triacylglycerol 48:0 measurement,Mathematical ability,Unipolar depression,Bmi-adjusted waist-hip ratio,Gut microbiome measurement,Rheumatoid arthritis,Hair colour measurement; Heel bone mineral density,Electrocardiography,Breast carcinoma,Fev/fec ratio; Response to bronchodilator,Conduct disorder; Parental emotion expression measurmement,Cingulate cortex measurement; Amyloid-beta measurement,Response to vaccine,-	COX7A2L
ENSG00000260273	ENSG00000260273	1.9582008429896	0.0123383349396079	MSU_vs_LPS	HSALNG0052637	integenic	Q50	hsa-miR-4447,hsa-miR-6803-5p	-	SMPD2
ENSG00000275186	ENSG00000275186	4.76958135937757	0.0123495058659829	MSU_vs_LPS	HSALNG0122756	anti_sense	Not conserved	hsa-miR-10392-3p	Platelet count,Mean platelet volume,Bmi-adjusted waist circumference,-	SLC66A2
ENSG00000224687	RASAL2-AS1	1.83032710099129	0.0123785255964179	MSU_vs_LPS	HSALNG0008683	integenic	Q75	hsa-miR-525-3p,hsa-miR-524-3p,hsa-miR-550b-2-5p,hsa-miR-4488,hsa-miR-6509-3p	-	SEC16B
ENSG00000232310	LINC03002	3.19638009881776	0.0124662731333756	MSU_vs_LPS	HSALNG0053635	integenic	Q75	hsa-miR-6838-5p		SGK1
ENSG00000223552	CCR5AS	1.09751779764418	0.0127030217784286	MSU_vs_LPS	HSALNG0025681	anti_sense	Not conserved	hsa-miR-455-3p,hsa-miR-619-5p	Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Ccl4 measurement,Leukocyte count,Granulocyte percentage of myeloid white cells,Ccl2 measurement,Aids,Blood urea nitrogen measurement,Monocyte count,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	LTF
ENSG00000188185	LINC00265	1.57309250502642	0.0127337018799944	MSU_vs_LPS	HSALNG0057380	sense	Not conserved	hsa-miR-3925-3p,hsa-miR-6089	-	RALA
ENSG00000274029	ENSG00000274029	-1.94842703493776	0.0133186098387184	MSU_vs_LPS	HSALNG0094571	integenic	Not conserved			P2RX7
ENSG00000288994	ENSG00000288994	3.01292084044157	0.0138467280709887	MSU_vs_LPS	HSALNG0014301	sense	Not conserved		Protein measurement,-	ATL2
ENSG00000237638	LINC02245	1.56560322588461	0.0140531003319986	MSU_vs_LPS	HSALNG0015516	integenic	Not conserved			RAB1A
ENSG00000290039	ENSG00000290039	3.29114995176708	0.0141193657961367	MSU_vs_LPS	HSALNG0117726	sense	Not conserved	hsa-miR-619-5p	-	TEX14
ENSG00000291233	ENSG00000291233	-1.17460966910813	0.0142624334516439	MSU_vs_LPS	NA	NA	NA	NA	NA	NBPF9
ENSG00000288909	ENSG00000288909	3.81743494369149	0.0144013536019194	MSU_vs_LPS	HSALNG0116633	integenic	Not conserved	hsa-miR-6813-5p		ARL4D
ENSG00000278869	ENSG00000278869	-1.64569987234064	0.0144013536019194	MSU_vs_LPS	HSALNG0136238	anti_sense	Q90	hsa-miR-874-3p,hsa-miR-4447,hsa-miR-4463,hsa-miR-1343-5p,hsa-miR-5088-3p,hsa-miR-6799-5p,hsa-miR-6877-3p	-	ALG12
ENSG00000262050	ENSG00000262050	3.24035305816967	0.0144021478010287	MSU_vs_LPS	HSALNG0113932	anti_sense	Q50	hsa-miR-619-5p	-	PAFAH1B1
ENSG00000259438	MAPK6-DT	2.86309981427011	0.0145216745373248	MSU_vs_LPS	HSALNG0105948	anti_sense	Q90	hsa-miR-612,hsa-miR-619-5p,hsa-miR-3621,hsa-miR-7113-3p	-	LEO1
ENSG00000273805	ENSG00000273805	-2.92741561384989	0.0146041217278588	MSU_vs_LPS	HSALNG0091671	integenic	Q50	hsa-miR-619-5p	Trochanter size,Hematocrit,Bmi-adjusted waist circumference; Body height,Platelet component distribution width,Body mass index,Intelligence,Self reported educational attainment,Body height; Cognitive function measurement,-	ATP23
ENSG00000228382	ITPKB-IT1	2.466984092773	0.0146902671379758	MSU_vs_LPS	HSALNG0011101	sense	Q75			ITPKB
ENSG00000275927	ENSG00000275927	2.74774392912095	0.0147015631531555	MSU_vs_LPS	HSALNG0109903	sense	Not conserved			XYLT1
ENSG00000251615	ENSG00000251615	-1.91974914354194	0.0148932705812056	MSU_vs_LPS	NA	NA	NA	NA	NA	ACOX3
ENSG00000289047	ENSG00000289047	1.15688067417486	0.0152677350530448	MSU_vs_LPS	HSALNG0049461	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4447	Manic or hypomanic episode,Lumbar disc degeneration	PSMB9
ENSG00000290835	ENSG00000290835	-1.51936971688162	0.0152694560263017	MSU_vs_LPS	HSALNG0056000	integenic	Not conserved	hsa-miR-619-5p	Neutrophil count,Leukocyte count; Myeloid white cell count,Ejection fraction measurement,Hematocrit; Hemoglobin measurement,Apoe carrier status,-	RSPH10B2
ENSG00000163081	CCDC140	-4.08305727843108	0.0153340421047927	MSU_vs_LPS	NA	NA	NA	NA	NA	SGPP2
ENSG00000291188	ENSG00000291188	2.5427443565276	0.0153699023427887	MSU_vs_LPS	HSALNG0110573	integenic	Not conserved			LAT
ENSG00000291114	SIGLEC17P	2.0818389542926	0.0154772473137993	MSU_vs_LPS	NA	NA	NA	NA	NA	SIGLEC7
ENSG00000244036	UBE2H-DT	3.04175937709341	0.0156376705813597	MSU_vs_LPS	HSALNG0061340	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6089	Creatinine measurement,Interleukin 13 measurement,Neutrophil count; Platelet crit; Basophil count; Platelet count; Eosinophil count,Parental longevity,Basophil count; Systolic blood pressure; Body height; Parental longevity; Platelet crit; Testosterone measurement; Age at menarche; Platelet count; Calcium channel blocker use measurement; Eosinophil count; Agents acting on the renin-angiotensin system use measurement; Coronary artery disease; Sex hormone-binding globulin measurement; Cardiovascular disease; Stroke; Myocardial infarction; Large artery stroke; Hemoglobin measurement; Cortical thickness; Diastolic blood pressure; Neutrophil count; Red blood cell distribution width; Myeloid white cell count; Leukocyte count; Hematocrit,-	KLHDC10
ENSG00000267365	KCNJ2-AS1	-2.24010511474976	0.0157061023616474	MSU_vs_LPS	HSALNG0118455	anti_sense	Q50		Body weight,-	ABCA5
ENSG00000287367	ENSG00000287367	2.90943979537392	0.0157187008038174	MSU_vs_LPS	HSALNG0041841	integenic	Q50		-	SNX18
ENSG00000233901	LINC01503	1.07442404303474	0.0157204701259856	MSU_vs_LPS	HSALNG0074718	integenic	Q75	hsa-miR-185-3p,hsa-miR-762,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4530,hsa-miR-1587,hsa-miR-6089,hsa-miR-6732-5p,hsa-miR-6791-5p,hsa-miR-8485	Atopic eczema,Protein measurement,Caudate nucleus measurement; Functional brain measurement; Response to reward,-	NA
ENSG00000228203	GRASLND	-4.09348962749873	0.0157401754889118	MSU_vs_LPS	HSALNG0012734	anti_sense	Q50	hsa-miR-4710		CMPK2
ENSG00000249859	PVT1	1.30903390037275	0.0158279310192377	MSU_vs_LPS	HSALNG0068477	integenic	Q50	hsa-miR-619-5p,hsa-miR-665,hsa-miR-4281,hsa-miR-4279,hsa-miR-4434,hsa-miR-4492,hsa-miR-4505,hsa-miR-4526,hsa-miR-4535,hsa-miR-1587,hsa-miR-4690-3p,hsa-miR-4691-3p,hsa-miR-3064-5p,hsa-miR-4749-3p,hsa-miR-4436b-3p,hsa-miR-6069,hsa-miR-6757-5p,hsa-miR-6858-3p,hsa-miR-6883-5p	Allergic sensitization measurement,Allergic sensitization measurement; Allergic rhinitis,Inhalant adrenergic use measurement; Tonsillectomy risk measurement,Ovarian serous carcinoma; Ovarian carcinoma,Body height,Platelet count,Platelet crit,Cognitive decline measurement,Lung carcinoma,Susceptibility to scarlet fever measurement,Waist-hip ratio,Psychosis,Calcium measurement,Hematocrit,Left ventricular systolic function measurement,Mean corpuscular volume; Mean corpuscular hemoglobin,Mean corpuscular volume,Mean corpuscular volume; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration,Reticulocyte measurement; Mean corpuscular hemoglobin concentration,Hemoglobin measurement,Hematocrit; Hemoglobin measurement,Hematocrit; Hemoglobin measurement; Mean corpuscular volume,Eosinophil count; Lymphocyte count; Basophil count,Neutrophil count,Reticulocyte count,Eosinophil count; Lymphocyte count; Eosinophil percentage of leukocytes,Neutrophil percentage of granulocytes; Eosinophil count; Non-melanoma skin carcinoma; Eosinophil percentage of granulocytes,Leukocyte count; Platelet-to-lymphocyte ratio; Lymphocyte count; Myeloid white cell count,Gut microbiome measurement,Leukocyte count; Thyroid preparation use measurement,Eosinophil count; Basophil count,Neutrophil percentage of leukocytes; Eosinophil percentage of leukocytes,Phosphatidylcholine 40:6 measurement,Bell's palsy; Mean corpuscular hemoglobin concentration,Hematocrit; Hemoglobin measurement; Blood protein measurement; Serum non-albumin protein measurement,Total blood protein measurement,Mean corpuscular hemoglobin concentration,Chronic kidney disease,Hodgkins lymphoma,Neoplasm of mature b-cells; Central nervous system non-hodgkin lymphoma,Diffuse large b-cell lymphoma; Non-hodgkins lymphoma; Lymphoma,Serum non-albumin protein measurement,Facial morphology measurement,Reticulocyte measurement,Sporadic amyotrophic lateral sclerosis,C-reactive protein measurement,Colorectal cancer,Tonsillectomy risk measurement,Autoimmune thyroid disease,Birth weight; Lung adenocarcinoma; Primary biliary cirrhosis,Erythrocyte count,Systemic lupus erythematosus,Bmi-adjusted waist circumference,Breast carcinoma,Renal transplant outcome measurement; Donor genotype effect measurement; Apol1 risk genotype carrier status,Major depressive disorder; Major depressive episode,Hodgkins lymphoma; Chronic lymphocytic leukemia; Multiple myeloma,Hypothyroidism,-	MYC
ENSG00000205861	PCOTH	1.88989402664511	0.0158751438047674	MSU_vs_LPS	HSALNG0095755	anti_sense	Q50	hsa-miR-4488,hsa-miR-6845-5p,hsa-miR-7160-3p	-	NA
ENSG00000288999	ENSG00000288999	1.28563510550656	0.0161184484029232	MSU_vs_LPS	HSALNG0010910	integenic	Not conserved	hsa-miR-4467		CAPN2
ENSG00000285230	RALY-AS1	1.48476005910621	0.0162380728624448	MSU_vs_LPS	HSALNG0129682	anti_sense	Q50	hsa-miR-6879-5p	-	EIF2S2
ENSG00000225377	NRSN2-AS1	-1.31034466205737	0.0164901736054715	MSU_vs_LPS	HSALNG0128021	integenic	Not conserved			C20orf96
ENSG00000280604	ENSG00000280604	-3.88269131483962	0.0165332242828891	MSU_vs_LPS	NA	NA	NA	NA	NA	PCBP3
ENSG00000287261	HPS1-AS1	2.35159167487031	0.0167815525734129	MSU_vs_LPS	HSALNG0080027	integenic	Not conserved			R3HCC1L
ENSG00000228403	ENSG00000228403	3.47505710567232	0.0168318205844247	MSU_vs_LPS	HSALNG0077854	sense	Not conserved			WDFY4
ENSG00000235834	ENSG00000235834	3.85607865239197	0.0172336273073592	MSU_vs_LPS	HSALNG0136855	sense	Not conserved		Triacylglycerol 52:6 measurement	NHS
ENSG00000266835	GAPLINC	1.21226640639243	0.0179485659531676	MSU_vs_LPS	HSALNG0119710	sense	Not conserved		Pr interval,Citrulline measurement,-	TGIF1
ENSG00000237036	ZEB1-AS1	4.12465567178884	0.0180004971591085	MSU_vs_LPS	HSALNG0077083	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-3178,hsa-miR-3960,hsa-miR-4685-3p,hsa-miR-4707-5p,hsa-miR-5587-3p,hsa-miR-6089,hsa-miR-6769b-3p,hsa-miR-7113-3p,hsa-miR-9901	Lumbar disc degeneration,Mathematical ability,Sex hormone-binding globulin measurement,Glucose homeostasis measurement; Disposition index measurement,Tinnitus; Response to cisplatin,Peripheral arterial disease; Traffic air pollution measurement,-	ZNF438
ENSG00000253210	DENND3-AS1	-1.32989710526694	0.0182577089870799	MSU_vs_LPS	HSALNG0069052	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-3155b,hsa-miR-4492,hsa-miR-4508,hsa-miR-6730-5p,hsa-miR-6797-5p,hsa-miR-6809-3p	-	SLC45A4
ENSG00000270022	ENSG00000270022	4.07862445081456	0.0184587785017205	MSU_vs_LPS	HSALNG0135725	anti_sense	Q90	hsa-miR-1303	Parental longevity,-	SERHL2
ENSG00000261795	ENSG00000261795	3.64477080919657	0.0185183224964176	MSU_vs_LPS	HSALNG0055499	integenic	Not conserved			PDGFA
ENSG00000215765	ENSG00000215765	-4.38277430318292	0.0185549007396266	MSU_vs_LPS	HSALNG0127569	sense	Not conserved		Blood protein measurement,Monocyte percentage of leukocytes,-	KIR2DL1
ENSG00000272668	ENSG00000272668	3.97810173069177	0.0188376039221223	MSU_vs_LPS	HSALNG0007790	anti_sense	Q90	hsa-miR-574-5p,hsa-miR-5586-5p,hsa-miR-6878-3p	Red blood cell density measurement,C-reactive protein measurement,Bilirubin measurement,-	SLAMF8
ENSG00000255857	PXN-AS1	1.70193532027912	0.0188578595226126	MSU_vs_LPS	HSALNG0094500	anti_sense	Q90	hsa-miR-3183,hsa-miR-3925-3p,hsa-miR-4497,hsa-miR-6089,hsa-miR-6769a-3p,hsa-miR-7843-5p,hsa-miR-10392-3p	C-reactive protein measurement,-	SIRT4
ENSG00000227230	ENSG00000227230	4.50826993821257	0.0188759100000061	MSU_vs_LPS	HSALNG0012018	anti_sense	Q90		-	SDCCAG8
ENSG00000226125	LINC01907	3.84223223800271	0.0188877310856641	MSU_vs_LPS	HSALNG0022889	integenic	Not conserved	hsa-miR-6089	-	GPR55
ENSG00000269446	ENSG00000269446	1.71854427600459	0.0193454069478363	MSU_vs_LPS	HSALNG0062712	integenic	Not conserved			UBE3C
ENSG00000289223	ENSG00000289223	4.04498520267447	0.0193555956943034	MSU_vs_LPS	HSALNG0088178	anti_sense	Not conserved			NFRKB
ENSG00000283265	ENSG00000283265	-5.03854898463412	0.0193665221843799	MSU_vs_LPS	HSALNG0053773	integenic	Q50	hsa-miR-3665	Hodgkins lymphoma,C-reactive protein measurement; Inflammatory bowel disease; Ulcerative colitis; Systemic lupus erythematosus; Primary biliary cirrhosis; Rheumatoid arthritis,Rheumatoid arthritis,Diffuse plaque measurement,Rheumatoid arthritis; Inflammatory bowel disease; Celiac disease,Oral ulcer; Tonsillectomy risk measurement; Celiac disease; Autoimmune disease; Rheumatoid arthritis,C-reactive protein measurement,Empathy measurement,Psoriasis,Breast milk measurement,Leukocyte count,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,-	TNFAIP3
ENSG00000267980	ENSG00000267980	2.33143754357016	0.0194193973153803	MSU_vs_LPS	HSALNG0145651	anti_sense	Q90		-	MPND
ENSG00000234608	MAPKAPK5-AS1	1.02681230522685	0.0195587971734091	MSU_vs_LPS	HSALNG0094063	anti_sense	Q90	hsa-miR-210-5p,hsa-miR-619-5p,hsa-miR-3197,hsa-miR-3960,hsa-miR-7974	-	TMEM116
ENSG00000276952	ENSG00000276952	2.5426907672254	0.0197693752613919	MSU_vs_LPS	HSALNG0129380	anti_sense	Not conserved			ABHD12
ENSG00000250041	ENSG00000250041	2.4575012510033	0.0197771602044007	MSU_vs_LPS	HSALNG0082662	integenic	Q90	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089,hsa-miR-6165	Heel bone mineral density,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,-	ZBED5
ENSG00000227502	MROCKI	-1.71111899802226	0.0198002812991522	MSU_vs_LPS	HSALNG0052921	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505		HDAC2
ENSG00000255491	ENSG00000255491	1.77439920564241	0.0198868605204809	MSU_vs_LPS	HSALNG0068289	integenic	Q50	hsa-miR-363-5p,hsa-miR-4505,hsa-miR-6089,hsa-miR-6754-5p	Platelet component distribution width,Triacylglycerol 58:6 measurement,Left ventricular ejection fraction measurement; Dilated cardiomyopathy; Left ventricular structural measurement; Left ventricular systolic function measurement; Hematocrit; Heart function measurement,Reticulocyte measurement,Hematocrit; Hemoglobin measurement; Pr interval,Pr interval; Left ventricular structural measurement; Atrial fibrillation,Left ventricular systolic function measurement,Platelet crit; Heart relative wall thickness; Left ventricular ejection fraction measurement; Fractional shortening; Left ventricular diastolic function measurement; Left ventricular systolic function measurement; Electrocardiography; Ejection fraction measurement,-	MTSS1
ENSG00000279317	ENSG00000279317	4.68699603516993	0.0198952727914757	MSU_vs_LPS	HSALNG0021960	anti_sense	Q90		Total blood protein measurement; Insomnia	RPE
ENSG00000260517	ENSG00000260517	2.40158192003445	0.0204132339385562	MSU_vs_LPS	HSALNG0110566	integenic	Not conserved		Lymphocyte count,-	LAT
ENSG00000288700	ENSG00000288700	1.75494342322681	0.0204697172217267	MSU_vs_LPS	HSALNG0147628	intronic_sense	Q50			CEP63
ENSG00000251127	ENSG00000251127	4.16867341617606	0.0208099612661189	MSU_vs_LPS	HSALNG0065695	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6826-3p	Blood protein measurement,-	ASPH
ENSG00000273702	ENSG00000273702	2.14890693892024	0.0210463377185604	MSU_vs_LPS	HSALNG0117777	anti_sense	Q75	hsa-miR-505-5p	Creatinine measurement; Glomerular filtration rate,-	PTRH2
ENSG00000239608	RUVBL1-AS1	4.01182002810349	0.0210603018647263	MSU_vs_LPS	HSALNG0028783	intronic_antisense	Q75	hsa-miR-1295a,hsa-miR-6808-5p	-	SEC61A1
ENSG00000289957	ENSG00000289957	2.95704202650763	0.0211992352398497	MSU_vs_LPS	HSALNG0118079	anti_sense	Q90		-	PRR29
ENSG00000288754	ENSG00000288754	1.47401096307737	0.0212617506533553	MSU_vs_LPS	HSALNG0136023	integenic	Q50	hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-4437,hsa-miR-4505,hsa-miR-1587,hsa-miR-6131	Ocular sarcoidosis,Adolescent idiopathic scoliosis,-	GRAMD4
ENSG00000271780	ENSG00000271780	1.87791835045137	0.0213177565458056	MSU_vs_LPS	HSALNG0103867	sense	Not conserved	hsa-miR-363-5p,hsa-miR-6089,hsa-miR-7160-3p	Body mass index,-,Age at menopause	DYNC1H1
ENSG00000237667	LINC01115	4.40631641875517	0.0213365840886113	MSU_vs_LPS	HSALNG0146388	integenic	Not conserved		Body mass index,Gut microbiome measurement,Susceptibility to childhood ear infection measurement,-	TMEM18
ENSG00000273142	LINC02604	1.15429457288675	0.0213696962777487	MSU_vs_LPS	HSALNG0149694	integenic	Not conserved			TMEM248
ENSG00000232679	LINC01705	1.66557612625107	0.0213947574095917	MSU_vs_LPS	HSALNG0010821	integenic	Q50	hsa-miR-619-5p,hsa-miR-6728-3p,hsa-miR-6729-3p,hsa-miR-8485	Eosinophil percentage of leukocytes,Homa-ir,Self reported educational attainment,Colorectal cancer,Adolescent idiopathic scoliosis,C-reactive protein measurement,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Colon carcinoma,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Progressive supranuclear palsy,Tonsillectomy risk measurement,Thyroid stimulating hormone measurement,Self reported educational attainment; Intelligence,Fev/fec ratio; Response to bronchodilator,Colorectal cancer; Colorectal adenoma,Colorectal cancer; Progressive supranuclear palsy,Cluster headache,-	DUSP10
ENSG00000268635	ENSG00000268635	3.88032917421341	0.0215049202261001	MSU_vs_LPS	HSALNG0085912	overlap_antisense,overlap_sense,anti_sense	Q50		Platelet component distribution width,Diastolic blood pressure,Age at menarche,Mean platelet volume,Fev/fec ratio; Response to bronchodilator,Body weight loss,-	AQP11
ENSG00000228013	IL6R-AS1	1.96815283623515	0.021515724554132	MSU_vs_LPS	HSALNG0007394	anti_sense	Q75	hsa-miR-4710,hsa-miR-6736-5p	C-reactive protein measurement,C-reactive protein measurement; Serum non-albumin protein measurement,Albumin:globulin ratio measurement,Total blood protein measurement,Serum non-albumin protein measurement,Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis,-	SHE
ENSG00000272666	KLHDC7B-DT	-2.36475489626627	0.0215288540264911	MSU_vs_LPS	HSALNG0136305	integenic	Q50	hsa-miR-5589-5p	Erythrocyte count,Monocyte count	SYCE3
ENSG00000280798	LINC00294	1.14040566129322	0.0215369231186352	MSU_vs_LPS	HSALNG0083507	anti_sense,sense	Not conserved		-	TCP11L1
ENSG00000254484	ENSG00000254484	3.40448291202556	0.0216620267427562	MSU_vs_LPS	HSALNG0085425	sense	Not conserved			PPFIA1
ENSG00000235531	MSC-AS1	-1.09565143254506	0.0216821081407492	MSU_vs_LPS	HSALNG0066120	anti_sense	Not conserved		Lung carcinoma,Gout,Clinical treatment,Attention deficit hyperactivity disorder,Smoking behaviour measurement,Mental development measurement,Diastolic blood pressure,Forced expiratory volume; Response to bronchodilator,-	KCNB2
ENSG00000228058	LINC01736	4.04023484278534	0.021769701121028	MSU_vs_LPS	HSALNG0011359	integenic	Not conserved			GALNT2
ENSG00000270164	LINC01480	2.02491861111708	0.0220219336434595	MSU_vs_LPS	HSALNG0126205	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6803-5p		CEACAM21
ENSG00000288924	ENSG00000288924	-1.0967782788645	0.0222264205406016	MSU_vs_LPS	HSALNG0074774	intronic_sense	Q50	hsa-miR-8485		FNBP1
ENSG00000250069	ENSG00000250069	2.88178107786346	0.0230308920135335	MSU_vs_LPS	HSALNG0045308	sense	Not conserved		Intelligence	CYSTM1
ENSG00000229989	MIR181A1HG	2.22815326438996	0.023140093392354	MSU_vs_LPS	HSALNG0009516	integenic	Q50			ATP6V1G3
ENSG00000234456	MAGI2-AS3	-1.32664818492972	0.0231585497048934	MSU_vs_LPS	HSALNG0059170	anti_sense	Q75	hsa-miR-339-5p,hsa-miR-4447,hsa-miR-3960,hsa-miR-5001-3p,hsa-miR-6749-3p,hsa-miR-6786-5p,hsa-miR-8485	-	GNAI1
ENSG00000272505	ENSG00000272505	2.23993631654452	0.023401302235003	MSU_vs_LPS	HSALNG0063375	anti_sense	Not conserved		Bmi-adjusted waist circumference; White matter microstructure measurement,Bmi-adjusted waist-hip ratio,Neuroticism measurement,Bmi-adjusted waist circumference,-	PRSS55
ENSG00000289340	ENSG00000289340	3.49788646858375	0.0235289633223555	MSU_vs_LPS	HSALNG0102506	integenic	Q50		-	TMED10
ENSG00000261596	ENSG00000261596	1.43395669795225	0.0240020365130238	MSU_vs_LPS	HSALNG0110129	sense	Q75		-	METTL9
ENSG00000229931	ATXN1-AS1	2.08625750483822	0.0240415016450446	MSU_vs_LPS	HSALNG0048332	anti_sense	Q75	hsa-miR-6799-5p	-	STMND1
ENSG00000253669	GASAL1	3.12902386316734	0.0240705939100824	MSU_vs_LPS	HSALNG0067472	anti_sense	Q50		Alkaline phosphatase measurement,Leukocyte count,Eosinophil count; Neutrophil count; Basophil count; Granulocyte count,Bmi-adjusted waist circumference,-	ATP6V1C1
ENSG00000269939	PCF11-AS1	-2.66600089320359	0.0243491803494587	MSU_vs_LPS	HSALNG0086125	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-6769b-5p	-	CCDC90B
ENSG00000258101	ENSG00000258101	3.79790994602611	0.0245433234547306	MSU_vs_LPS	HSALNG0090930	anti_sense	Q75		Ovarian serous carcinoma; Squamous cell lung carcinoma; Colorectal cancer; Estrogen-receptor negative breast cancer; Breast carcinoma; Ovarian endometrioid carcinoma; Ovarian carcinoma; Lung carcinoma; Lung adenocarcinoma; Prostate carcinoma; Reaction time measurement,Mean platelet volume; Platelet count; Heel bone mineral density,Bone density,-	TUBA1A
ENSG00000227258	SMIM2-AS1	2.27279213351146	0.0246809046484962	MSU_vs_LPS	HSALNG0096738	integenic	Not conserved			NA
ENSG00000260005	ENSG00000260005	2.70388510830397	0.0247119284075762	MSU_vs_LPS	HSALNG0145178	anti_sense	Q50	hsa-miR-6862-5p	Blood protein measurement,-	NDUFAF8
ENSG00000287584	ENSG00000287584	3.81356539212507	0.0250375858771816	MSU_vs_LPS	HSALNG0057374	integenic	Q50		Intelligence,-	MPLKIP
ENSG00000266498	ENSG00000266498	2.36315507908249	0.0250812531255204	MSU_vs_LPS	HSALNG0114928	sense	Not conserved		-	FLCN
ENSG00000271830	ENSG00000271830	-4.34114065704316	0.0251824876246648	MSU_vs_LPS	HSALNG0067527	anti_sense,sense	Q90	hsa-miR-1233-5p,hsa-miR-6089,hsa-miR-6726-3p,hsa-miR-6748-3p,hsa-miR-7150,hsa-miR-8485	-	NA
ENSG00000228242	XPC-AS1	3.91489164629006	0.0256186376335756	MSU_vs_LPS	HSALNG0024318	anti_sense,sense	Q50	hsa-miR-663b,hsa-miR-4257,hsa-miR-4447,hsa-miR-4456,hsa-miR-3155b,hsa-miR-6763-5p	-	NA
ENSG00000288957	ENSG00000288957	3.54948830371991	0.0256883167624276	MSU_vs_LPS	HSALNG0041819	sense	Q50	hsa-miR-204-3p,hsa-miR-619-5p,hsa-miR-6875-3p,hsa-miR-8485	Red blood cell distribution width,Reticulocyte count; Reticulocyte measurement; Red blood cell distribution width,Reticulocyte count; Reticulocyte measurement,Reticulocyte count,Cognitive decline measurement,Guanosine diphosphate measurement,Dna methylation,Protein measurement,-	HSPB3
ENSG00000290644	ENSG00000290644	4.00403011154387	0.0258537694285486	MSU_vs_LPS	HSALNG0072753	integenic	Not conserved	hsa-miR-3178,hsa-miR-4505,hsa-miR-6514-3p	-	CENPP
ENSG00000276075	ENSG00000276075	3.52772501530258	0.02599996332051	MSU_vs_LPS	HSALNG0112214	anti_sense	Q90	hsa-miR-23b-5p,hsa-miR-4508,hsa-miR-4525,hsa-miR-4534,hsa-miR-6735-5p,hsa-miR-6764-5p,hsa-miR-6769b-5p,hsa-miR-6879-5p	Empathy measurement,Mean corpuscular hemoglobin,Vital capacity,Mean platelet volume; Fev/fec ratio,Lymphocyte count,Hemoglobin measurement,Heel bone mineral density,Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,High density lipoprotein cholesterol measurement,Blood protein measurement,-	AGRP
ENSG00000228288	PCAT6	3.86006339584214	0.0260102978094653	MSU_vs_LPS	HSALNG0009743	integenic	Q90	hsa-miR-23a-5p,hsa-miR-4508,hsa-miR-6089	-	TMEM183A
ENSG00000263731	ENSG00000263731	1.24133132204529	0.0262040128361894	MSU_vs_LPS	HSALNG0119325	integenic	Not conserved			ALYREF
ENSG00000215039	CD27-AS1	1.1533021387469	0.0262985876233179	MSU_vs_LPS	HSALNG0088857	anti_sense	Q50	hsa-miR-642a-5p,hsa-miR-4292,hsa-miR-3620-5p,hsa-miR-4447,hsa-miR-1587,hsa-miR-6514-3p,hsa-miR-6752-3p,hsa-miR-6784-5p,hsa-miR-6890-3p	-	VAMP1
ENSG00000249131	PSD2-AS1	3.52628590617433	0.0263635379294901	MSU_vs_LPS	HSALNG0045274	integenic	Q90	hsa-miR-331-3p,hsa-miR-4294,hsa-miR-4286,hsa-miR-4292,hsa-miR-4508,hsa-miR-6736-5p,hsa-miR-6850-3p	Forced expiratory volume; Response to bronchodilator,-	NRG2
ENSG00000253490	LINC02099	4.44854043325079	0.0263751914829771	MSU_vs_LPS	HSALNG0064314	integenic	Q50		Balding measurement,-	LEPROTL1
ENSG00000260278	BMP2K-DT	3.41479467729085	0.0264609264531339	MSU_vs_LPS	HSALNG0035406	integenic	Q75			PAQR3
ENSG00000162913	OBSCN-AS1	2.80506586521154	0.0264905753117689	MSU_vs_LPS	HSALNG0142443	anti_sense	Q90		-	MRPL55
ENSG00000234694	CDC20-DT	3.817414232474	0.0267323234109685	MSU_vs_LPS	HSALNG0003089	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-939-3p,hsa-miR-6798-5p,hsa-miR-6845-5p,hsa-miR-10392-3p	Platelet count,-	ELOVL1
ENSG00000267549	ZSCAN5A-AS1	2.7929902326906	0.0267599563132214	MSU_vs_LPS	HSALNG0127749	anti_sense	Not conserved		-	EDDM13
ENSG00000239569	KMT2E-AS1	1.56605806146697	0.0268010213583159	MSU_vs_LPS	HSALNG0060291	anti_sense	Q90	hsa-miR-483-3p,hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-4505,hsa-miR-1587,hsa-miR-6779-3p,hsa-miR-6887-3p	Intelligence; Mathematical ability,Vital capacity,Intelligence,Risk-taking behaviour,Vitamin d measurement,Interleukin-6 measurement,Self reported educational attainment; Intelligence,-	SRPK2
ENSG00000290469	ENSG00000290469	-4.48744308524267	0.0273511460139412	MSU_vs_LPS	HSALNG0089152	anti_sense	Q50	hsa-miR-892b,hsa-miR-6801-3p	Hodgkins lymphoma,Dna methylation,Obesity,Gut microbiome measurement,Blood protein measurement,-	CLEC2D
ENSG00000257588	AQP5-AS1	4.09696245802382	0.027383881284281	MSU_vs_LPS	HSALNG0090990	anti_sense	Q50		-	RACGAP1
ENSG00000276121	ENSG00000276121	3.86821977753835	0.0276267200027121	MSU_vs_LPS	HSALNG0105593	integenic	Not conserved		-	PATL2
ENSG00000288910	ENSG00000288910	3.89978869155011	0.0281748303894973	MSU_vs_LPS	NA	NA	NA	NA	NA	ARID1B
ENSG00000232194	ENSG00000232194	-1.61194645278967	0.0282695922877995	MSU_vs_LPS	HSALNG0008257	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-6891-5p,hsa-miR-10392-3p	-	MPZL1
ENSG00000251432	LINC02615	2.25097333909557	0.0286033163729078	MSU_vs_LPS	HSALNG0037069	integenic	Q50			LARP1B
ENSG00000289259	ENSG00000289259	3.7566656752878	0.0286831110331353	MSU_vs_LPS	HSALNG0084895	integenic	Q50		-	LTBP3
ENSG00000213963	ENSG00000213963	1.28852412467641	0.0290043289830719	MSU_vs_LPS	HSALNG0020668	sense	Not conserved			NFE2L2
ENSG00000281501	SEPSECS-AS1	1.76599909938375	0.0290067896594974	MSU_vs_LPS	HSALNG0033386	anti_sense,sense	Q75	hsa-miR-6089,hsa-miR-6816-5p	Idiopathic osteonecrosis of the femoral head,Cannabis dependence measurement,-	PI4K2B
ENSG00000245112	SMARCA5-AS1	-2.56927442079795	0.0293065530810964	MSU_vs_LPS	HSALNG0148463	anti_sense	Q90	hsa-miR-1247-5p	-	FREM3
ENSG00000287925	ENSG00000287925	3.91176236553325	0.0293600552863886	MSU_vs_LPS	HSALNG0076403	anti_sense	Q50	hsa-miR-8072,hsa-miR-8485	-	PTER
ENSG00000272405	ENSG00000272405	2.89494409038977	0.0296212110251851	MSU_vs_LPS	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES
ENSG00000253582	OXR1-AS1	2.81791491618415	0.0297067607598877	MSU_vs_LPS	HSALNG0067614	anti_sense	Not conserved		C-reactive protein measurement	ABRA
ENSG00000235954	TTC28-AS1	1.24640292479843	0.0297726380076603	MSU_vs_LPS	HSALNG0134754	anti_sense	Q75	hsa-miR-2467-3p,hsa-miR-5787	Hemoglobin measurement,Bmi-adjusted waist-hip ratio,Body height; Bmi-adjusted waist-hip ratio,Heel bone mineral density,Prostate carcinoma,Body mass index,Obesity,-	HSCB
ENSG00000280832	GSEC	-2.22924792243518	0.0301484091781768	MSU_vs_LPS	HSALNG0088026	anti_sense	Q50		Neutrophil count,Low density lipoprotein cholesterol measurement,-	KIRREL3
ENSG00000286136	ENSG00000286136	-2.12522936914504	0.0301484091781768	MSU_vs_LPS	HSALNG0036295	integenic	Q50			OSTC
ENSG00000248360	LINC00504	1.55681582050393	0.0305810767510683	MSU_vs_LPS	HSALNG0033029	integenic	Q75	hsa-miR-5047	Diacylglycerol 36:2 measurement,Protein measurement,Skin pigmentation,Nausea,Systolic blood pressure,-	FBXL5
ENSG00000272686	WASL-DT	1.4966380913713	0.0307541415557213	MSU_vs_LPS	HSALNG0061027	anti_sense	Q75		Mean corpuscular hemoglobin concentration,Reticulocyte count; Reticulocyte measurement,-	HYAL4
ENSG00000228192	ZNF691-DT	1.41804875883018	0.0312252928548539	MSU_vs_LPS	HSALNG0003039	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4492,hsa-miR-5693	Red blood cell distribution width,-	SVBP
ENSG00000233610	LINC00462	3.43590615662496	0.0317613721113334	MSU_vs_LPS	HSALNG0097004	anti_sense	Not conserved			RCBTB2
ENSG00000288767	ENSG00000288767	-2.10330577509513	0.0320553276816512	MSU_vs_LPS	HSALNG0096284	integenic	Not conserved			RFC3
ENSG00000236432	MFF-DT	2.02418933148478	0.0320940212514236	MSU_vs_LPS	HSALNG0022730	anti_sense	Q50	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-5699-3p,hsa-miR-6089	Refractive error,Abnormality of refraction,Glucose metabolism decline measurement,Diabetic nephropathy; Albuminuria,Central corneal thickness; Resting heart rate; Intraocular pressure measurement,Hematuria,Intraocular pressure measurement,Hematocrit,Mhpg measurement; 5-hiaa measurement,Atrophic macular degeneration; Age-related macular degeneration; Wet macular degeneration,-,Central corneal thickness; Corneal topography,Hematocrit; Central corneal thickness,Erythrocyte count	TM4SF20
ENSG00000286379	ENSG00000286379	3.1338700274753	0.0325053402737875	MSU_vs_LPS	NA	NA	NA	NA	NA	SH3D21
ENSG00000231312	MAP4K3-DT	1.08101416215151	0.0325090138642536	MSU_vs_LPS	HSALNG0014372	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-4447,hsa-miR-6089,hsa-miR-8485	Hematocrit; Hemoglobin measurement,Hematocrit; Erythrocyte count,Hematocrit,Hemoglobin measurement,Red blood cell density measurement,Response to candesartan,-	TMEM178A
ENSG00000196696	PDXDC2P-NPIPB14P	1.34782854192111	0.0325090138642536	MSU_vs_LPS	HSALNG0112405	integenic	Not conserved	hsa-miR-3201	Information processing speed,Vital capacity,Age at menarche,-	EXOSC6
ENSG00000247572	CKMT2-AS1	1.64040268611936	0.0325704726210372	MSU_vs_LPS	HSALNG0043022	overlap_antisense,sense	Not conserved		Empathy measurement,-	ACOT12
ENSG00000265148	TSPOAP1-AS1	1.23241663594165	0.0325735297212701	MSU_vs_LPS	HSALNG0117711	anti_sense	Q75	hsa-miR-92a-2-5p,hsa-miR-361-3p,hsa-miR-4472,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-6791-5p,hsa-miR-6803-5p,hsa-miR-6813-5p,hsa-miR-6769b-5p,hsa-miR-6877-3p,hsa-miR-7150	Platelet crit; Late-onset alzheimers disease; Platelet count; Monocyte count; Family history of alzheimer’s disease,Reaction time measurement,Thrombin generation potential measurement,Monocyte count; Platelet count; Platelet crit; Monocyte percentage of leukocytes,Leukocyte count,Red blood cell distribution width,Uterine fibroid; Eosinophil percentage of leukocytes,Intelligence,Health study participation,Prostate carcinoma,Mean corpuscular volume,Unipolar depression,Pancreatic carcinoma; Hypertension; Systolic blood pressure,Stroke,Refractive error,Cardiovascular disease; Agents acting on the renin-angiotensin system use measurement,Dna methylation,Verbal-numerical reasoning measurement,-,Hemoglobin measurement; Mean corpuscular hemoglobin concentration; Mean corpuscular hemoglobin; Ferritin measurement; Hematocrit; Mean corpuscular volume,Anemia (phenotype),Mean corpuscular hemoglobin	LPO
ENSG00000230387	ENSG00000230387	3.99162158905482	0.0325919045988135	MSU_vs_LPS	HSALNG0129227	integenic	Q50	hsa-miR-151b,hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-5006-5p,hsa-miR-8485	Serum alanine aminotransferase measurement,Susceptibility to mycobacterium tuberculosis infection measurement,Venous thromboembolism	SSTR4
ENSG00000262370	ENSG00000262370	1.01258195314669	0.0329608980816891	MSU_vs_LPS	HSALNG0109115	anti_sense	Not conserved	hsa-miR-4329	Body height,-	ZSCAN10
ENSG00000283674	ENSG00000283674	2.47369024406221	0.03299487659484	MSU_vs_LPS	HSALNG0063498	integenic	Not conserved	hsa-miR-1304-3p,hsa-miR-6803-5p	-	FAM86B2
ENSG00000273344	PAXIP1-DT	-1.61979950579483	0.0331485521875288	MSU_vs_LPS	HSALNG0062543	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4508	-	HTR5A
ENSG00000274818	ENSG00000274818	-1.79422121594761	0.0332363743839495	MSU_vs_LPS	HSALNG0102246	integenic	Q75			MAP3K9
ENSG00000287494	ENSG00000287494	1.9397249140111399	0.0333180577366062	MSU_vs_LPS	HSALNG0144545	anti_sense	Q50	hsa-miR-5787	Fev/fec ratio,Platelet component distribution width	PIF1
ENSG00000267655	ENSG00000267655	1.95717058977693	0.034029684534243	MSU_vs_LPS	HSALNG0122734	sense	Not conserved			ATP9B
ENSG00000248890	HHIP-AS1	-3.61674096975967	0.0341960259418632	MSU_vs_LPS	HSALNG0037609	anti_sense,sense	Q50	hsa-miR-4692,hsa-miR-6826-3p	Bmi-adjusted waist circumference; Body height; Physical activity measurement,Infant body height; Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Physical activity measurement; Body height; Smoking behavior,Body height; Birth weight,Body fat distribution,Body height; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Femoral neck size; Hip bone size,Susceptibility to chronic sinus infection measurement,Mean corpuscular volume,Bmi-adjusted hip circumference,-	NA
ENSG00000232807	ENSG00000232807	-3.9979637009666	0.0342696656727459	MSU_vs_LPS	HSALNG0075906	anti_sense,sense	Q90	hsa-miR-619-5p,hsa-miR-3194-5p,hsa-miR-4472,hsa-miR-4722-5p	Adolescent idiopathic scoliosis,-	IL15RA
ENSG00000267283	ENSG00000267283	-1.87762765549066	0.0347963622213934	MSU_vs_LPS	HSALNG0123116	anti_sense	Q75	hsa-miR-939-3p,hsa-miR-4437,hsa-miR-4505,hsa-miR-6085	-	CSNK1G2
ENSG00000271742	ENSG00000271742	4.10380417737323	0.0348998816636507	MSU_vs_LPS	HSALNG0001104	integenic	Q50	hsa-miR-888-3p,hsa-miR-1249-5p		AGMAT
ENSG00000261071	ENSG00000261071	2.20545069046373	0.0349743820834229	MSU_vs_LPS	HSALNG0048171	anti_sense	Q50	hsa-miR-204-3p,hsa-miR-3176,hsa-miR-3940-5p,hsa-miR-6504-5p,hsa-miR-6880-3p	-	RANBP9
ENSG00000286194	ENSG00000286194	1.28323414728645	0.0349805687458226	MSU_vs_LPS	HSALNG0145040	integenic	Not conserved	hsa-miR-4463		RNF135
ENSG00000256116	ENSG00000256116	2.17786504053086	0.0351129227828686	MSU_vs_LPS	HSALNG0084760	anti_sense	Q50	hsa-miR-6741-3p,hsa-miR-6799-5p	Platelet crit,Platelet count,-	TRPT1
ENSG00000290928	ENSG00000290928	1.23243223106576	0.0354057252236615	MSU_vs_LPS	HSALNG0115658	integenic	Not conserved			ATAD5
ENSG00000288971	ENSG00000288971	-3.61557555429508	0.0354700483428714	MSU_vs_LPS	NA	NA	NA	NA	NA	BMAL2
ENSG00000242258	LINC00996	-2.12350593228065	0.0354989895368362	MSU_vs_LPS	HSALNG0062275	sense	Not conserved		Electroencephalogram measurement	GIMAP8
ENSG00000245213	GALNT7-DT	2.2468365814218	0.0355545709235405	MSU_vs_LPS	HSALNG0038578	integenic	Not conserved			HMGB2
ENSG00000274929	ENSG00000274929	2.61769769220585	0.0356613218427182	MSU_vs_LPS	HSALNG0096999	anti_sense,sense	Not conserved			RCBTB2
ENSG00000288021	ENSG00000288021	4.03344606013597	0.0359901375802651	MSU_vs_LPS	HSALNG0051727	integenic	Not conserved	hsa-miR-6882-3p	C-x-c motif chemokine 10 measurement,Triglyceride measurement,Response to clozapine,Cognitive decline measurement,-	NT5E
ENSG00000270562	FOXP1-DT	-2.40037376103075	0.0361417915531581	MSU_vs_LPS	HSALNG0026764	anti_sense	Q90		-	GPR27
ENSG00000253477	ENSG00000253477	-4.14279385440048	0.0362276400121789	MSU_vs_LPS	HSALNG0067527	anti_sense,sense	Q90	hsa-miR-1233-5p,hsa-miR-6089,hsa-miR-6726-3p,hsa-miR-6748-3p,hsa-miR-7150,hsa-miR-8485	-	NA
ENSG00000289485	ENSG00000289485	-3.63367256932236	0.0362571271703309	MSU_vs_LPS	HSALNG0116006	anti_sense	Not conserved		C-c motif chemokine 3 measurement,Blood protein measurement,Clopidogrel metabolite measurement,Visual perception measurement,Protein measurement,Refractive error; Ccl4 measurement; Blood protein measurement; Age at onset; Myopia	TBC1D3B
ENSG00000289880	ENSG00000289880	-2.09460681220725	0.0362764824477821	MSU_vs_LPS	NA	NA	NA	NA	NA	FAM177B
ENSG00000232814	COL4A2-AS1	3.50786507684003	0.0363233486438901	MSU_vs_LPS	HSALNG0099371	anti_sense	Q75		Septic shock,-,Sex interaction measurement; Bilirubin measurement	RAB20
ENSG00000267298	ENSG00000267298	3.05903667188347	0.0363826349474011	MSU_vs_LPS	HSALNG0127739	overlap_antisense,sense	Not conserved	hsa-miR-6763-5p	Pancreatic carcinoma,-	ZSCAN5A
ENSG00000237753	SLC20A1-DT	2.28617418682851	0.0365529474324732	MSU_vs_LPS	HSALNG0017985	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4443,hsa-miR-4508,hsa-miR-378j	-	CKAP2L
ENSG00000178722	C5orf64	4.24891244868351	0.0366062961716361	MSU_vs_LPS	HSALNG0148619	integenic	Q50	hsa-miR-665	-	ZSWIM6
ENSG00000289221	ENSG00000289221	3.99835090480704	0.0369001679492535	MSU_vs_LPS	HSALNG0147179	integenic	Not conserved		Serum urea measurement,Fev/fec ratio; Pulmonary function measurement	CLDN14
ENSG00000235978	ENSG00000235978	2.64491651654966	0.0372207336295621	MSU_vs_LPS	HSALNG0023883	anti_sense	Q75	hsa-miR-3155b	Systolic blood pressure,Serum gamma-glutamyl transferase measurement,Thrombin activatable fibrinolysis inhibitor activation peptide measurement,-	SUMF1
ENSG00000245937	SLC12A2-DT	1.05807215346003	0.0372872476188808	MSU_vs_LPS	HSALNG0044716	anti_sense	Q50	hsa-miR-140-3p,hsa-miR-4691-3p	Facial hair thickness measurement,Red blood cell distribution width; Apolipoprotein a 1 measurement; Myeloid white cell count; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Skin and soft tissue staphylococcus aureus infection,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; Waist-hip ratio; Total blood protein measurement; High density lipoprotein cholesterol measurement; Appendicular lean mass; Vital capacity; Aspartate aminotransferase measurement,Lean body mass,Systolic blood pressure,Varicose veins; Sex hormone-binding globulin measurement; Fev/fec ratio; High density lipoprotein cholesterol measurement; Serum albumin measurement,Red blood cell distribution width,Body height,Lymphocyte percentage of leukocytes; Lymphocyte count; Bmi-adjusted waist circumference; Nicotine dependence symptom count; Neutrophil percentage of leukocytes; Platelet-to-lymphocyte ratio,Serum alanine aminotransferase measurement; Appendicular lean mass,Bmi-adjusted waist-hip ratio,Body fat distribution; Lymphocyte count; Red blood cell distribution width,Calcium measurement; Sex hormone-binding globulin measurement; Serum albumin measurement; Red blood cell distribution width,Breast carcinoma,-	FBN2
ENSG00000257839	PHLDA1-DT	2.49789864695115	0.0373890871951046	MSU_vs_LPS	HSALNG0092520	anti_sense	Not conserved			GLIPR1
ENSG00000288886	ENSG00000288886	1.95933204792088	0.0376028285013264	MSU_vs_LPS	HSALNG0014491	anti_sense	Q50		Response to aromatase inhibitor,Protein measurement,Mean corpuscular volume,Response to rhododendrol; Vitiligo,Hypospadias,-	MTA3
ENSG00000215022	ENSG00000215022	2.23449887519477	0.0376800605775103	MSU_vs_LPS	HSALNG0048149	anti_sense,sense	Q90		-	TBC1D7
ENSG00000186019	ZNF225-AS1	3.37049672017304	0.0378163644471805	MSU_vs_LPS	HSALNG0126426	anti_sense	Not conserved		Cytokine measurement,-	ZNF235
ENSG00000260190	ENSG00000260190	3.67111531754776	0.037874038396452	MSU_vs_LPS	HSALNG0075323	integenic	Not conserved			FBXW5
ENSG00000223749	MIR503HG	1.37551580213593	0.0379618574048551	MSU_vs_LPS	HSALNG0140233	integenic	Q90	hsa-miR-4292	Body height; Testosterone measurement,Testosterone measurement	PLAC1
ENSG00000228824	MIR4500HG	3.84375532951124	0.0380886560619926	MSU_vs_LPS	HSALNG0144006	overlap_antisense	Not conserved		Varicose veins,-	SLITRK6
ENSG00000272159	ENSG00000272159	4.17546418489498	0.038245564134967	MSU_vs_LPS	HSALNG0064654	anti_sense,sense	Q90		-	FGFR1
ENSG00000215244	LINC02649	-1.49229924464769	0.0383609990142728	MSU_vs_LPS	HSALNG0142500	integenic	Not conserved		Rheumatoid arthritis,Thyroid preparation use measurement	PFKFB3
ENSG00000291073	ENSG00000291073	1.03238749107919	0.0385318498393067	MSU_vs_LPS	HSALNG0110122	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4673		NPIPB3
ENSG00000235185	MICOS10-DT	2.79948171700396	0.0389109015905466	MSU_vs_LPS	HSALNG0001387	anti_sense	Q75	hsa-miR-4443	-	TMCO4
ENSG00000227748	ENSG00000227748	-4.52543674710399	0.0395053529445353	MSU_vs_LPS	HSALNG0054151	integenic	Q50		-	ADGB
ENSG00000274536	MIR223HG	3.3688063293509	0.0400308807549798	MSU_vs_LPS	HSALNG0138297	anti_sense	Q50	hsa-miR-331-3p	Balding measurement,Eosinophil count,Alopecia,Mean platelet volume; Platelet count,Eosinophil percentage of leukocytes	HEPH
ENSG00000273175	ENSG00000273175	-2.76870753499395	0.0402730250394317	MSU_vs_LPS	HSALNG0012114	integenic	Not conserved			COX20
ENSG00000272221	ENSG00000272221	-1.61161828267389	0.0403139690356768	MSU_vs_LPS	HSALNG0049245	anti_sense,sense	Q75	hsa-miR-556-3p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-1199-5p,hsa-miR-6803-5p	Membranous glomerulonephritis,Crohn's disease; Toxic epidermal necrolysis; Stevens-johnson syndrome,Hiv-1 infection; Neutrophil count; Basophil count,Body height; Multiple myeloma,Age at diagnosis,Neutrophil count; Bmi-adjusted waist-hip ratio,Cleft lip; Bmi-adjusted waist-hip ratio; Cleft palate,Aging,Psoriatic arthritis,Susceptibility to cold sores measurement,Bmi-adjusted hip circumference,Hemoglobin measurement,Psoriasis,Bmi-adjusted waist-hip ratio,Parental longevity,Von willebrand factor measurement,Lung carcinoma,Tonsillectomy risk measurement,Monocyte count,Monocyte percentage of leukocytes,Mean platelet volume,Reticulocyte measurement,Sneeze,Multiple myeloma,Platelet-to-lymphocyte ratio,Squamous cell lung carcinoma; Peptic ulcer and gastro-oesophageal reflux disease (gord) drug use measurement; Upper aerodigestive tract neoplasm; Susceptibility to pneumonia measurement,Blood protein measurement,Intelligence; Diastolic blood pressure; Susceptibility to mycobacterium tuberculosis infection measurement,Cytokine measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to shingles measurement,Platelet crit; Monocyte count,Lymphocyte count,Bmi-adjusted waist circumference,Serum igg glycosylation measurement,Coronary artery disease,Platelet count,Autism spectrum disorder; Parental longevity,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Autism spectrum disorder,Takayasu arteritis,Serum ige measurement,High density lipoprotein cholesterol measurement,Cancer,Response to vaccine,Susceptibility to plantar warts measurement,Eosinophil count,Sarcoidosis,Basophil count,Reticulocyte count,C-reactive protein measurement,Cervical carcinoma,Platelet-to-lymphocyte ratio; Lymphocyte count; Neutrophil count; Monocyte count,Drugs used in diabetes use measurement,Ulcerative colitis,Bmi-adjusted hip circumference; Basal cell carcinoma,Susceptibility to childhood ear infection measurement,Leukocyte count,Total cholesterol measurement; Low density lipoprotein cholesterol measurement; Platelet count,Eosinophil percentage of leukocytes,Lymphocyte count; Neutrophil count; Bmi-adjusted waist circumference; Basophil count; Bmi-adjusted hip circumference; Leukocyte count; Bmi-adjusted waist-hip ratio; Eosinophil count; Granulocyte count,Chronic hepatitis b virus infection; Hepatitis b virus infection,Chronic hepatitis b virus infection,Serum metabolite measurement,Neutrophil-to-lymphocyte ratio; Lymphocyte percentage of leukocytes,Prostate carcinoma,Viral subtype carrier status,Mean corpuscular volume,Leukocyte count; Myeloid white cell count; Anti-anoctamin 2 antibody measurement; Monocyte count,Mean corpuscular hemoglobin,Waist-hip ratio,Triglyceride measurement; Bmi-adjusted hip circumference,Leukocyte count; Neutrophil count; Lymphocyte count; Myeloid white cell count,Bmi-adjusted waist-hip ratio; Cytokine measurement,Irritable bowel syndrome; Bmi-adjusted waist-hip ratio,Dna methylation,Protein measurement,Lymphocyte count; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Skin pigmentation measurement,Smoking behavior; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Varicose veins,Granulocyte percentage of myeloid white cells,Erythrocyte count,Mean reticulocyte volume,Vitiligo,Monoclonal gammopathy; Multiple myeloma,Mean corpuscular hemoglobin concentration; Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Leukocyte count; Body height,Cd4:cd8 lymphocyte ratio; Cd8-positive t-lymphocyte count,Leprosy,Eczema,Bmi-adjusted waist-hip ratio; Gastric carcinoma,Systemic lupus erythematosus,Granzyme a measurement,Leukocyte count; Reticulocyte count,Neutrophil count,Interleukin 18 measurement,Aids; Psoriasis; Cutaneous psoriasis measurement,Triglyceride measurement; Body height; Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Nasopharyngeal neoplasm,Atopic eczema,Psoriasis; Psoriasis vulgaris,Crohn's disease,Eosinophil count; Basophil count; Eosinophil percentage of leukocytes,Total cholesterol measurement; Low density lipoprotein cholesterol measurement; Body height; Blood protein measurement; Triglyceride measurement,Hypertension,Autoimmune disease,Mean corpuscular volume; Bmi-adjusted waist-hip ratio,Stomach polyp,Sex hormone-binding globulin measurement,Oral ulcer,Major depressive disorder; Major depressive episode,Unipolar depression,Mhc class i polypeptide-related sequence a measurement,Myeloid white cell count,Body weight; Bmi-adjusted hip circumference; Perceived unattractiveness to mosquitos measurement,Body height,Maximum cigarettes per day measurement,Lymphocyte percentage of leukocytes,Myelodysplastic syndrome,Appendicular lean mass,Angiopoietin-1 receptor measurement,Vasodilators used in cardiac diseases use measurement,Intelligence; Unipolar depression,Severe aplastic anemia,Non-melanoma skin carcinoma,Systemic lupus erythematosus; Bmi-adjusted waist-hip ratio,Post-traumatic stress disorder,Triglyceride measurement,Chronic obstructive pulmonary disease; Smoking status measurement,Susceptibility to mycobacterium tuberculosis infection measurement,Alpha-2-macroglobulin receptor-associated protein measurement,Psoriasis vulgaris,Facial morphology measurement,Feeling miserable measurement,Psoriasis; Membranous glomerulonephritis,Response to interferon beta; Mean corpuscular hemoglobin concentration; Human papilloma virus infection; Anti-drug antibody measurement; Hiv-1 infection; Oral cavity cancer; Beta-2 microglobulin measurement,Hiv viral set point measurement,Diffuse large b-cell lymphoma; Visual perception measurement,Immunoglobulin isotype switching measurement; Bmi-adjusted hip circumference; Rheumatic heart disease,Atopic asthma,Apolipoprotein a 1 measurement; Autism spectrum disorder; Feeling nervous measurement,Allergic rhinitis; Nasal cavity polyp; Adult onset asthma,Serum albumin measurement,Angina pectoris; Liver neoplasm,Seasonal allergic rhinitis; Platelet count,Neutrophil count; Basophil count,Bmi-adjusted waist circumference; Platelet-to-lymphocyte ratio; Bmi-adjusted hip circumference,Hypothyroidism; Mean corpuscular hemoglobin; Bmi-adjusted waist-hip ratio,Self reported educational attainment; Metabolic syndrome; Bmi-adjusted hip circumference; Mathematical ability; Triglyceride measurement,Mean reticulocyte volume; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Cannabis use; Bmi-adjusted waist-hip ratio; Age at onset,Cirrhosis of liver,Chronic hepatitis c virus infection,Pneumonia,Cognitive function measurement; Mathematical ability,Iga glomerulonephritis; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Myocardial infarction,17-hydroxyprogesterone measurement,Gastroesophageal reflux disease,Glomerular filtration rate,Keratinocyte carcinoma,Body fat percentage,Proliferative diabetic retinopathy; Skin neoplasm,Frontal fibrosing alopecia,Ankylosing spondylitis,Cx3cl1 measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Bmi-adjusted hip circumference; Monocyte count,Susceptibility to mumps measurement,Susceptibility to chickenpox measurement,Autism spectrum disorder; Small cell lung carcinoma,Mean corpuscular volume; Bmi-adjusted hip circumference; Erythrocyte count,Triglyceride measurement; Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Eosinophil percentage of granulocytes,Susceptibility to strep throat measurement,Mosquito bite reaction itch intensity measurement,Colorectal cancer; Colorectal adenoma; Mean platelet volume,Neutrophil percentage of leukocytes,Albumin:globulin ratio measurement; Serum non-albumin protein measurement,Red blood cell density measurement,Platelet component distribution width,Behcet's syndrome,Mean platelet volume; Bipolar disorder; Eosinophil percentage of leukocytes,Hiv-1 infection; Anxiety measurement,Trichloroethylene-induced hypersensitivity,Marginal zone b-cell lymphoma,Diastolic blood pressure; Systolic blood pressure,Autism spectrum disorder; Bmi-adjusted waist-hip ratio; Atopic asthma,Squamous cell lung carcinoma,Bmi-adjusted hip circumference; White matter integrity; Bmi-adjusted waist-hip ratio,Anterior uveitis,Neutrophil count; Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Basophil count; Bmi-adjusted waist-hip ratio,Tropical spastic paraparesis,Neutrophil-to-lymphocyte ratio; Monocyte count,Eosinophil count; Lymphocyte count; Bmi-adjusted hip circumference,Neutrophil percentage of leukocytes; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Gastroesophageal reflux disease; Bmi-adjusted waist circumference; Oral ulcer; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio; Aspirin use measurement,Oral ulcer; Bmi-adjusted hip circumference; Aspirin use measurement; Calcium channel blocker use measurement; Antithrombotic agent use measurement,Systolic blood pressure,Iritis,Pulse pressure measurement; Systolic blood pressure,Blood protein measurement; Heel bone mineral density,Viral load,Self reported educational attainment; Cognitive function measurement,Mathematical ability,Antithrombotic agent use measurement,Bmi-adjusted waist circumference; Mhc class i polypeptide-related sequence a measurement,Platelet crit,Hematocrit,Sjogren syndrome,Neutrophil percentage of granulocytes,Eosinophil count; Basophil count,Basophil percentage of granulocytes,Body height; Cerebrospinal fluid biomarker measurement,Graves disease; Thyrotoxic periodic paralysis,Body height; Bmi-adjusted hip circumference; Low density lipoprotein cholesterol measurement,Allergic sensitization measurement,Rheumatoid arthritis,Chronic obstructive pulmonary disease; Rosacea severity measurement,Surfactant protein d measurement; Blood protein measurement; Chronic obstructive pulmonary disease; Adult onset asthma,Gastric carcinoma,Autoimmune disease; Bmi-adjusted hip circumference,Anterior uveitis; Ankylosing spondylitis,Hemoglobin a1 measurement,Eosinophil count; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Response to sulfasalazine; Bmi-adjusted waist-hip ratio; Drug-induced agranulocytosis,Anti-anoctamin 2 antibody measurement,Autism spectrum disorder; Bmi-adjusted hip circumference,Sclerosing cholangitis,Hepatocellular carcinoma,Hiv-1 infection,Beta-2 microglobulin measurement,Autoimmune thyroid disease,Female reproductive system disease,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Conotruncal heart malformations; Bmi-adjusted waist-hip ratio,Heel bone mineral density,Serum iga measurement,Uveitis,Hiv-1 infection; Mhc class i polypeptide-related sequence a measurement; Susceptibility to common cold measurement; Mean platelet volume,Body height; Bmi-adjusted hip circumference; Basophil percentage of leukocytes,Platelet component distribution width; Eosinophil percentage of leukocytes,Temporal arteritis; Blood protein measurement,Platelet count; Atopic asthma,Platelet-to-lymphocyte ratio; Bmi-adjusted hip circumference,Cervical intraepithelial neoplasia grade 2/3; Mhc class i polypeptide-related sequence a measurement; Bmi-adjusted hip circumference; Cervical carcinoma,Mosquito bite reaction size measurement; Aspirin use measurement; Calcium channel blocker use measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Body weight,Response to antineoplastic agent,Bmi-adjusted hip circumference; Neutrophil count; Lymphocyte count,Bmi-adjusted waist-hip ratio; Red blood cell distribution width,Blood protein measurement; Trefoil factor 3 measurement,Mhc class i polypeptide-related sequence a measurement; Hemoglobin measurement,Platelet-derived growth factor bb measurement,Platelet aggregation; Prostate carcinoma,Uterine fibroid; Bmi-adjusted waist-hip ratio,Red blood cell distribution width,Keratinocyte carcinoma; Squamous cell carcinoma,Apolipoprotein b measurement,Intelligence,Mhc class i polypeptide-related sequence a measurement; Blood protein measurement,Body height; Stromal cell-derived factor 1 alpha measurement,Susceptibility to mononucleosis measurement,Hiv-1 infection; Aids; Psoriasis; Drug-induced liver injury,Renal system measurement,Myositis,Polymyositis; Physical activity measurement; Bmi-adjusted waist-hip ratio; Myositis,Eosinophil count; Platelet count,Cytokine measurement; Herpes zoster,Thyroid peroxidase antibody measurement,Squamous cell lung carcinoma; Mmr-related febrile seizures; Bmi-adjusted waist circumference; Lung carcinoma; Eosinophil count,Glucose measurement,Bmi-adjusted hip circumference; Mhc class i polypeptide-related sequence b measurement; Bmi-adjusted waist-hip ratio,Upper aerodigestive tract neoplasm; Bmi-adjusted hip circumference; Anilide use measurement; Lung carcinoma; Body weight,Visual perception measurement,Carpal tunnel syndrome,Herpes zoster,Thyrotoxic periodic paralysis,Susceptibility to cold sores measurement; Eosinophil percentage of leukocytes,Neonatal systemic lupus erythematosus; Myositis; Metabolic syndrome,Hodgkins lymphoma,Lymphocyte count; Basophil count; Myositis; Leukocyte count; Monocyte count,Serum alanine aminotransferase measurement,Bmi-adjusted waist-hip ratio; Mhc class i polypeptide-related sequence b measurement,Angina pectoris,Clinical treatment,Beta blocking agent use measurement,Blood protein measurement; Susceptibility to mumps measurement,Anti-tetanus toxoid igg measurement; Response to vaccine; Malaria,Arterial stiffness measurement,Bmi-adjusted waist circumference; Autism spectrum disorder; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Mhc class i polypeptide-related sequence b measurement,Alcohol use disorder measurement,Testosterone measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Mathematical ability,Lobe attachment; Lymphocyte count,Atopic eczema; Susceptibility to strep throat measurement,Comparative body size at age 10, self-reported,Response to thioamide; Drug-induced agranulocytosis,Surfactant protein d measurement; Chronic obstructive pulmonary disease,Mean platelet volume; Neutrophil count; Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Basophil count; Leukocyte count; Platelet count; Monocyte count; Eosinophil count; Mean corpuscular volume; Erythrocyte count,Toxic epidermal necrolysis; Response to reverse transcriptase inhibitor; Stevens-johnson syndrome,Triglyceride measurement; C-reactive protein measurement,Response to rhododendrol; Vitiligo,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Eczema; Allergic rhinitis,Ovarian serous carcinoma; Squamous cell lung carcinoma; Colorectal cancer; Breast carcinoma; Ovarian endometrioid carcinoma; Ovarian carcinoma; Lung carcinoma; Lung adenocarcinoma; Prostate carcinoma; Estrogen-receptor negative breast cancer,Cervical intraepithelial neoplasia grade 2/3; Cervical carcinoma,Response to anti-thyroid drug; Drug-induced agranulocytosis,Hypersensitivity reaction disease; Response to reverse transcriptase inhibitor,Response to drug; Drug-induced agranulocytosis,Human papilloma virus infection; Oropharynx cancer,Puberty; Height growth measurement,Parental genotype effect measurement; Birth weight,Body mass index; Visceral adipose tissue measurement,Toxic epidermal necrolysis; Stevens-johnson syndrome,Prion disease; Psychotic symptoms,Response to bezlotoxumab; Clostridium difficile infection,Colorectal cancer; Colorectal adenoma,Hiv-1 infection; Crohn's disease; Inflammatory bowel disease,Handedness,Lupus nephritis; Blood protein measurement,Leukocyte count; Lymphocyte count,Glucose metabolism decline measurement; Cingulate cortex measurement,Igg galactosylation measurement,Mean platelet volume; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Reticulocyte count; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference; Human herpesvirus 6 seropositivity; Neutrophil count; Bmi-adjusted waist-hip ratio,Lymphocyte count; Neutrophil count; Bmi-adjusted waist circumference; Neutrophil percentage of leukocytes; Bmi-adjusted waist-hip ratio; Platelet-to-lymphocyte ratio,Autism spectrum disorder; Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Angiopoietin-1 receptor measurement; Platelet count; Platelet crit,Bmi-adjusted hip circumference; Basophil count,Drug-induced agranulocytosis; Response to clozapine,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Basal cell carcinoma,Low density lipoprotein cholesterol measurement,Apolipoprotein a 1 measurement,Age at onset,Susceptibility to pneumonia measurement,Bmi-adjusted waist circumference; Hypertension; Bmi-adjusted waist-hip ratio,-	HLA-B
ENSG00000271869	DCTN6-DT	1.92247445846314	0.0406159460560873	MSU_vs_LPS	HSALNG0064342	anti_sense	Not conserved			MBOAT4
ENSG00000256508	MRGPRF-AS1	3.39298615640098	0.0411157245706412	MSU_vs_LPS	HSALNG0085291	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-877-3p,hsa-miR-4505,hsa-miR-4710,hsa-miR-6735-3p,hsa-miR-6792-5p,hsa-miR-6803-5p,hsa-miR-6808-5p,hsa-miR-7108-3p	Reticulocyte count,Hair colour measurement,Mosquito bite reaction size measurement,-	TPCN2
ENSG00000249740	OSMR-DT	-3.62439184047326	0.041463593708939	MSU_vs_LPS	HSALNG0041294	anti_sense	Not conserved	hsa-miR-6873-3p	Waist-hip ratio; Bmi-adjusted waist-hip ratio,Gut microbiome measurement,Bmi-adjusted waist circumference,Reticulocyte count,Hemoglobin measurement,Colorectal adenoma,Retinal vasculature measurement,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Response to selective serotonin reuptake inhibitor,Hematocrit; Hemoglobin measurement; Erythrocyte count,Hematocrit,Erythrocyte count,Heart rate variability measurement; Response to antipsychotic drug,-	LIFR
ENSG00000254837	LIPT2-AS1	2.62698978801199	0.0417742101792128	MSU_vs_LPS	HSALNG0143021	sense	Not conserved			POLD3
ENSG00000241544	LINC02029	2.47444743088465	0.0417859082962839	MSU_vs_LPS	HSALNG0030091	integenic	Q50	hsa-miR-6793-3p,hsa-miR-6799-5p	Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Pr interval,Bmi-adjusted waist circumference,Mental or behavioural disorder,Electrocardiography,Coronary artery disease,Bmi-adjusted waist circumference; Testosterone measurement,-	LEKR1
ENSG00000288758	ENSG00000288758	4.05402891210169	0.0420241546413313	MSU_vs_LPS	HSALNG0148706	anti_sense	Not conserved			HSPA4
ENSG00000248734	ENSG00000248734	2.08898092039748	0.0421196461939989	MSU_vs_LPS	HSALNG0043658	anti_sense,sense	Q75		Psoriasis; Psoriasis vulgaris,Protein measurement; Anterior uveitis,Protein measurement,Systolic blood pressure,Agents acting on the renin-angiotensin system use measurement,Platelet count; Platelet crit,Calcium channel blocker use measurement,Behcet's syndrome; Blood protein measurement; Endoplasmic reticulum aminopeptidase 1 measurement,Protein measurement; Psoriasis; Diastolic blood pressure,-	CAST
ENSG00000177788	RAB4A-AS1	3.0305216178914	0.0429932299611576	MSU_vs_LPS	HSALNG0011302	anti_sense	Not conserved	hsa-miR-188-3p,hsa-miR-4281,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-4733-3p,hsa-miR-2467-3p,hsa-miR-8485	Response to antidepressant,Mean arterial pressure; Alcohol drinking,Parental genotype effect measurement; Food allergy measurement,-	CCSAP
ENSG00000288586	ENSG00000288586	3.8330790128694	0.0431412741883254	MSU_vs_LPS	HSALNG0070925	integenic	Q75	hsa-miR-4505	-	CD72
ENSG00000289241	ENSG00000289241	3.96159500139698	0.0440819790156073	MSU_vs_LPS	HSALNG0148115	integenic	Not conserved	hsa-miR-8485		MTHFD2L
ENSG00000203804	ADAMTSL4-AS1	-1.52247868433135	0.0443779286422097	MSU_vs_LPS	HSALNG0007053	anti_sense,sense	Q50	hsa-miR-30b-3p,hsa-miR-3196,hsa-miR-4508,hsa-miR-7160-3p	Aspartate aminotransferase measurement,Pulse pressure measurement,Eosinophil count; Eosinophil percentage of leukocytes,Basophil count,Total blood protein measurement; Neutrophil percentage of leukocytes; Blood protein measurement,Oral ulcer,Coronary artery disease,-	MCL1
ENSG00000176868	ENSG00000176868	4.29121007905639	0.0448053800254321	MSU_vs_LPS	HSALNG0074873	anti_sense	Q75		-	UCK1
ENSG00000259905	PWRN1	3.49937860739512	0.0449508027583907	MSU_vs_LPS	HSALNG0104539	integenic	Not conserved			NPAP1
ENSG00000255240	ENSG00000255240	3.62413941268052	0.0450275628375651	MSU_vs_LPS	HSALNG0084381	anti_sense	Not conserved	hsa-miR-4492,hsa-miR-8485	Body height,Mathematical ability,Sex hormone-binding globulin measurement,-	GLYATL2
ENSG00000226519	LINC00390	4.14067568156734	0.0451055174090494	MSU_vs_LPS	HSALNG0096736	intronic_sense	Not conserved		-	SMIM2
ENSG00000272918	ENSG00000272918	2.9460806202863	0.0451083069785469	MSU_vs_LPS	HSALNG0060298	anti_sense	Q75		Autism spectrum disorder,-	SRPK2
ENSG00000215417	MIR17HG	1.67088793858724	0.0451487700296963	MSU_vs_LPS	HSALNG0098601	integenic	Q90	hsa-miR-1224-3p,hsa-miR-3960	Monocyte count,Monocyte percentage of leukocytes,Red blood cell distribution width,Body height,Body height; Bmi-adjusted hip circumference,Self reported educational attainment; Intelligence; Cognitive function measurement,Blood protein measurement,Bmi-adjusted waist circumference; Body height,Bmi-adjusted hip circumference,Self reported educational attainment; Intelligence,Mathematical ability,Self reported educational attainment,-	GPC5
ENSG00000229484	LINC02766	3.56948610291431	0.0452143717195488	MSU_vs_LPS	HSALNG0000944	integenic	Not conserved		-	VPS13D
ENSG00000223834	ENSG00000223834	4.01713531231489	0.0452662373502798	MSU_vs_LPS	HSALNG0077094	integenic	Q50		-	ZEB1
ENSG00000248275	TRIM52-AS1	1.34225117897084	0.0452662373502798	MSU_vs_LPS	HSALNG0047244	anti_sense	Q50	hsa-miR-596,hsa-miR-619-5p,hsa-miR-4486,hsa-miR-4710,hsa-miR-5004-5p,hsa-miR-6085,hsa-miR-6129	-	TRIM41
ENSG00000175147	TMEM51-AS1	1.17875806431129	0.0454011908451768	MSU_vs_LPS	HSALNG0001056	anti_sense	Q50	hsa-miR-25-5p,hsa-miR-1203,hsa-miR-4492,hsa-miR-2467-3p	-	CASP9
ENSG00000265907	ENSG00000265907	2.76346006152879	0.045482682375465	MSU_vs_LPS	HSALNG0119666	anti_sense	Q50		-	EMILIN2
ENSG00000291003	ENSG00000291003	1.04689991220367	0.045482682375465	MSU_vs_LPS	HSALNG0104483	integenic	Not conserved			GOLGA6L22
ENSG00000253227	ENSG00000253227	1.71273749829334	0.0455314193267567	MSU_vs_LPS	HSALNG0068255	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-1285-5p		FER1L6
ENSG00000258168	ENSG00000258168	3.84178951540721	0.0456676595325896	MSU_vs_LPS	HSALNG0092318	anti_sense	Q50	hsa-miR-4312,hsa-miR-4455,hsa-miR-5787	Leukocyte count,Hiv-1 infection; Peripheral neuropathy; Response to reverse transcriptase inhibitor,-	KCNMB4
ENSG00000265206	MIR142HG	-1.1563564128739	0.0457806642437756	MSU_vs_LPS	HSALNG0117712	integenic	Q75	hsa-miR-4313,hsa-miR-4722-5p,hsa-miR-6780a-3p	Platelet crit; Late-onset alzheimers disease; Platelet count; Monocyte count; Family history of alzheimer’s disease,Leukocyte count,-	TSPOAP1
ENSG00000272384	ENSG00000272384	4.0208723156626	0.0458439140332802	MSU_vs_LPS	HSALNG0068166	integenic	Q50	hsa-miR-185-3p,hsa-miR-4258,hsa-miR-6763-3p	-	DERL1
ENSG00000247092	SNHG10	1.2868568498388	0.0458576475897066	MSU_vs_LPS	HSALNG0103440	anti_sense	Q50	hsa-miR-6089,hsa-miR-6779-5p,hsa-miR-6780a-3p	Corneal endothelial cell measurement,Erythrocyte count,-	SYNE3
ENSG00000247317	LY6E-DT	-4.19084690212832	0.0459732958215873	MSU_vs_LPS	HSALNG0069213	anti_sense	Not conserved	hsa-miR-6132,hsa-miR-6779-5p,hsa-miR-6784-5p,hsa-miR-6869-3p,hsa-miR-8485	-	LY6S
ENSG00000288156	ENSG00000288156	2.7491862681372	0.0461374317132342	MSU_vs_LPS	HSALNG0123151	intronic_sense	Not conserved		-	NA
ENSG00000259005	ENSG00000259005	2.40003574187088	0.0463651502413646	MSU_vs_LPS	HSALNG0102437	sense	Q50	hsa-miR-4312	Intraocular pressure measurement,Upper aerodigestive tract neoplasm,Refractive error,-	NPC2
ENSG00000250126	ENSG00000250126	2.75463063711372	0.0464284883425605	MSU_vs_LPS	HSALNG0037343	integenic	Q75	hsa-miR-6825-5p	Parental longevity,Energy intake,Systemic lupus erythematosus,Sleep duration; Triglyceride measurement,Triglyceride measurement; High density lipoprotein cholesterol measurement,-	PCDH18
ENSG00000237338	FTCD-AS1	3.74359851262886	0.0473612841830574	MSU_vs_LPS	HSALNG0147098	anti_sense	Q90		-	COL6A2
ENSG00000260528	FAM157C	-3.63455520723444	0.0474037559891654	MSU_vs_LPS	HSALNG0113696	integenic	Not conserved	hsa-let-7g-3p	-	GAS8
ENSG00000287863	ENSG00000287863	-4.04785417508388	0.0474905363560958	MSU_vs_LPS	HSALNG0096873	integenic	Q50	hsa-miR-619-5p	-	LRRC63
ENSG00000287644	ENSG00000287644	3.80147560837747	0.0475576685182762	MSU_vs_LPS	HSALNG0145286	anti_sense	Q90	hsa-miR-34b-5p,hsa-miR-4492,hsa-miR-6783-3p	-	GJD3
ENSG00000254102	BHLHE22-AS1	-3.76035293564891	0.0481060601194981	MSU_vs_LPS	HSALNG0065796	anti_sense	Q50		Risk-taking behaviour,Systolic blood pressure,-	CYP7B1
ENSG00000272501	ENSG00000272501	-1.49246354052492	0.048512747550048	MSU_vs_LPS	HSALNG0049245	anti_sense,sense	Q75	hsa-miR-556-3p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-1199-5p,hsa-miR-6803-5p	Membranous glomerulonephritis,Crohn's disease; Toxic epidermal necrolysis; Stevens-johnson syndrome,Hiv-1 infection; Neutrophil count; Basophil count,Body height; Multiple myeloma,Age at diagnosis,Neutrophil count; Bmi-adjusted waist-hip ratio,Cleft lip; Bmi-adjusted waist-hip ratio; Cleft palate,Aging,Psoriatic arthritis,Susceptibility to cold sores measurement,Bmi-adjusted hip circumference,Hemoglobin measurement,Psoriasis,Bmi-adjusted waist-hip ratio,Parental longevity,Von willebrand factor measurement,Lung carcinoma,Tonsillectomy risk measurement,Monocyte count,Monocyte percentage of leukocytes,Mean platelet volume,Reticulocyte measurement,Sneeze,Multiple myeloma,Platelet-to-lymphocyte ratio,Squamous cell lung carcinoma; Peptic ulcer and gastro-oesophageal reflux disease (gord) drug use measurement; Upper aerodigestive tract neoplasm; Susceptibility to pneumonia measurement,Blood protein measurement,Intelligence; Diastolic blood pressure; Susceptibility to mycobacterium tuberculosis infection measurement,Cytokine measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to shingles measurement,Platelet crit; Monocyte count,Lymphocyte count,Bmi-adjusted waist circumference,Serum igg glycosylation measurement,Coronary artery disease,Platelet count,Autism spectrum disorder; Parental longevity,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Autism spectrum disorder,Takayasu arteritis,Serum ige measurement,High density lipoprotein cholesterol measurement,Cancer,Response to vaccine,Susceptibility to plantar warts measurement,Eosinophil count,Sarcoidosis,Basophil count,Reticulocyte count,C-reactive protein measurement,Cervical carcinoma,Platelet-to-lymphocyte ratio; Lymphocyte count; Neutrophil count; Monocyte count,Drugs used in diabetes use measurement,Ulcerative colitis,Bmi-adjusted hip circumference; Basal cell carcinoma,Susceptibility to childhood ear infection measurement,Leukocyte count,Total cholesterol measurement; Low density lipoprotein cholesterol measurement; Platelet count,Eosinophil percentage of leukocytes,Lymphocyte count; Neutrophil count; Bmi-adjusted waist circumference; Basophil count; Bmi-adjusted hip circumference; Leukocyte count; Bmi-adjusted waist-hip ratio; Eosinophil count; Granulocyte count,Chronic hepatitis b virus infection; Hepatitis b virus infection,Chronic hepatitis b virus infection,Serum metabolite measurement,Neutrophil-to-lymphocyte ratio; Lymphocyte percentage of leukocytes,Prostate carcinoma,Viral subtype carrier status,Mean corpuscular volume,Leukocyte count; Myeloid white cell count; Anti-anoctamin 2 antibody measurement; Monocyte count,Mean corpuscular hemoglobin,Waist-hip ratio,Triglyceride measurement; Bmi-adjusted hip circumference,Leukocyte count; Neutrophil count; Lymphocyte count; Myeloid white cell count,Bmi-adjusted waist-hip ratio; Cytokine measurement,Irritable bowel syndrome; Bmi-adjusted waist-hip ratio,Dna methylation,Protein measurement,Lymphocyte count; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Skin pigmentation measurement,Smoking behavior; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Varicose veins,Granulocyte percentage of myeloid white cells,Erythrocyte count,Mean reticulocyte volume,Vitiligo,Monoclonal gammopathy; Multiple myeloma,Mean corpuscular hemoglobin concentration; Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Leukocyte count; Body height,Cd4:cd8 lymphocyte ratio; Cd8-positive t-lymphocyte count,Leprosy,Eczema,Bmi-adjusted waist-hip ratio; Gastric carcinoma,Systemic lupus erythematosus,Granzyme a measurement,Leukocyte count; Reticulocyte count,Neutrophil count,Interleukin 18 measurement,Aids; Psoriasis; Cutaneous psoriasis measurement,Triglyceride measurement; Body height; Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Nasopharyngeal neoplasm,Atopic eczema,Psoriasis; Psoriasis vulgaris,Crohn's disease,Eosinophil count; Basophil count; Eosinophil percentage of leukocytes,Total cholesterol measurement; Low density lipoprotein cholesterol measurement; Body height; Blood protein measurement; Triglyceride measurement,Hypertension,Autoimmune disease,Mean corpuscular volume; Bmi-adjusted waist-hip ratio,Stomach polyp,Sex hormone-binding globulin measurement,Oral ulcer,Major depressive disorder; Major depressive episode,Unipolar depression,Mhc class i polypeptide-related sequence a measurement,Myeloid white cell count,Body weight; Bmi-adjusted hip circumference; Perceived unattractiveness to mosquitos measurement,Body height,Maximum cigarettes per day measurement,Lymphocyte percentage of leukocytes,Myelodysplastic syndrome,Appendicular lean mass,Angiopoietin-1 receptor measurement,Vasodilators used in cardiac diseases use measurement,Intelligence; Unipolar depression,Severe aplastic anemia,Non-melanoma skin carcinoma,Systemic lupus erythematosus; Bmi-adjusted waist-hip ratio,Post-traumatic stress disorder,Triglyceride measurement,Chronic obstructive pulmonary disease; Smoking status measurement,Susceptibility to mycobacterium tuberculosis infection measurement,Alpha-2-macroglobulin receptor-associated protein measurement,Psoriasis vulgaris,Facial morphology measurement,Feeling miserable measurement,Psoriasis; Membranous glomerulonephritis,Response to interferon beta; Mean corpuscular hemoglobin concentration; Human papilloma virus infection; Anti-drug antibody measurement; Hiv-1 infection; Oral cavity cancer; Beta-2 microglobulin measurement,Hiv viral set point measurement,Diffuse large b-cell lymphoma; Visual perception measurement,Immunoglobulin isotype switching measurement; Bmi-adjusted hip circumference; Rheumatic heart disease,Atopic asthma,Apolipoprotein a 1 measurement; Autism spectrum disorder; Feeling nervous measurement,Allergic rhinitis; Nasal cavity polyp; Adult onset asthma,Serum albumin measurement,Angina pectoris; Liver neoplasm,Seasonal allergic rhinitis; Platelet count,Neutrophil count; Basophil count,Bmi-adjusted waist circumference; Platelet-to-lymphocyte ratio; Bmi-adjusted hip circumference,Hypothyroidism; Mean corpuscular hemoglobin; Bmi-adjusted waist-hip ratio,Self reported educational attainment; Metabolic syndrome; Bmi-adjusted hip circumference; Mathematical ability; Triglyceride measurement,Mean reticulocyte volume; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Cannabis use; Bmi-adjusted waist-hip ratio; Age at onset,Cirrhosis of liver,Chronic hepatitis c virus infection,Pneumonia,Cognitive function measurement; Mathematical ability,Iga glomerulonephritis; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Myocardial infarction,17-hydroxyprogesterone measurement,Gastroesophageal reflux disease,Glomerular filtration rate,Keratinocyte carcinoma,Body fat percentage,Proliferative diabetic retinopathy; Skin neoplasm,Frontal fibrosing alopecia,Ankylosing spondylitis,Cx3cl1 measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Bmi-adjusted hip circumference; Monocyte count,Susceptibility to mumps measurement,Susceptibility to chickenpox measurement,Autism spectrum disorder; Small cell lung carcinoma,Mean corpuscular volume; Bmi-adjusted hip circumference; Erythrocyte count,Triglyceride measurement; Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Eosinophil percentage of granulocytes,Susceptibility to strep throat measurement,Mosquito bite reaction itch intensity measurement,Colorectal cancer; Colorectal adenoma; Mean platelet volume,Neutrophil percentage of leukocytes,Albumin:globulin ratio measurement; Serum non-albumin protein measurement,Red blood cell density measurement,Platelet component distribution width,Behcet's syndrome,Mean platelet volume; Bipolar disorder; Eosinophil percentage of leukocytes,Hiv-1 infection; Anxiety measurement,Trichloroethylene-induced hypersensitivity,Marginal zone b-cell lymphoma,Diastolic blood pressure; Systolic blood pressure,Autism spectrum disorder; Bmi-adjusted waist-hip ratio; Atopic asthma,Squamous cell lung carcinoma,Bmi-adjusted hip circumference; White matter integrity; Bmi-adjusted waist-hip ratio,Anterior uveitis,Neutrophil count; Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Basophil count; Bmi-adjusted waist-hip ratio,Tropical spastic paraparesis,Neutrophil-to-lymphocyte ratio; Monocyte count,Eosinophil count; Lymphocyte count; Bmi-adjusted hip circumference,Neutrophil percentage of leukocytes; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Gastroesophageal reflux disease; Bmi-adjusted waist circumference; Oral ulcer; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio; Aspirin use measurement,Oral ulcer; Bmi-adjusted hip circumference; Aspirin use measurement; Calcium channel blocker use measurement; Antithrombotic agent use measurement,Systolic blood pressure,Iritis,Pulse pressure measurement; Systolic blood pressure,Blood protein measurement; Heel bone mineral density,Viral load,Self reported educational attainment; Cognitive function measurement,Mathematical ability,Antithrombotic agent use measurement,Bmi-adjusted waist circumference; Mhc class i polypeptide-related sequence a measurement,Platelet crit,Hematocrit,Sjogren syndrome,Neutrophil percentage of granulocytes,Eosinophil count; Basophil count,Basophil percentage of granulocytes,Body height; Cerebrospinal fluid biomarker measurement,Graves disease; Thyrotoxic periodic paralysis,Body height; Bmi-adjusted hip circumference; Low density lipoprotein cholesterol measurement,Allergic sensitization measurement,Rheumatoid arthritis,Chronic obstructive pulmonary disease; Rosacea severity measurement,Surfactant protein d measurement; Blood protein measurement; Chronic obstructive pulmonary disease; Adult onset asthma,Gastric carcinoma,Autoimmune disease; Bmi-adjusted hip circumference,Anterior uveitis; Ankylosing spondylitis,Hemoglobin a1 measurement,Eosinophil count; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Response to sulfasalazine; Bmi-adjusted waist-hip ratio; Drug-induced agranulocytosis,Anti-anoctamin 2 antibody measurement,Autism spectrum disorder; Bmi-adjusted hip circumference,Sclerosing cholangitis,Hepatocellular carcinoma,Hiv-1 infection,Beta-2 microglobulin measurement,Autoimmune thyroid disease,Female reproductive system disease,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Conotruncal heart malformations; Bmi-adjusted waist-hip ratio,Heel bone mineral density,Serum iga measurement,Uveitis,Hiv-1 infection; Mhc class i polypeptide-related sequence a measurement; Susceptibility to common cold measurement; Mean platelet volume,Body height; Bmi-adjusted hip circumference; Basophil percentage of leukocytes,Platelet component distribution width; Eosinophil percentage of leukocytes,Temporal arteritis; Blood protein measurement,Platelet count; Atopic asthma,Platelet-to-lymphocyte ratio; Bmi-adjusted hip circumference,Cervical intraepithelial neoplasia grade 2/3; Mhc class i polypeptide-related sequence a measurement; Bmi-adjusted hip circumference; Cervical carcinoma,Mosquito bite reaction size measurement; Aspirin use measurement; Calcium channel blocker use measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Body weight,Response to antineoplastic agent,Bmi-adjusted hip circumference; Neutrophil count; Lymphocyte count,Bmi-adjusted waist-hip ratio; Red blood cell distribution width,Blood protein measurement; Trefoil factor 3 measurement,Mhc class i polypeptide-related sequence a measurement; Hemoglobin measurement,Platelet-derived growth factor bb measurement,Platelet aggregation; Prostate carcinoma,Uterine fibroid; Bmi-adjusted waist-hip ratio,Red blood cell distribution width,Keratinocyte carcinoma; Squamous cell carcinoma,Apolipoprotein b measurement,Intelligence,Mhc class i polypeptide-related sequence a measurement; Blood protein measurement,Body height; Stromal cell-derived factor 1 alpha measurement,Susceptibility to mononucleosis measurement,Hiv-1 infection; Aids; Psoriasis; Drug-induced liver injury,Renal system measurement,Myositis,Polymyositis; Physical activity measurement; Bmi-adjusted waist-hip ratio; Myositis,Eosinophil count; Platelet count,Cytokine measurement; Herpes zoster,Thyroid peroxidase antibody measurement,Squamous cell lung carcinoma; Mmr-related febrile seizures; Bmi-adjusted waist circumference; Lung carcinoma; Eosinophil count,Glucose measurement,Bmi-adjusted hip circumference; Mhc class i polypeptide-related sequence b measurement; Bmi-adjusted waist-hip ratio,Upper aerodigestive tract neoplasm; Bmi-adjusted hip circumference; Anilide use measurement; Lung carcinoma; Body weight,Visual perception measurement,Carpal tunnel syndrome,Herpes zoster,Thyrotoxic periodic paralysis,Susceptibility to cold sores measurement; Eosinophil percentage of leukocytes,Neonatal systemic lupus erythematosus; Myositis; Metabolic syndrome,Hodgkins lymphoma,Lymphocyte count; Basophil count; Myositis; Leukocyte count; Monocyte count,Serum alanine aminotransferase measurement,Bmi-adjusted waist-hip ratio; Mhc class i polypeptide-related sequence b measurement,Angina pectoris,Clinical treatment,Beta blocking agent use measurement,Blood protein measurement; Susceptibility to mumps measurement,Anti-tetanus toxoid igg measurement; Response to vaccine; Malaria,Arterial stiffness measurement,Bmi-adjusted waist circumference; Autism spectrum disorder; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Mhc class i polypeptide-related sequence b measurement,Alcohol use disorder measurement,Testosterone measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Mathematical ability,Lobe attachment; Lymphocyte count,Atopic eczema; Susceptibility to strep throat measurement,Comparative body size at age 10, self-reported,Response to thioamide; Drug-induced agranulocytosis,Surfactant protein d measurement; Chronic obstructive pulmonary disease,Mean platelet volume; Neutrophil count; Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Basophil count; Leukocyte count; Platelet count; Monocyte count; Eosinophil count; Mean corpuscular volume; Erythrocyte count,Toxic epidermal necrolysis; Response to reverse transcriptase inhibitor; Stevens-johnson syndrome,Triglyceride measurement; C-reactive protein measurement,Response to rhododendrol; Vitiligo,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Eczema; Allergic rhinitis,Ovarian serous carcinoma; Squamous cell lung carcinoma; Colorectal cancer; Breast carcinoma; Ovarian endometrioid carcinoma; Ovarian carcinoma; Lung carcinoma; Lung adenocarcinoma; Prostate carcinoma; Estrogen-receptor negative breast cancer,Cervical intraepithelial neoplasia grade 2/3; Cervical carcinoma,Response to anti-thyroid drug; Drug-induced agranulocytosis,Hypersensitivity reaction disease; Response to reverse transcriptase inhibitor,Response to drug; Drug-induced agranulocytosis,Human papilloma virus infection; Oropharynx cancer,Puberty; Height growth measurement,Parental genotype effect measurement; Birth weight,Body mass index; Visceral adipose tissue measurement,Toxic epidermal necrolysis; Stevens-johnson syndrome,Prion disease; Psychotic symptoms,Response to bezlotoxumab; Clostridium difficile infection,Colorectal cancer; Colorectal adenoma,Hiv-1 infection; Crohn's disease; Inflammatory bowel disease,Handedness,Lupus nephritis; Blood protein measurement,Leukocyte count; Lymphocyte count,Glucose metabolism decline measurement; Cingulate cortex measurement,Igg galactosylation measurement,Mean platelet volume; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Reticulocyte count; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference; Human herpesvirus 6 seropositivity; Neutrophil count; Bmi-adjusted waist-hip ratio,Lymphocyte count; Neutrophil count; Bmi-adjusted waist circumference; Neutrophil percentage of leukocytes; Bmi-adjusted waist-hip ratio; Platelet-to-lymphocyte ratio,Autism spectrum disorder; Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Angiopoietin-1 receptor measurement; Platelet count; Platelet crit,Bmi-adjusted hip circumference; Basophil count,Drug-induced agranulocytosis; Response to clozapine,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Basal cell carcinoma,Low density lipoprotein cholesterol measurement,Apolipoprotein a 1 measurement,Age at onset,Susceptibility to pneumonia measurement,Bmi-adjusted waist circumference; Hypertension; Bmi-adjusted waist-hip ratio,-	POU5F1
ENSG00000289003	ENSG00000289003	2.27560186571857	0.0485397942684539	MSU_vs_LPS	HSALNG0014372	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-4447,hsa-miR-6089,hsa-miR-8485	Hematocrit; Hemoglobin measurement,Hematocrit; Erythrocyte count,Hematocrit,Hemoglobin measurement,Red blood cell density measurement,Response to candesartan,-	TMEM178A
ENSG00000289845	ENSG00000289845	4.35788136225808	0.0485634393521961	MSU_vs_LPS	NA	NA	NA	NA	NA	FAM187B
ENSG00000278022	ENSG00000278022	3.64913217955834	0.0488331309578924	MSU_vs_LPS	HSALNG0108509	sense	Q50			IGF1R
ENSG00000264269	DYM-AS1	-2.73433645212903	0.0489323520810427	MSU_vs_LPS	HSALNG0121468	anti_sense	Q50	hsa-miR-7107-5p,hsa-miR-7703	Apolipoprotein a 1 measurement,Bmi-adjusted hip circumference,Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement; Total cholesterol measurement,Waist-hip ratio,-	CTIF
ENSG00000227398	KIF9-AS1	2.34030032026024	0.0491375243498835	MSU_vs_LPS	HSALNG0025756	integenic	Not conserved	hsa-miR-4259,hsa-miR-6089,hsa-miR-8485		KLHL18
